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ABSTRACT 
Lipopolysaccharide (LPS) and the inflammation associated with its stimulation of the 
innate immune responses can have major implications for human and animal health and 
production. This dissertation research goal was to further understand dietary modulation of 
intestinal LPS permeability and LPS associated inflammation. Additionally, we sort to 
examine LPS detoxification and the relationship LPS has with swine health and feed 
efficiency.  
High caloric and high dietary fat increases the risk of endotoxemia which can result in 
a low grade inflammation, a predisposing factor for common metabolic diseases such as 
Type II diabetes and atherosclerosis. However, little is known about the effect of dietary oil 
fatty acid composition on intestinal LPS permeability and postprandial endotoxemia. 
Therefore, we examined whether dietary oil composition differentially modulated intestinal 
LPS permeability and postprandial endotoxemia. Our in vivo and ex vivo research using pigs 
and isolated pig intestinal tissues indicated that a single administration of oils rich in long 
chain n-3 polyunsaturated fatty acids (PUFA), such as fish oil and cod liver oil, decreases 
LPS permeability and postprandial circulating LPS levels (P<0.05). Furthermore, oils rich in 
saturated fatty acids, such as coconut oil, augmented LPS permeability and postprandial 
endotoxemia (P<0.05). Mechanistically, this may be associated with the structure and 
function of cell membrane lipid raft microdomain structures.  
Dietary long chain n-3 PUFA such as eicosapentaenoic acid (EPA) and 
docoasahexaenoic acid (DHA) have been shown to antagonize LPS signaling. Therefore, we 
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examined the ability of dietary EPA and DHA to attenuate intestinal LPS permeability and 
lipid raft localization of key LPS signaling proteins. Long term dietary EPA and DHA 
supplementation to pigs enriched intestinal epithelial membrane with EPA and DHA 
(P<0.05).  Phospholipid fatty acid composition of the lipid raft fractions also revealed 
enrichment of phosphatidyl ethanolamine and phosphatidyl serine with EPA and DHA. 
Mechanistically, membrane EPA and DHA enrichment decreased localization of LPS 
signaling proteins, TLR4 and CD14, into ileum and colon lipid raft microdomains. 
Collectively, this decreased ex vivo LPS permeability and circulating LPS concentrations 
(P<0.05). Interestingly, an acute systemic inflammatory challenge resulted in a decreased 
localization of TLR4 and CD14 into lipid rafts, which has the potential to desensitize the pigs 
to a subsequent immune challenge otherwise known as LPS tolerance.  
The ability of the maternal diet and prenatal nutrition to impact postnatal growth, 
development and health has received much attention in recent years. Knowing that DHA and 
EPA can regulate the innate immune response to an LPS challenge, we wanted to study if 
maternal n-3 PUFA supplementation of n-3 PUFA could modulate an acute inflammatory 
challenge in the offspring later in life. Sows and piglets received nutrition devoid or enriched 
with EPA and DHA during gestation and lactation or throughout life from gestation to ten 
weeks of age. The offspring was then challenged with LPS or saline to initiate an 
inflammatory response and buffy coats isolated 4 h post challenge. Interestingly, maternal n-
3 PUFA supplementation attenuated the LPS induced inflammatory response in the offspring 
late in the nursery phase of growth (P<0.05). This was comparable to that of continuous n-3 
PUFA supplementation. Both treatment groups exposed to DHA and EPA had a decreased 
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febrile and serum TNF-α cytokine response to LPS, buffy coat mRNA abundance of TNF-α, 
IL-1β and IL-10 and the mRNA abundance of the LPS signaling proteins, TLR4, CD14 and 
Myd88, compared to control group (P<0.05).   
Lastly, we used pig lines divergently selected for residual feed intake (RFI, with low 
RFI being more efficient compared to high RFI) to understand the relationship between 
intestinal barrier integrity, LPS and associated inflammation with pig feed efficiency. Our 
research indicates that HRFI pigs seem to be undergoing a greater level of basal 
inflammation contrary to pigs selected for LRFI. The LRFI pigs had a lower circulating 
endotoxin concentration, more robust intestinal and liver LPS detoxification and higher 
active anti-microbial enzymes including alkaline phosphatase and lysozyme (P<0.05). 
Furthermore, LRFI pigs had a reduced activity of the inflammatory biomarker enzyme 
myeloperoxidase (P<0.05). Altogether, LPS and low grade inflammation may partially 
explain the divergence in feed efficiency and RFI in grow-finisher pigs.  
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CHAPTER 1.  GENERAL INTRODUCTION 
Introduction 
Gram negative bacteria such as Salmonella and Escherichia contain 
lipopolysaccharide (LPS) in their cell wall outer membrane which is a potential stimulator of 
the innate immune system of humans and livestock species. Over the recent years, LPS has 
received much attention due to its ability to stimulate a low grade inflammation. 
Lipopolysaccharide is a glycolipid composed of a hydrophobic domain lipid A through 
which it is attached to the outer membrane of the cell wall, a core and distal oligosaccharide 
and two phosphate molecules. Even though the terms LPS and endotoxin are interchangeably 
used in the literature, there are biochemical and molecular differences between these two 
compounds. To reflect our original experimental nature we will be using lipopolysaccharide 
more commonly throughout this dissertation. Lipopolysaccharide recognition and the 
associated inflammation have been widely studied.   It is first recognized by the innate 
immune system, which is usually non-specific towards the foreign molecules. The innate 
immune system depends on pattern recognition receptors (PRR) which recognize specific 
patterns of molecular structures present in the microbes. Lipopolysaccharide is recognized by 
Toll-like receptor 4 (TLR4), present on the cell membrane of immune cells, adipocytes, 
myocytes, and epithelial cells (Abreu, 2010; Beutler, 2004; Gabler et al., 2008; Lenardo and 
Baltimore, 1989). After recognition, the host cells initiate an inflammatory response via the 
activation of the master transcription factor, nuclear factor- κB (NF-κB). The resulting 
increase in pro-inflammatory cytokines helps in recruiting other immune cells, inducing 
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febrile response to remove the foreign agent, and communicating with the adaptive immune 
system (McGettrick and O’Neill, 2010).  
Gram-negative bacteria are present ubiquitously in the environment and also in the 
respiratory and gastrointestinal tract. Thus, most mammals are constantly exposed to LPS. In 
humans, low grade endotoxemia induced by persistent presence of LPS in the blood has been 
shown to be a predisposing factor for the development of metabolic diseases including Type 
II diabetes, obesity, and atherosclerosis (Delzenne and Cani, 2011; Vaarala et al., 2008). 
Moreover, high fat, high caloric diet or high carbohydrate diets have been shown to increase 
the serum lipopolysaccharide levels (Erridge et al., 2007; Ghanim et al., 2009). In production 
animals such as pigs, LPS exposure antagonizes appetite, digestion, and skeletal muscle 
protein synthesis that ultimately leads to diversion of nutrients and energy away from 
important production orientated pathways and systems (skeletal muscle, reproductive tract 
etc…) to support the immune system (Johnson, 1997). Although this is important for immune 
system function and health of the animal, long term exposure to LPS and subsequent 
activation of immune system and the development of metabolic syndrome affects growth and 
production efficiencies.   
Considering the significance of LPS and its effect on human and animal health and 
metabolism, little is known or studied on the pathways through which LPS enters circulation 
via the intestinal tract and also its detoxification.  This is surprising considering the 
gastrointestinal tract is a major source of gram negative bacteria and LPS. The mode of LPS 
permeability across the intestinal epithelium and into systemic circulation may be through a 
transcellular route or paracellular route between two epithelial cells through tight junctions. 
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Additionally, micelle facilitated LPS permeability also happens when the dietary fat 
digestion occurs in the intestine (Kelly et al., 2012; Tomlinson and Blikslager, 2004).  
Therefore, the overall goal of this dissertation research presented herein is to further 
understand and characterize intestinal LPS permeability and LPS signaling. Furthermore, this 
new knowledge gained could be used to develop dietary, genetic, or pharmacological 
mitigation strategies to promote health, growth, and metabolic efficiencies in humans and 
livestock. To address this goal, the specific objectives of this dissertation were: 
1. To evaluate the composition of dietary fat to differentially modulate intestinal LPS 
permeability and postprandial endotoxemia.  
2. To identify whether dietary n-3 PUFA alter intestinal membrane composition and 
function resulting in attenuated LPS permeability. 
3. To examine whether maternal exposure to dietary n-3 PUFA would attenuate the febrile 
response and inflammatory response to an exogenous LPS challenge later in the life.  
4. To evaluate the contribution of intestinal endogenous LPS and its associated uptake and 
detoxification to feed efficiency using pigs divergently selected for residual feed intake.  
 
Dissertation organization 
Based on the work to achieve the objectives of this dissertation, five manuscripts 
were written for submission. Each of the manuscript is presented as a separate chapter in the 
format prepared for the journal we submitted then for publication.  A review of literature as 
background for this research is outlined in Chapter 2. This chapter has, in part, been 
published in the Journal of animal science as a symposium review paper pertaining to LPS, 
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gastrointestinal tract LPS permeability and LPS associated inflammation and detoxification. 
In Chapter 3, the effect of dietary oil composition on intestinal LPS permeability and 
postprandial endotoxemia was studied. This article was submitted to Nutrition & Metabolism 
journal and is under review. Chapter 4 examines the effects of dietary n-3 PUFA 
eicosapentaenoic acid and docosahexaenoic acid supplementation on intestinal epithelial cell 
membrane composition and lipid raft associated LPS permeability in pigs. This research will 
be submitted to the Journal of Lipid Research for review and publication.  The evaluation of 
maternal n-3 PUFA supplementation on LPS induced febrile response and inflammation is 
presented in Chapter 5. This research will be submitted to the Journal of Nutrition. The final 
research chapter uses pigs divergently selected for feed efficiency to examine the role of 
endogenous LPS on finisher pig growth and performance (Chapter 6). This research is 
submitted to the Journal of Animal Science and is under review. The final chapter (#7) 
includes general conclusions and an overall discussion of the research. 
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CHAPTER 2. REVIEW OF LITERATURE: LIPOPOLYSACCHARIDE, 
INFLAMMATION AND INTESTINAL FUNCTION1 
 
V. Mani*,† 
 
*Department of Animal Science, Iowa State University, Ames 50011; 
†Interdepartmental Toxicology Graduate Program, Iowa State University, Ames 50011  
 
Abstract:  Lipopolysaccahride (LPS) often referred to as endotoxin, can stimulate localized 
or systemic inflammation via the activation of pattern recognition receptors. Additionally, 
LPS and associated inflammation can regulate intestinal epithelial function by altering 
epithelial barrier integrity as well as nutrient transport and utilization. The gastrointestinal 
tract is a large reservoir of both Gram positive and negative bacteria, of which the Gram 
negative bacteria serve as a source of LPS. Luminal LPS can enter circulation via three major 
routes: 1) nonspecific paracellular permeation through epithelial cell tight junctions and 2) 
transcellular permeation through lipid raft membrane domains involving receptor mediated 
                                                 
  1 Based on a presentation at the Growth and Development Symposium titled 
“Understanding and Mitigating the Impacts of Inflammation on Animal Growth and 
Development” at the Joint Annual  animal science meeting, July 10-14, New Orleans, LA”. 
A modified version of this Chapter was published in the Journal of Animal Science 90: 
1452-65 (2012). 
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endocytosis, 3) through micellar assisted permeation while fat is consumed through diet.  
Paracellular permeability of LPS occurs through dissociation of tight junction protein 
complexes resulting in reduced intestinal barrier integrity, which can be a result of enteric 
disease, inflammation, or environmental and metabolic stress. Transcellular permeability, via 
specialized membrane regions rich in glycolipids, sphingolipids, cholesterol, and saturated 
fatty acids, is a result of raft recruitment of LPS-related signaling proteins leading to 
signaling and endocytosis. All permeability routes and sensitivity to LPS may be altered by 
diet, environmental and metabolic stresses. Intestinal derived LPS and inflammation result in 
suppressed appetite, activation of the immune system, and partitioning of energy and 
nutrients away from growth towards supporting the immune system requirements. In 
livestock, this leads to the suppression of growth, particularly, suppression of lean tissue 
accretion. In this chapter, we summarize the evidence that intestinal permeability of LPS and 
the subsequent inflammation leads to decrease in the production performance of agricultural 
animals, and we present an overview about LPS detoxification mechanisms in livestock. 
Key words:  Lipopolysaccharide, Endotoxin, Intestine, Inflammation 
 
Introduction 
Growth performance of agricultural animals in commercial settings and human health 
is affected by various physical, social, and microbial factors that may predispose animals to 
physiological or immunological stresses (Holck et al., 1998). Among the stressors that can 
attenuate the growth performance and alter metabolism are viruses, live bacteria, and dead 
bacteria that contain cell wall compounds such as lipopolysaccharide (LPS) and 
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peptidoglycans (Schinckel et al., 1995; Smith, 1998). Additionally, recent biomedical 
evidence suggests that low grade inflammation caused by intestinal derived LPS is linked to 
metabolic diseases like Type II diabetes, atherosclerosis and cardiovascular diseases (Cani 
and Delzenne, 2010). Importantly, the mucosal epithelium of the gastrointestinal tract serves 
as a major barrier to the LPS whereas the bacteria present in the intestinal lumen acts as a 
major source of LPS (Ravin et al., 1960; Schweinburg and Fine, 1960; Wiznitzer et al., 
1960). Specific to the focus of this review, we will discuss LPS, otherwise referred to as 
endotoxin in the literature, the cell wall component of Gram negative bacteria which is a 
potent immune stimulator in the context of livestock production and human health. 
Lipopolysaccharide in mammals is recognized by various cells expressing the pattern 
recognition receptor, Toll-like receptor (TLR)4, and other proteins including LPS binding 
protein (LBP), cluster of differentiation 14 (CD14), and MD-2. These proteins and receptors 
are also shown to be present in intestinal epithelial cells and have been associated with the 
permeability of luminal LPS into circulation (Hornef et al., 2003; Neal et al., 2006). Once in 
the systemic circulation, LPS can be deactivated or detoxified by immune cells, such as 
macrophages, Kupffer cells present in the liver or splenic cells, or by binding with plasma 
proteins (Buttenschoen et al., 2010; Rutenburg et al., 1967; Satoh et al., 2008). However, if 
there is failure of systemic detection and deactivation because there is more permeability of 
LPS from the intestinal tract the resulting increased circulating LPS can lead to systemic 
inflammation which can lead to endotoxemia, multi organ failure and even death (Rice et al., 
2003; Zweifach and Janoff, 1965). The importance of LPS to livestock production is that 
chronic activation of the immune system has been shown to antagonize the growth and 
performance of animals, as nutrients are being partitioned towards production of cytokines, 
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acute phase proteins, and other immune modulators rather than towards the anabolic 
processes that support milk and muscle synthesis (Johnson, 1997; Spurlock, 1997). Further, 
LPS can lead to various diseases including laminitis in equines and also endotoxemia is the 
leading cause of death in equine species (Sykes BW, 2005; Werners et al., 2005). 
Lipopolysaccharide has also been shown to activate the heterophils and up-regulate the pro-
inflammatory cytokine and chemokine expression in poultry (Kogut et al., 2005). In human 
health, presence of LPS in the circulation have been shown to contribute to the development 
of chronic inflammatory processes which eventually promote the development of 
dysregulated metabolism which results in many metabolic diseases like type II diabetes and 
non-alcoholic fatty liver disease through the stimulation of TLR4 (Erridge, 2011).  
Interestingly, permeability of LPS from the intestine has been shown to be modulated 
by dietary factors, as well as by stressors including heat stress, systemic disease, and also by 
feed restriction or malnutrition (Cani and Delzenne, 2010; Hall et al., 2001). The major 
dietary factor that appears to modulate the permeability of luminal LPS is dietary fat. As 
indicated in the biomedical and human health literature, as the percentage of dietary fat 
increases, so does the concentration of circulating LPS (Amar et al., 2008; Erridge et al., 
2007). Further, the form of the lipid ingested may modulate the LPS permeability with 
emulsified lipids increasing LPS permeability (Laugerette et al., 2011). In ruminants, feeding 
easily-digestible carbohydrates and grains have been shown to increase the permeability of 
LPS to the peripheral circulation, indicating that carbohydrates could also influence LPS 
permeability (Khafipour et al., 2009; Zebeli et al., 2011). In addition to dietary nutrients, 
systemic increases in intestinal-derived LPS can also be attributed to environmental and 
immunological stressors. Hyperthermia increases intestinal permeability and, presumably, 
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intestinal LPS permeability too (Lambert, 2004, 2008; Pearce et al., 2011).  Plasma 
antibodies to LPS are inversely related to growth in malnourished young children and are 
associated with increased intestinal permeability and systemic immune system activation 
(Campbell et al., 2003). Further studies are warranted to investigate the relationship between 
LPS, growth, and metabolic changes. 
 
Lipopolysaccharide 
Lipopolysaccharide is a glycolipid present in the outer membrane of Gram negative 
bacterial cell wall. It consists of a hydrophobic domain, lipid A, through which it is inserted 
into the outer leaflet of the outer membrane of the bacterial cell wall, a core oligosaccharide 
and a distal oligosaccharide (Elin and Wolff, 1976; Raetz and Whitfield, 2002a). The 
hydrophobic lipid A domain is the most biologically active portion of the LPS molecule and 
it is synonymously known as ‘endotoxin’ because of its ability to stimulate the innate 
immune cells (Erridge et al., 2002). In a wild type Escherichia coli, lipid A contains the 
following structural properties: 1) the backbone of the lipid A contains di-glucosamine, 
which is phosphorylated at positions 1 and 4'; 2) two 3-hydroxymyristate molecules are 
directly attached to each glucosamine, and 3) at positions 2' and 3', the hydroxyl groups of 
the fatty acids are substituted by laurate and myristate, and they form an acyloxyacyl bond 
with the primary fatty acid chains (Figure 1). Diphosphorylated hexaacyl lipid A molecules 
have been shown to be effective stimulators of the immune system because they have been 
optimally recognized by the mammalian immune system. Mono-phosphorylated or 
dephosphorylated LPS molecules have been shown to substantially lose their potency and 
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immune reactivity (Holst et al., 1996; Munford, 2005). However, monophosphorylated lipid 
A is a potent adjuvant and is being formulated into vaccines being used for humans.  Another 
important characteristic of lipid A is that mostly all the fatty acyl chains are made up of 
saturated fatty acids. If the saturated fatty acids are replaced with unsaturated fatty acids, the 
resultant LPS molecule induces an attenuated immune response (Kitchens et al., 1992; 
Munford and Hall, 1986). 
Lipopolysaccharide can enter systemic circulation from live bacteria, or as cell wall 
components of dead bacteria. Either way, if the amounts are too great, they can ultimately 
antagonize anabolic growth (Kimball et al., 2003; Orellana et al., 2007) or lead to septic 
shock and death (Moore and Morris, 1992). Lipopolysaccharide is released not only during 
bacterial death but also during growth and division, making it a ubiquitous contaminant 
(Petsch and Anspach, 2000; Yaron et al., 2000). The biological activity of the LPS is 
measured in endotoxin units (EU). For example, 100 pg of LPS is considered to have 1 EU 
of activity, or 10 EU is equivalent to 1 ng of LPS. A single Gram negative bacteria contains 
approximately 1015 g of LPS and 105 bacteria can generate 1 EU. It has been shown that a 
single E. coli contains approximately 106 lipid A residues (Raetz et al., 1991). Furthermore, 
the size of the individual LPS molecules varies between 10 to 20 kDa in monomeric form 
and because of the amphiphilic nature; they can arrange themselves into large micellar 
structure achieving 1,000 kDa. 
Innate Immune Response 
The innate immune response is the first line of defense against infectious diseases and 
foreign particles. Compared to adaptive immune system, innate immune response is 
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instantaneous, usually activated within minutes to hours of a stimulus, whereas the adaptive 
immune response takes hours to days (Janeway and Medzhitov, 2002). The innate immune 
response contains five key elements for protection: 1) physical barriers like skin, epithelial 
layers, and mucus to prevent the entry of pathogens; 2) enzymes with antimicrobial 
properties  like lysozyme and muramidase in body fluids to kill the invading agents; 3) a 
recognition system like germ line encoded pattern recognition receptors (PRRs) such as 
TLRs) and NOD-like receptors allow for immediate detection and response; 4) anti-
microbial responses including the complement system; and 5) the recruitment of other 
immune cells for an enhanced response (Aderem and Ulevitch, 2000; Beutler, 2004; Heeg, 
2007; Hoffmann et al., 1999). Like the adaptive response, the innate immune system can also 
be classified into cellular and humoral components.  Hematopoietic cells like macrophages, 
dendritic cells, mast cells, neutrophils, eosinophils, natural killer cells and non-hematopoietic 
cells such as epithelial cells make up the cellular component. Complement proteins, LPS 
binding proteins, C-reactive protein, collectins, and anti-microbial peptides like defensin’s 
make up the humoral component (Turvey and Broide, 2010).    
The innate immune system was thought to be non-specific; however, a series of 
discoveries in the late-1990s proved that this theory was only partially true and that innate 
receptors recognized a narrow range of compounds from particular organisms, e.g. TLR4 can 
recognize LPS from many organisms (Medzhitov et al., 1997). There are specific receptors 
present in immune cells, such as macrophages, dendritic cells, B cells, and certain types of T 
cells, that could recognize a particular pattern in the invading microbes which came to be 
known as PRRs (Janeway and Medzhitov, 2002; Medzhitov, 2001). Moreover, myocytes and 
adipocytes also express these same PRRs (Gabler and Spurlock, 2008). These ‘patterns’ 
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present in the different microbial species are essential for their survival and have come to be 
known as pathogen associated molecular patterns (PAMP), later to be renamed microbe 
associated molecular patterns (MAMP) to include all the microbes including pathogens and 
non-pathogens (Akira et al., 2006; Ausubel, 2005). Collectively, the family of PRRs senses 
the presence of a variety of molecules from the invading pathogens, as well as commensals, 
and regulates the immune response by stimulating the secretion of various immune mediators 
(Brikos and O'Neill, 2008). More recently, PRRs have been shown to recognize not only the 
pathogenic patterns, but also commensals, as well as cellular degradation products from the 
same organism, which are known as damage associated molecular patterns (Chen and Nuñez, 
2010; Rosin and Okusa, 2011). The first Toll-like pattern recognition receptor to be 
identified was TLR4, which recognizes bacterial LPS and other proteins including heat shock 
proteins (Poltorak et al., 1998). At present, there are 11 human and 13 murine TLRs, which 
recognize different pathogen components including flagella, peptidoglycan, double-stranded 
RNA, and DNA (McGettrick and O’Neill, 2010; Moresco et al., 2011).  
Recognition of inflammatory compounds by PRRs leads to the activation of the 
master transcription factor nuclear factor-κB (NF-kB). After NF-kB activation, increased 
transcription and secretion of a class of pleiotropic molecules, known as cytokines occurs. 
Cytokines then act on other cells to induce specific cellular immune response (Lenardo and 
Baltimore, 1989). Cytokines can exert autocrine, paracrine, and even endocrine functions. 
The physiological actions of cytokines include development of cellular and humoral immune 
response, induction of the inflammatory response, regulation of hematopoiesis, control of 
cellular proliferation and differentiation, and healing of wounds (Arai et al., 1990; Kindt et 
al., 2007). Cytokines can be pro- and anti-inflammatory and lead to the increase or decrease 
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in the magnitude of the inflammatory response. Tumor necrosis factor-α (TNF-α), 
interleukin (IL)-6 and IL-8 are considered pro-inflammatory, whereas IL-10 and 
transforming growth factor-β are considered anti-inflammatory. These classes of cytokines 
are secreted by immune cells and many other cell types (Ashley et al., 2012).  For example, 
IL-1β secreted by monocytes, endothelial cells and epithelial cells, TNF-α secreted by 
macrophages, IL-12 secreted by macrophages and dendritic cells, interferon-β secreted by 
fibroblasts are some of the examples of cytokines of innate immune cells. Interleukin-2 
secreted by T cells, interferon γ secreted by TH1 cells,   and IL-4 secreted by TH2 cells and 
mast cells, are some of the examples of cytokines of adaptive immunity. Overall, cytokines 
exert their function through acting on five classes of receptors: 1) immunoglobulin 
superfamily receptors, 2) class I and 3) class II cytokine receptor family, 4) TNF receptor 
family and 5) chemokine receptor family (Borish and Steinke, 2003; Dinarello, 2000; 
Miyajima et al., 1992). Chemokines are a sub-family of cytokines with approximately 90-130 
amino acids and mainly helps in the leukocyte recruitment (Allen et al., 2007).  
Classically, innate immune response is characterized by inflammation. Inflammation 
is associated with clinical signs such as redness, pain, heat, swelling, and loss of function. 
Inflammation can be acute or chronic depending on the duration it takes to remove the 
immune stimuli. The inflammatory process is usually compartmentalized to the affected 
tissue (Kindt et al., 2007). During acute inflammation, when the tissue damage occurs by the 
immune stimulant, innate immune cells which encounter the invading agent secrete pro-
inflammatory mediators. This results in the classical signs of inflammation as well as 
bringing together of leukocytes, antimicrobial mediators like defensins, cathelicidins and 
interferons, complement system, kinins, clotting and fibrinolytic proteins, lipid mediators like 
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prostaglandins, leukotrienes, platelet-activating factor, peptides and amines like histamine, 
serotonin, neuropeptides and pro-inflammatory peptides and cytokines such as IL-1α, IL-1β, 
TNF-α and IL-6 which act to destroy the invading agent. Neutrophils are the first immune 
cells to be recruited followed by macrophages, eosinophils, and platelets, and followed by 
lymphocytes. If the invading agent is eliminated, the anti-inflammatory process mediated by 
cytokines such as IL-10 and transforming growth factor-β takes over to limit the damage to 
the surrounding tissues (Ballou, 2012; Dolgachev and Lukacs, 2010; Kindt et al., 2007; 
Libby, 2002).  
If the local inflammatory process is not contained within the affected tissue, it may 
lead to a systemic response, otherwise known as acute-phase response. The cytokines 
secreted during the initial response then enters systemic circulation and act on bone marrow, 
hypothalamus and liver. Stimulation of bone marrow results in the increased production of 
leukocytes needed to fight the infection. Activation of hypothalamus by the cytokines, 
directly through cytokine receptors or indirectly through vagus nerve, stimulates the secretion 
of prostaglandins which results in a fever response. This febrile response helps in preventing 
the growth of the pathogen and increases the overall immune response (Johnson, 1997; Karin 
et al., 2006; Wright et al., 2000). Fever is a regulated change in homeostasis of the body and 
a complex acute phase response in which a temporary resetting of the body’s thermostatic set 
point causing an increase in core body temperature (Hasday et al., 2000; Kluger et al., 1996). 
Apart from preventing the pathogen growth and inducing immune response, fever also results 
in uncoupling of electrons during oxidative phosphorylation resulting in decreased ATP 
synthesis and decreased feed efficiency. Fever also reduces the appetite and, thus, acquisition 
of iron from the diet which is required by most pathogens. Also, the acute phase response 
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results in an increase in the production of transferrin and lactoferrin which further restricts 
the availability of iron for the pathogen (Kozak et al., 2000).  
Further, hypothalamus activates the pituitary gland resulting in the release of 
adrenocorticotropic hormone (ACTH) which stimulates the secretion of corticosteroids from 
adrenal cortex. Together, the cytokines and hypothalamus-pituitary axis results in the 
secretion of acute phase proteins (APP) primarily from the liver. C-reactive protein, serum 
amyloid A, fibrinogen, haptoglobin, mannose-binding protein, and complement components 
are the major APP secreted (Steel and Whitehead, 1994). Their concentration increases 
dramatically, particularly C-reactive protein and serum amyloid A, after an acute phase 
response. Acute phase proteins usually bind to the inflammatory agent which in turn helps 
facilitates its neutralization through the complement system (Balaji et al., 2000; Eckersall and 
Bell, 2010; Gabay and Kushner, 1999).  
 
Lipopolysaccharide Signaling and Permeability 
Lipopolysaccharide is recognized and signaled by the PRR, TLR4 (Poltorak et al., 
1998).  However, the presence of LPS is not sensed by TLR4 alone. Lipopolysaccharide is 
usually present as an aggregate bound to other LPS molecules on which LBP acts and 
separates a monomer which is then presented to CD14 receptor. The CD14 receptor is 
present in two forms, membrane-bound (mCD14) or soluble (sCD14). The CD14 protein 
doesn’t have an intracellular domain so it associates with TLR4, which has a Toll-interleukin 
1 receptor (TIR) intracellular domain through which it can transmit the intracellular signal 
(Beutler, 2000; Triantafilou and Triantafilou, 2002). Toll-like receptor 4 then dimerizes and 
17 
 
 
 
binds with MD-2 which transmits the signal through the TIR intracellular domain through 
two different pathways. One is a myeloid differentiation factor 88 (MyD88) dependent and 
the other one is a MyD88 independent pathway. The first pathway leads to translocation of 
nuclear factor kappa beta (NFB) to the nucleus and the initiation of transcription of 
inflammatory mediators. Alternately, the independent pathway leads to the activation of 
interferon regulatory factor 3 (IRF3) as well as NFB (Coll and O'Neill, 2010; Verstrepen et 
al., 2008). Basically, both pathways lead to the secretion and stimulation of pro-inflammatory 
cytokines and other immune mediators. The signaling is quenched by endocytosis of TLR4, 
along with LPS, to an endosome where it is then degraded (Saitoh, 2009). Current research 
indicates that apart from the signaling proteins, lipid rafts are essential for the TLR4 
signaling (Figure 2) and permeability through the membrane to occur (Olsson and Sundler, 
2006; Pfeiffer et al., 2001; Triantafilou et al., 2002; Triantafilou et al., 2004).  
Lipid rafts are small (10-200 nm), heterogeneous, highly dynamic, sterol-and 
sphingolipid-enriched domains that compartmentalize cellular signaling processes. Small 
rafts can sometimes be stabilized to form larger platforms through protein-protein and 
protein-lipid interaction (Pike, 2006). They are specialized membrane domains, which are 
rich in saturated fatty acids, cholesterol, and glycosphingolipids (Brown and London, 1998; 
Pike, 2003). Some proteins are thought to be preferentially localized in the raft region, 
particularly GPI anchored proteins like CD14 (Brown and Rose, 1992).  Lipid rafts have 
been shown to act as a membrane signaling hub for many receptors and have been implicated 
in forming the signaling complex in T cell signaling (He and Marguet, 2008; Janes et al., 
2000; Yaqoob, 2009). Lipid rafts have also been implicated in endocytosis of pathogens 
(Manes et al., 2003). Interestingly, TLR4 has been shown to localize to these membrane raft 
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domains upon LPS stimulation and disruption of LPS signaling occurs if the lipid raft is 
dissociated (Triantafilou et al., 2002). Further saturated and unsaturated fats have been 
shown to reciprocally modulate the TLR4 localization into lipid raft and its signaling. 
Saturated fatty acids stimulate the TLR4 to localize into rafts and start the inflammatory 
signaling cascade whereas n-3 PUFA’s prevent the stimulation and localization into lipid raft 
(Wong et al., 2009). 
 
MicroRNA Regulation of LPS Signaling 
MicroRNA (miRNA) are small non-coding RNA molecules of endogenous origin 
measuring approximately 22-25 nucleotides that regulate gene expression at the post-
transcriptional level (Figure 3) (He and Hannon, 2004). They are encoded in the genome and 
can be found in both introns and exons, and RNA polymerase II is the main enzyme 
responsible for their transcription (Wahid et al., 2010). The majority of miRNA genes are 
located in intergenic regions and oriented in either sense or antisense fashion to already 
annotated genes (Zhou et al., 2011). MiRNA genes are transcribed into poly-cistronic 
primary miRNAs (Pri-miRNA) which are processed into approximately 70 nucleotide 
imperfect stem-loop structure precursors (Pre-miRNA) by the nuclear localized RNase-III 
enzyme, Drosha. Pre-miRNA is exported into the cytoplasm through the Ran-GTP dependent 
nucleo/cytoplasmic cargo transporter, exportin 5 (Lund et al., 2004). Here they are cleaved 
by another RNase-III enzyme, Dicer, into a dsRNA duplex of approximately 21-25 
nucleotide strands with only two complementary strands without the stem loop structure. One 
strand of the duplex is loaded into argonaute proteins to produce the effector RNA induced 
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silencing complex which helps the miRNAs reach their target (Khvorova et al., 2003). 
miRNA bind to the 3' untranslated region of the mRNA through imperfect complementarity 
at multiple sites which leads to either decreased translational efficiency or decreased mRNA 
expression. Of these two processes, decreased mRNA expression has been shown to account 
for approximately 84 % of the decreased protein production (Guo et al., 2010). Further, very 
highly conserved miRNA have been shown to bind to several hundred distinct mRNA 
indicating the promiscuous nature of miRNA. Additionally, they have the potential to 
regulate most of the transcribed mRNA in a mammalian cell (Baek et al., 2008). It is 
predicted that approximately 30-50 % of all mammalian protein-coding genes are targeted by 
miRNA and almost all the cellular processes have been shown to be miRNA regulated 
(Filipowicz et al., 2008). Because miRNA cannot completely knockdown the function of a 
target mRNA, it is assumed that miRNA fine tune gene expression rather than exerting 
complete control over any specific target (Contreras and Rao, 2012).  
With regard to the innate immune response, recent research indicates that miRNA are 
expressed in immune cells and evidences have been published showing their ability to 
regulate an inflammatory reaction (O'Neill et al., 2011). An inflammatory stimulant such as 
LPS increases the expression of proteins which interact with miRNA and cytokines decrease 
the expression of Dicer, which is necessary for processing miRNA (Ma et al., 2011). miRNA 
expression could be affected through TLR signaling and could also be dependent on the 
transcription factor NF-κB (O'Neill et al., 2011; Zhou et al., 2011). The major miRNAs 
which are under the exclusive regulation of NF-κB and thus play significant role in the 
inflammatory process include miR-146a, mir-155, and mir-21 (Boldin and Baltimore, 2012). 
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These act as both positive and negative regulators of inflammatory pathways resulting in 
enhancing or decreasing an immune response (Lindsay, 2008). Further, the adaptive immune 
response is also regulated by miRNA. Extensive miRNA regulation has been shown during 
the selection and differentiation of T and B lymphocytes (O'Connell et al., 2012).  
Recent evidences also indicate that diet could modify the expression of miRNA 
associated with cancer (Saini et al., 2010). High saturated fats have been shown to up-
regulate mir-143, which plays a major role in the pathophysiology of obesity (Takanabe et 
al., 2008). Nutritional amounts of polyphenols have also been shown to affect miRNA 
expression in liver (Milenkovic et al., 2012). Further, n-3 PUFA supplementation in a rat 
model of colon cancer can suppress the expression of miRNA (Davidson et al., 2009). 
Therefore, dietary factors can be used to regulate miRNA expression which could modify 
subsequent expression of genes involving various physiological pathways depending on the 
nature of the dietary supplement.   
Gastrointestinal Tract Function 
The lumen of the gastrointestinal tract (GIT) is considered a space outside the body 
because of its continuity with the external environment. Gastrointestinal track has the 
arduous task of absorbing the nutrients that are essential for the organism while preventing 
the absorption of substances that are not needed and harmful to the system. The GIT 
primarily serves two important functions, absorbing nutrients from the lumen and forming a 
barrier between the luminal contents and systemic circulation. Primarily, the intestinal tract 
aids in the digestion and absorption of proteins, carbohydrates, lipids, vitamins, minerals, and 
water. A single layer of intestinal epithelial cells (IECs), which line the intestine selectively 
21 
 
 
 
absorbs most of the nutrients needed through active and passive processes with the help of 
specific transporters or carrier proteins. For example, glucose and fructose are absorbed 
through Na-dependent glucose transporter 1 and glucose transporter 5, respectively. Water is 
absorbed through aquaporin receptors, and amino acids and di- and tri-peptides are absorbed 
through numerous transporter proteins located on the apical and basolateral membranes. 
Additionally, the GIT serves as a major excretory organ which helps in waste products 
including excessive nutrients and toxic substances secreted by the biliary system. All these 
functions becomes more difficult given the fact that only a single layer of IEC acts as a 
selective permeability barrier throughout the intestinal tract. 
The epithelial or intestinal integrity is critical for maintaining a physical barrier 
between the intestinal lumen and the body. This is dependent largely on the junctional 
complexes connecting enterocytes together and is achieved via a well-organized intercellular 
array of tight junctions, adhesion junctions, and desmosomes surrounding the apical region of 
epithelial cells. Cell to cell adhesion and tight junctions are regulated by the membrane 
spanning proteins claudin, occludin, zonula occudens (ZO) 1 and 2, and cingulin (Oswald, 
2006; Turner, 2006). Additionally, adhesion junction proteins, such as E-cadherin, also 
contribute to gut integrity. Tight junctions are the most apical junctions between two 
epithelial cells that are formed by claudin and occludin family protein strands along with 
other protein complexes (Chiba et al., 2008; Denker and Nigam, 1998). It is becoming clear 
that there are different claudin isoforms that participate in intestinal barrier function. 
Together, claudin and occludin proteins are attached to actin cytoskeleton through other 
proteins, such as ZO-1 and junction adhesion molecules (Nusrat et al., 2000; Turner, 2006). 
It was initially thought that tight junctions form a physical barrier without any cellular 
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regulation, but recent research indicates that tight junction proteins are dynamic and very 
well regulated; intracellular translocation of tight junction proteins from the cell membrane 
and back occurs regularly during normal cellular processes (Shen et al., 2011).  
 
Intestinal LPS Permeability 
Circulating LPS can be derived from the environment where the bacteria can be 
ingested along with feed and water or through respiration (Spaan et al., 2006). The other 
major source is the commensal bacteria in the GIT particularly members of the 
Enterobacteriaceae such as E. coli and Salmonella., which is a rich source of Gram negative 
organisms (Ley et al., 2006; Wiznitzer et al., 1960). The bacterial population is very scarce in 
the stomach because of the acidic environment, but the numbers increase exponentially the 
more distal the location along the intestinal tract from duodenum to colon (Magalhaes et al., 
2007; Tlaskalová-Hogenová et al., 2004). The main entry point for pathogenic bacteria, LPS, 
mycotoxin, and other pathogens is via the digestive tract. Thus, the intestine forms a major 
physical barrier to prevent pathogens and toxic compounds from entering the mucosa and 
circulation and then activating the immune system.  
The permeability of LPS from the GIT lumen to the systemic circulation is not fully 
understood, but two primary routes exist. The first mode is through the paracellular route 
where the LPS permeability occurs through tight junctions formed between two intestinal 
epithelial cells (Drewe et al., 2001; Hietbrink et al., 2009). Various factors have been shown 
to regulate the permeability properties of the intestinal tight junction barrier (Shen et al., 
2011). When animals are under stress or have intestinal inflammation, small quantities of 
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luminal contents including LPS, commensals, and pathogens may enter the epithelium and 
circulation through the tight junctions. These pathogens and MAMPs can stimulate the 
localized secretion of pro-inflammatory cytokines, including TNF-α and IL-1β from immune 
and intestinal epithelial cells. Consequently, these inflammatory and stress responses may 
cause the phosphorylation of myosin light chain by myosin light chain kinase, which results 
in the contraction and opening of the intestinal epithelial tight junctions and increases 
intestinal permeability (Chen et al., 2006; Moriez et al., 2005; Turner et al., 1997; Turner, 
2009, 2011).  
Disruption of tight junctions and increased paracellular permeability by oxidative 
stress has also been demonstrated in IEC. Treating Caco-2 intestinal epithelial-like cells with 
the oxidant hydrogen peroxide, increases barrier permeability and leads to a redistribution of 
ZO-1 and occludin (Sheth et al., 2009). Interestingly, Caco-2 cell monolayers treated with 
LPS increases lipid peroxidation and paracellular permeability (Courtois et al., 2003). The 
increased permeability can be reversed by treatment with the antioxidant butylated 
hydroxytoluene. This indicates that LPS itself can decrease intestinal barrier function by a 
mechanism that is mediated by oxidative stress. Further indicating a link between redox 
status and intestinal barrier function is the finding that treating Caco-2 cells with bile salts 
(e.g., Cholic acid) increases paracellular permeability by increasing reactive oxygen species 
(Araki et al., 2005). Blocking the increase in reactive oxygen species with the antioxidant, n-
acetyl cysteine, prevents the decrease in trans-epithelial electrical resistance (TER) in bile 
acid treated IEC. Bile acid treatment leads to ZO-1 and occludin redistribution and the 
increased permeability can be reversed by 1-(5-iodonaphthalene-1-sulfonyl)-1H-hexahydro-
1,4-diazepine hydrochloride, a myosin light chain kinase inhibitor, indicating a linkage 
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between cellular redox status and tight junctions. 
Under normal physiological conditions, tight junction barrier integrity remains intact, 
and luminal contents and transport of molecules across the tight junctions is very well 
regulated (Edelblum and Turner, 2009). Nevertheless, metabolic stress and environmental 
stresses, such as heat stress, have been reported to cause increased intestinal permeability or 
‘leaky gut’ (Lambert et al., 2002; Lambert, 2004; Singleton and Wischmeyer, 2006). 
However, the pathways through which tight junction proteins are regulated by these 
conditions are not fully characterized. 
Intestinal and systemic diseases are associated with leaky epithelial barrier and 
increased intestinal permeability to LPS. The TER of cell monolayers or intestinal epithelial 
membranes is a good indicator of the degree of tight junction organization and gut integrity. 
Pigs challenged with LPS showed altered intestinal TER compared to their controls, 
indicating changes have occurred in intestinal integrity and junctional organization (Albin et 
al., 2007). Furthermore, treatment with the omega-3 fatty acids, eicosapentaenoic acid (EPA) 
and docosahexaenoic acid (DHA), has effectively been shown to prevent reduced TER 
induced by the pro-inflammatory cytokines, interferon-γ and TNF-α, and prevent the 
redistribution of occludin and ZO-1 (Li et al., 2008). Also, DHA   treatment of Caco-2 
monolayers has been shown to increase paracellular permeability via the intracellular 
redistribution of the tight junction proteins (Roig-Perez et al., 2004). 
The second mode of intestinal LPS and bacteria permeability is via transcellular 
permeability occurring through epithelial cells (Neal et al., 2006; Tomita et al., 2004). 
Further, evidence indicates that lipid rafts are required for the recruitment of TLR4 and that 
receptor-mediated endocytosis is a key mechanism of transcellular permeability of bacteria 
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and LPS in in many cell types (Ancuta et al., 2008; Chassin et al., 2008; Triantafilou et al., 
2002). Initially, it was thought that IEC did not have the necessary receptors to recognize the 
innate immune ligands like MAMPs and damage associated molecular patterns. However, 
research over the past 10 years has discovered that IEC do play a major role in the 
recognition of pathogens and endotoxin, and IEC express specific receptors including TLRs, 
nucleotide oligomerization domain receptors, and RIG-I-like receptors (Cario et al., 2000; 
Cario, 2005; Santaolalla et al., 2011). The expression of mRNA for all of the TLRs, which 
are expressed by immune cells, have been described in human IEC (Abreu, 2010b). The 
confounding issue regarding the presence of TLR in IEC is that they are expressed on the 
apical side of the membrane; however, they are not believed to be continually activated by 
the presence of luminal LPS.  Research with IEC has shown that TLR4 is present on the 
apical and basolateral membranes, as well as within the golgi apparatus (Abreu, 2010a; Cario 
and Podolsky, 2006; Hornef et al., 2003). However, the overall consensus regarding the 
TLR4 location and expression indicates that IEC have a hypo-responsiveness towards LPS 
and that the location of TLR4 within the cell may be a major contributing factor for the hypo-
responsiveness (Vamadevan, 2010).  
Both paracellular and transcellular mode of LPS permeability are two important ways 
through which most of the LPS enters systemic circulation from the gut. The gut is the first 
line of defense against LPS and if compromised via nutrition, stress or metabolic state, LPS 
permeability can increase (Clark et al., 2009; Liu et al., 2009; Suganuma et al., 2002). A 
greater understanding of gut LPS permeability will allow for the development of nutritional 
and pharmacological mitigation strategies to avert the negative effects of LPS.  
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Lipopolysaccharide Detoxification 
After crossing the intestinal barrier, LPS is transported by both lymph and blood; 
however, most of the LPS is transported to the liver through the portal vein where a major 
portion of the LPS detoxification process occurs (Lemaire et al., 1999; Olofsson et al., 1986; 
Van Leeuwen et al., 1994). If the amount of LPS entering the GIT overwhelms the barrier 
function of IECs and the detoxification capacity of liver, endotoxemia ensues (Olofsson et 
al., 1985). Mammals have developed an elaborate system to tolerate and detoxify LPS at 
either the mucosal surface or in systemic circulation. Lipopolysaccharide tolerance can also 
occur by the down-regulation of proteins that participate in LPS signaling and the innate 
immune response (Fan and Cook, 2004). Bile plays an important role in detoxifying LPS 
because of the detergent action of bile salts in the intestinal lumen. Furthermore, after LPS 
detection by hepatocytes and Kupffer cells in liver, active and inactive forms of LPS may be 
transferred to the bile and excreted into the lumen (Lóránd, 2004; Maitra et al., 1981). 
Approximately 7 % of the absorbed LPS is excreted through bile. Munford (2005) describes 
four mechanisms through which LPS may be neutralized. First, there are molecules that bind 
LPS and prevent it from engaging TLR4. Second, there are enzymes that degrade lipid A to 
decrease its activity. Third, LPS can be deactivated following its uptake by the liver. Lastly, 
there are target cell adaptations that modify the response to LPS.  Moreover, reports show 
that incubation of LPS with plasma makes it less pyrogenic and less inflammatory (Rall et 
al., 1957; Rudbach and Johnson, 1964; Ulevitch and Johnston, 1978).  Specific plasma 
proteins are able to bind LPS and this is speculated to aid in the inactivation and 
detoxification of LPS (Brade and Brade, 1985; Johnson et al., 1977; Rudbach and Johnson, 
1966). Serum amyloid A has been shown to increase during the acute phase response, and 
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also binds to LPS monomers and eliminates this toxin via the liver (Coetzee et al., 1986; 
Emmanuel et al., 2008). Additionally, proteins such as collectins, along with bactericidal 
permeability increasing protein and neutrophil granules, are also plasma proteins that bind 
and neutralize LPS (Chaby, 2004; Munford, 2005). 
Intestinal chylomicrons, which are involved in transporting the absorbed fatty acids, 
have been shown to promote the absorption of LPS (Ghoshal et al., 2009). However, 
chylomicrons have been reported to mitigate the toxic effects of LPS by binding the LPS and 
promoting its inactivation via contact and the action of bile (Harris et al., 1993; Read et al., 
1993). Further, LBP can bind to the chylomicrons and enhance the binding of LPS to the 
chylomicrons, which helps in reducing its bioactivity (Vreugdenhil et al., 2003). Binding of 
LPS to the chylomicron helps in its recognition by low density lipoproteins (LDL) and LDL-
associated receptors present in hepatocytes, which promote the endocytosis of LPS into the 
cell and its rapid clearance from circulation (Harris et al., 2002). Presence of apolipoprotein 
E in the chylomicrons is also protective against LPS because it delivers the LPS directly to 
hepatocytes, bypassing Kupffer cells and their pro-inflammatory cytokine production (Van 
Oosten et al., 2001). Lipopolysaccharide is also found to bind with high density lipoprotein 
(HDL) (Ulevitch et al., 1979). The role of HDL in detoxifying LPS seems to be 
controversial. It is suggested that HDL aids in sequestering and detoxifying LPS, but also 
makes it more difficult to clear from circulation (Birjmohun et al., 2007; Vreugdenhil et al., 
2003). Further, LPS may be transferred from HDL to LDL with the help of LBP and 
phospholipid transfer proteins. The transfer of LPS to LDL results in dyslipidemia and the 
loss of HDL’s capacity to bind cholesterol leading to metabolic diseases (Levels et al., 2005). 
A major detoxification mechanism for LPS is by enzyme modification via 
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acyloxyacyl hydrolase (AOAH). This hydrolase enzyme is classified as a lipase and is 
present in macrophages, dendritic cells, neutrophils, Kupffer cells in liver and renal cortical 
tubule cells (Erwin and Munford, 1991). Interestingly, AOAH can be produced by the renal 
cortical tubule cells where it is secreted into the urine and can deacylate and neutralize LPS 
(Feulner et al., 2004). Acyloxyacyl hydrolase selectively removes the secondary fatty acyl 
chains attached to the primary chains in the lipid A moiety producing a LPS structure that is 
capable of binding MD2/TLR4 but doesn’t initiate the signal or only can be a partial agonist 
(Lu et al., 2005). It is believed that AOAH plays a role in mediating macrophage tolerance to 
LPS because AOAH mRNA levels are increased in LPS -primed and -tolerant macrophages 
versus LPS-naïve macropahges (Mages et al., 2007). When compared with wild-type mice, 
mice that lack AOAH and are challenged with LPS have enlarged livers and sustained 
hepatic cytokine production, indicating that this enzyme prevents prolonged inflammatory 
reaction to LPS (Shao et al., 2011). Regarding agriculturally relevant species, AOAH activity 
is increased during localized inflammation in cattle, and its activity has been localized to 
neutrophils (McDermott and Fenwick, 1992). The regulation of AOAH by stressors and diet, 
together with its direct role in intestinal detoxification warrants further investigation in 
livestock. 
Further evidence that enzyme modification of LPS plays a role in LPS neutralization 
and detoxification is supported by recent reports that intestinal alkaline phosphatase (AP) 
directly deactivates LPS (Bates et al., 2007; Goldberg et al., 2008). Mechanistically, AP 
deactivates LPS by dephosphorylating the diphosphoryl moiety of lipid A, rendering it 
inactive (Koyama et al., 2002; Munford et al., 2009; Poelstra et al., 1997). Alkaline 
phosphatase had been shown to inactivate LPS in zebra fish (Bates et al., 2007) and its 
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activity is increased in inflamed intestinal tissue (Sanchez de Medina et al., 2004). Also, 
there is debate regarding how AP dephosphorylates LPS and evidence is limited in livestock 
as to its role in detoxification. The expression and activity of intestinal AP can be modulated 
by stress and dietary factors (Lalles, 2010). Dietary lipids regulate the activity of intestinal 
AP. For example, jejunal AP activity was greater in pigs fed a diet high in saturated fat (i.e., 
15% beef tallow) versus pigs fed a diet high in unsaturated fat (i.e., 15% corn oil) (Dudley et 
al., 1994). Another example indicating that AP is regulated by dietary lipids is that n-3 fatty 
acid rich cod liver oil has been shown to increase the secretion of intestinal AP (Kaur et al., 
2007). Interestingly, this may be explained by the increased expression of resolvin-E1, an 
anti-inflammatory n-3 fatty acid lipid mediator, which induces AP activity (Campbell et al., 
2010). Furthermore, high dietary fat consumption reduces intestinal AP activity in obesity-
prone rodents (de La Serre et al., 2010). Interestingly, the decrease in ileal AP activity is 
associated with an increase in plasma LPS and increased inflammation as assessed by 
myeloperoxidase activity (de La Serre et al., 2010).  
Mechanistically, the alteration of intestinal AP by dietary lipids may be mediated by 
pro-inflammatory cytokines, such as IL-1β and TNF-α, which inhibit the induction of AP 
(Malo et al., 2006). Stress and disease in livestock may decrease intestinal AP via reductions 
in feed intake (Goldberg et al., 2008; Lalles and David, 2011). It has been observed that 
weaning pigs at a young age (i.e., 10 d) decrease both the expression and activity of AP in 
the jejunum compared to pigs weaned at 28 days of age (Lackeyram et al., 2010). This same 
age period near weaning is also associated with decreased feed intake and increased intestinal 
pro-inflammatory cytokine expression (Pie et al., 2004), perhaps both of which are 
responsible for decreased intestinal AP expression and activity that occurs with weaning in 
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pigs. Altogether, dietary factors and stressors likely impact intestinal and systemic 
inflammation and LPS concentrations via alterations in mechanisms of detoxification and 
neutralization. 
 
Dietary Fat and Inflammation 
Fatty acids (FA) are monocarboxylic acids usually having an aliphatic chain length 
between C4 and C22 and consumed as individual fatty acids or part of larger lipid molecules 
such as triacylglycerol, phospholipids, and sphingolipids. Fatty acids are concentrated in 
energy (Mangold, 1995). Apart from their main function as energy storing molecules, FA are 
an integral part of phospholipids which are part of  the cell membrane and essential for 
structural integrity, used as lubricants, and also used as signaling molecules (Mangold, 1995; 
Tvrzicka et al., 2011). Based on the chain length FAs can be classified as short chain (6 or 
less carbons), medium chain (6-12 carbons), long chain (13-21 carbons), and very long chain 
(greater than 22 carbons) FA. Further, whether they have double bonds in their structure will 
determine if they are classified as saturated, monounsaturated or polyunsaturated FA (Table 
1). Polyunsaturated fatty acids (PUFA) are classified into n-3 and n-6 (more commonly 
referred to as omega-3 and omega-6) FA depending on the carbon number of the first double 
bond from the methyl end (Calder, 2008; Tvrzicka et al., 2011). Linoleic and α-linolenic acid 
are the simplest members of n-6 and n-3 family, respectively. These two fatty acids are 
considered essential fatty acids as they cannot be synthesized by mammals because they lack 
the Δ5, Δ6, and Δ15 desaturase enzymes necessary for synthesizing these fatty acids 
(Hornstra et al., 1995). So, both fatty acids need to be supplemented through dietary sources 
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either through plant foods or marine sources. After ingestion, mammals can metabolize 
linoleic acid into long chain n-6 PUFA like arachidonic acid (AA; 20:4n-6) and α-linolenic 
acid into n-3 PUFA like EPA (20:4n-3) and DHA (22:6n-3) (Calder, 2012).  
Recent research indicates that short chain FA, particularly lauric (C:12) myristic 
(C:14) and palmitic (C:16) are the ones which form the fatty acyl chains of lipid A or the 
endotoxic  component of LPS. Saturated FAs have been shown to activate the LPS receptor 
TLR4 and consumption of high saturated fat diets have been postulated to lead to a chronic 
inflammatory state and associated metabolic diseases (Erridge et al., 2002; Raetz and 
Whitfield, 2002b; Schaeffler et al., 2009; Vaarala et al., 2008).  
Eicosanoids are inflammatory mediators synthesized from n-3 and n-6 PUFA cleaved 
from cell membrane phospholipids where these fatty acids play a structural role (Calder, 
2012). Arachidonic acid is the major n-6 PUFA in the membrane phospholipids and is 
cleaved by phospholipase A2, resulting in the release of free AA. Arachidonic acid acts as a 
substrate for inflammatory mediator enzymes lipoxygenase (LOX) and cyclooxygenase 
(COX) I and II. This results in the secretion of prostaglandins, thorombaxanes and 
leukotrienes  which play important roles in the inflammation signaling (Fetterman and 
Zdanowicz, 2009; Kremmyda et al., 2011). Prolonged consumption of n-3 PUFA, such as 
EPA and DHA, also leads to enrichment of cell membranes at the expense of arachidonic 
acid which will have positive health consequences. Further, EPA and DHA also compete 
with AA as substrates for both COX and LOX enzymes (Figure 4). This result in the 
secretion of either eicosanoids which are 10-100 fold less pro-inflammatory properties or 
anti-inflammatory mediators resolvins, ultimately resulting in reduced pro-inflammatory 
reactions (Chapkin et al., 2008a; Kremmyda et al., 2011).  
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 Interestingly, n-3 PUFA also have many other beneficial effects including 
antagonizing the activation of pro-inflammatory transcription factor, NF-κB, and decreasing 
the secretion of inflammatory cytokines such as TNF-α and IL-6 (McMurray et al., 2011). 
Additionally, n-3 PUFA enhances the anti-inflammatory transcription factor PPAR-γ leading 
to attenuated immune response (Sampath and Ntambi, 2005). Further, n-3 PUFA 
incorporation into the cell membrane causes increased fluidity which will have positive 
health consequences. Recent evidences indicate that n-3 PUFA supplementation leads to its 
incorporation into cell membrane microdomains called lipid rafts which act as a signaling 
hub for numerous important cellular activities (Ma et al., 2004). Incorporation of n-3 PUFA 
in lipid rafts occurs at the cost of AA and saturated fatty acids, which has the potential to 
reduce inflammation. The unsaturated fatty acids, particularly long chain PUFAs have a 
“kink” in their structure because of the unsaturated bonds, which prevents the compact 
structure formation needed for lipid raft. The intercalation of PUFAs into the cell membrane 
results in the dissociation of lipid rafts and decreases the LPS signaling which might be 
beneficial to the animals (Chapkin et al., 2008b; Shaikh et al., 2012; Wassall and Stillwell, 
2008).  
 
Implications of Intestinal LPS and Inflammation 
The GIT is the major site of nutrient uptake. The nutrient transport function of the 
GIT decreases when the intestine is under prolonged inflammatory or metabolic stress. A 
study looking at small intestinal absorptive function during endotoxemia showed that Na and 
Cl ions, as well as glucose absorption, was decreased even 24 h after the administration of 
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LPS (Kanno et al., 1996). Further, marked epithelial inflammation occurs around 6 h after 
challenge and villous atrophy occurs at 24 h but there are signs of recovery after 7 d.  It has 
also been shown that LPS challenge results in decreased absorption of various sugars and 
amino acids (Albin et al., 2007; Flinn et al., 2010; Meng et al., 2005). One mechanism for 
this decreased transport might be through the inhibition of Na-dependent system of transport, 
as well as a decrease in the Na+/K+ ATPase activity (Abad et al., 2001; Amador et al., 2007a; 
García-Herrera et al., 2003). Further, the pro-inflammatory cytokine, TNF-α, has been shown 
to decrease the absorption of galactose (Amador et al., 2007b).  
Overall, LPS mediated inhibition of nutrient absorption seems to be manifested by 
several interrelated signaling cascades including those involving protein kinase C, protein 
kinase A, and mitogen activated protein kinases, as well as proteasomal degradation (Amador 
et al., 2008; García-Herrera et al., 2008). While the animal itself is trying to fight the cause of 
the stress, the intestine develops a reduced ability to transport nutrients and carry out other 
functions.  The end result is an increased catabolic cascade and degradation of muscle 
proteins (Daiwen et al., 2008; Webel et al., 1998) to support gluconeogenesis and increased 
whole body metabolic energy demands. 
Because of its strategic position between the luminal microbes and essentially sterile 
systemic circulation, the intestine needs to possess excellent immune capabilities to defend 
against any pathogenic attack. Thus, evolutionarily, the intestine developed an extensive 
immune system network. The GIT can be classified as the largest immune organ in the body 
(Collins et al., 1998; Targan et al., 2003). There are specific lymph nodes that are part of gut-
associated lymphoid tissue placed in the submucosal layer to defend against any invading 
pathogens. A variety of mononuclear phagocytes, such as monocytes, macrophages, and 
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dendritic cells, are present in the gut associated lymphoid tissue, as well as dispersed 
throughout the sub-epithelial connective tissue, the lamina propria. Interestingly, these 
immune cells, when isolated from inflamed tissue, display pro-inflammatory profiles and 
secrete cytokines such as TNF-α (Bar-On et al., 2011). A typical intestinal inflammatory 
response progresses through the following steps. A leaky intestinal epithelial barrier allows 
luminal commensal organism components to enter the sub-mucosa and stimulate local 
immune cells. Dendritic cells, through their PRRs, recognize commensal constituents as 
pathogenic components and initiate the activation of T cells and natural killer cells. The 
immune cells can also be activated by their own PRRs. This leads to the secretion of 
regulatory cytokines by T cells, which in turn, stimulate the secretion of TNF-α, IL-1β, and 
IL-6 by macrophages. Natural killer cells also play an active role by secreting cytokines, as 
well as causing tissue damage (Baumgart and Carding, 2007). The interplay between immune 
cells, LPS, and cytokines can augment the inflammatory state of the intestine. 
During an inflammatory response, nutrient partitioning is redirected towards meeting 
the metabolic requirements of the immune system. Inflammation is associated with increase 
in body temperature and an increase in 1 °C equates to a 13 % increase in basal metabolism 
(Kluger, 1978). The rise in the levels of pro-inflammatory cytokines, such as TNF-α and IL-
1β, have been shown to decrease feed consumption (Plata-Salamán et al., 1996), rates of 
weight gain, and efficiency of feed utilization (Evock-Clover et al., 1997; Steiger et al., 
1999). Thus, LPS -associated inflammation results in an estimated 30 % increase in energetic 
costs and leads to a significant negative nitrogen balance because of protein breakdown and 
decreased weight gain (Lochmiller and Deerenberg, 2000). Further, multiple immune 
challenges occurring simultaneously lead to a cumulative reduction in growth performance 
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too (Hanssen et al., 2004). 
All the evidence indicates that a significant decrease in feed intake occurs during an 
inflammatory challenge. Appetite regulation is a complex process and it occurs mainly 
through the neuronal control through the vagus nerve or through hormonal control via the 
secretion of leptin, ghrelin, cholecystokinin, and glucagon-like peptide 1.  The hypothalamus 
receives and integrates these signals and brings about the desired effect of altered appetite 
control (Cummings, 2006; Sartin et al., 2011). The appetite regulation under an immune 
challenge might occur through either one or both of these mechanisms. During most disease 
conditions in livestock, there is a reduction in feed intake accompanied by an increase in 
metabolic rate, which is significantly different than fasting because during fasting the 
decrease in feed intake is accompanied by decreased metabolic rate (Sartin et al., 2011). The 
inflammatory cytokines secreted upon an LPS challenge decrease feed intake and nutrient 
transport by acting on the somatotrophic axis (Johnson, 1997, 1998). Tumor necrosis factor-α 
has been shown to be present in the central nervous system after an immune challenge with 
LPS which indicates that it could act on the appetite regulatory center directly (Sakumoto et 
al., 2003). The appetite-stimulating neurotransmitters in the hypothalamus, such as 
neuropeptide Y and Agouti-related protein, maybe reduced or unchanged, whereas appetite-
inhibiting neurotransmitters including proopiomelanocortin and cocaine- and amphetamine-
regulated transcript are increased during immune challenges. During disease stress, the latter 
may promote α-melanocyte stimulating hormone suppression of appetite via the MC4 
receptors to decrease appetite (Sartin et al., 2008; Sartin et al., 2011). This mechanism of 
action results in typical sickness behavior such as decreased appetite and increased energy 
expenditure (Grossberg et al., 2010).  
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The other plausible mechanism by which appetite is regulated under an LPS 
challenge and inflammation is that LPS and other TLR4 ligands, such as saturated fatty acids, 
have been shown to activate enteroendocrine cells that act as nutrient sensors in the intestine. 
This leads to the secretion of appetite regulating peptides, such as cholecytokinin and 
glucagon-like peptide 1, from the enteroendocrine cells which act on the satiety centers in the 
hypothalamus and ultimately results in reduced feed intake and nutrient absorption from the 
intestine (Bogunovic et al., 2007; de Lartigue et al., 2011). While this has been shown in the 
cell lines, further research is needed to prove this theory in vivo. 
 
Summary and Conclusion 
The literature reviewed herein describes how luminal LPS enters the circulation and 
its effects on gastrointestinal function and animal performance (Figure 5). Additionally, we 
briefly describe plausible mechanisms of LPS detoxification and neutralization. Even at low 
concentration, LPS is a potent stimulator of pro-inflammatory cytokine production from 
various cell types within the body, not just immune competent cells. The resulting immune 
activation and associated inflammation makes LPS an important factor that is commonly 
overlooked in livestock production. However, more research is needed to understand how 
LPS enters the circulation and its effect on metabolism and energetics. Additionally, research 
describing how stress and nutrition modulate LPS permeability and clearance in agricultural 
relevant species is warranted.  
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Figure 1.  Simplified structure of lipopolysaccharide (LPS) from Gram negative bacteria 
such as Escherichia coli. Lipopolysaccharide contains a distal ‘O’ polysaccharide region, a 
core polysaccharide region divided into outer and inner core and an interior lipid A 
component through which LPS is inserted into the cell membrane. ‘O’ polysaccharide region 
is highly variable and contains approximately 10 to 25 repeated units and made up of 
common hexose (Hex) sugars. Outer core polysaccharide contains common hexose sugars 
such as glucose (Glc) and galactose (Gal) whereas inner core polysaccharide contains 
unusual sugar such as 3-deoxy-D-manno-octulosonic acid (Kdo). Lipid A structure is 
explained in the text. Arrows with acronyms AP (alkaline phosphatase) and acyloxyacyl 
hydrolase (AOAH) indicate the cleavage points where these enzymes cleave the phosphate 
and secondary fatty acyl chains respectively. GlcN - N-acetyl glucosamine; Hep - Heptose
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Figure 2. Pathways of TLR 4 signaling. Lipopolysaccharide is recognized by TLR4 which 
causes its localization to lipid raft. From lipid raft, TLR4 signals either through a MyD88 –
dependent pathway or TRIF-dependent pathway which results in the translocation of NF-κβ 
or IRF3 to the nucleus and transcription of inflammatory cytokines. Adapted from 
(McGettrick and O’Neill, 2010; Uematsu and Akira, 2007) 
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Endotoxin 
Nuclear Membrane 
Lipid Plasma Membrane 
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Figure 3. MicroRNA biogenesis and function in animal cells. MicroRNA is transcribed as 
primary miRNA and then cleaved in the nucleus by RNAse enzyme Drosha to a pre-miRNA 
which is exported to the cytoplasm. In cytoplasm Dicer cleaves the Pre-miRNA to a 21-25 
nucleotide dimer. This dimer is loaded into RNA induced silencing complex and one strand 
is destroyed and the other strand binds to the target mRNA either by repressing the 
translation or by destabilizing the mRNA. Adapted from (Lodish et al., 2008) 
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Figure 4. Production of eicosanoids by n-3 and n-6 PUFA. Even though the pathway and the 
enzymes remain the same, n-3 PUFA produces less potent or anti-inflammatory eicosanoids. 
Dotted arrows indicate a decrease in synthesis. AA, arachidonic acid; EPA, Eicosapentaenoic 
acid; DHA, Docosahexaenoic acid; LOX, Lipoxygenase; COX, Cyclooxygenase; CYP, 
Cytochrome 450 enzymes. (Adapted from (Stipanuk, 2006)) 
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Figure 5. A summary of intestinal endotoxin/LPS permeability and inflammation on gut 
integrity and function. Gram negative bacteria in the intestine releases LPS during growth, 
division,  and death (1). Endotoxin/LPS may be free or bound to proteins such as LPS 
binding protein (LBP) in the lumen. Recruitment of toll-like receptor 4 (TLR4), and 
associated proteins to membrane lipid raft regions allow receptor mediated endocytosis of 
bacteria and LPS in cells (2). Intracellular endotoxin/LPS may be transported bound to 
organelles (i.e., golgi) or albumin proteins in the cytosol (3). Opening of tight junctions (TJ) 
and increased paracellular permeability of LPS (4) can occur due to intestinal inflammation 
or stress. Increased proinflammatory cytokine secretion and activation of innate and adaptive 
immune cells and intestinal inflammation occurs from LPS transported across the intestinal 
barrier (5). Secreted cytokines may enter the IEC through the basolateral side, resulting in 
increased inflammation and the activation of myosin light chain kinase (MLCK) and 
phosphorylate-myosin light chain (P-MLC). Together, this causes the disruption of tight 
junction (TJ) complexes (6) and increased paracellular LPS permeability. After sensing of 
LPS via TLR4, suppression of nutrient transport and enteroendocrine cell signaling (7) can 
reduce appetite via the depolarization and secretion of appetite regulating neuropeptides such 
as cholecystokinin (CCK) and glucagon like peptide-1 (GLP-1). 
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Table 1. General classification and major sources and functions of common fatty acids 
Fatty acid class Nomenclature Major sources Important functions 
Saturated  
 -Lauric 
 
 -Myristic 
 
 -Palmitic 
 
 -Stearic 
 
 -Arachidic  
C12:0 Coconut oil 
 
Energy storing molecule 
 
Structural integrity  
 
Signaling molecules 
C14:0 
Coconut oil, 
butterfat, cod liver oil
C16:0 
Palm oil, lard, 
butterfat, beef tallow, 
cotton seed oil, cod 
liver oil 
C18:0 
Beef tallow, lard, 
butterfat, flax seed oil
C20:0 Peanut oil, corn oil 
Monounsaturated 
 
 -oleic C18:1n-9 
Olive oil, almond oil, 
canola oil, peanut oil, 
lard, beef tallow  
Energy storing molecule 
 
Structural integrity  
 
Signaling molecules 
n-3 Polyunsaturated 
 - α-Linolenic (ALA) 
 
 -Eicosapentaenoic      
  (EPA) 
 
 -Docosahexaenoic  
  (DHA) 
C18:3n-3 
 Flaxseed oil, canola 
oil, soybean oil, 
walnut 
Structural integrity  
 
Signaling molecule 
 
Production of anti-
inflammatory eicosanoids 
such as prostaglandins, 
leukotriene’s and 
resolving’s. 
C20:5n-3 Sardines, salmon, certain algae 
C22:6n-3 Sardines, salmon, certain algae 
n-6 Polyunsaturated 
 - Linoleic (LA) 
 
 
  
 - Arachidonic (ARA) 
C18:2n-6 
Sunflower oil, corn 
oil, soybean oil, 
cottonseed oil, 
sesame oil, peanut 
oil,  canola oil 
Structural integrity  
 
Signaling molecule 
 
Production of pro-
inflammatory eicosanoids 
such as prostaglandins and 
leukotriene’s. 
C20:4n-6 Chicken, egg, beef tallow, lard 
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CHAPTER 3: DIETARY OIL COMPOSITION DIFFERENTIALLY MODULATES 
INTESTINAL ENDOTOXIN TRANSPORT AND POSTPRANDIAL 
ENDOTOXEMIA 
Submitted and accepted with minor revision to Nutrition and Metabolism: An International 
Journal 
V. Mani,1,2 J. H. Hollis3 and N. K. Gabler, 1, 2. 
Abstract 
Background: Uptake of intestinal derived endotoxin and the subsequent endotoxemia can be 
considered major predisposing factors for diseases such as atherosclerosis, sepsis, obesity 
and diabetes. Dietary fat has been shown to increase postprandial endotoxemia. Therefore, 
the aim of this study was to assess the effects of different dietary oils on intestinal endotoxin 
transport and postprandial endotoxemia using swine as a model. We hypothesized that oils 
rich in saturated fatty acids (SFA) would augment, while oils rich in n-3 polyunsaturated 
fatty acids (PUFA) would attenuate endotoxin transport from the intestine and reduce 
circulating concentrations. 
Methods: Postprandial endotoxemia was measured in twenty four pigs following a porridge 
meal made with either water (Control), fish oil (FO), vegetable oil (VO) or coconut oil (CO). 
Blood was collected at 0, 1, 2, 3 and 5 hours postprandial and measured for endotoxin.  
Furthermore, ex vivo ileum endotoxin transport was assessed using modified Ussing 
chambers and intestines treated with either no oil or 12.5% (v/v) VO, FO, cod liver oil 
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(CLO), CO or olive oil (OO). Ex vivo mucosal to serosal endotoxin transport permeability 
(Papp) was then measured by the addition of fluorescent labeled-lipopolysaccharide. 
Results: Postprandial serum endotoxin concentrations were increased after a meal rich in 
saturated fatty acids and decreased with higher n-3 PUFA intake. Compared to the no oil 
control, fish oil and CLO which are rich in n-3 fatty acids reduced ex vivo endotoxin Papp by 
50% (P<0.05). Contrarily, saturated fatty acids increased the Papp by 60% (P=0.008). Olive 
and vegetable oils did not alter intestinal endotoxin Papp.  
Conclusion: Overall, these results indicate that saturated and n-3 PUFA differentially 
regulate intestinal epithelial endotoxin transport. This may be associated with fatty acid 
regulation of intestinal membrane lipid raft mediated permeability.  
Key words: Dietary fat, Endotoxin, Intestine 
 
Background 
The link between dietary fat and endogenous blood endotoxin has attracted increased 
medical and biomedical interest over the last few years. Furthermore, hyperphagia, increased 
adiposity and metabolic changes associated with high fat feeding can be recapitulated in mice 
chronically infused with LPS for four weeks [1]. It has been reported that the structure of fat 
consumed (emulsion vs. free oil) changes the extent of endotoxemia and that altering the 
composition, structure and quality of dietary fats could improve health [2]. In healthy 
humans, postprandial plasma endotoxin concentrations increase on average 18% after a high 
fat meal (approximately 380 kcal from fat, 42 % of total energy) compared to the fasted state 
[3]. These authors concluded that increased postprandial LPS may contribute to the 
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development of postprandial inflammation and disease. Ghanim et al. [4, 5] also showed that 
in healthy adults, high fat, high carbohydrate meal (~900 kcal) increased postprandial plasma 
LPS concentrations by 70%. However, Laugerette et al. [6] recently reported that dietary oil 
composition differentially modulated murine inflammation and endotoxin permeability. 
These authors also showed that fat composition, not quantity in the diet (22 vs. 3%) was 
critical in modulating plasma endotoxemia. Collectively, these data show that dietary fat 
intake and composition is able to modulate blood endotoxin and that this is associated with 
acute inflammation and the metabolic diseases of obesity and diabetes.  
Both Gram positive and Gram negative bacteria are present in large quantities in the 
intestine. Interestingly, the total quantity of endotoxin, which is the gram negative bacterial 
outer cell wall component, in the intestine alone could be up to one gram [7]. Even very 
small quantities of endotoxin, pico-gram scale, in the systemic circulation have the potential 
to elicit an inflammatory response in humans and animals [8]. Endotoxin is also 
synonymously referred to as lipopolysaccharide (LPS), and both of these compounds are 
major immunogens that elicit an inflammatory response in numerous tissues and cell types 
via their recognition through pathogen-associated molecular patterns (PAMPs) and Toll-like 
receptors in the innate immune system [9].  Lipopolysaccharide is thought to enter circulation 
by permeability across the intestinal epithelium either via paracellular pathways through the 
openings of intestinal tight junctions between two epithelial cells or by a transcellular 
pathway [7].  Transcellular permeability and the associated endocytosis of intestinal derived 
endotoxin may be facilitated by intracellular signaling processes mediated by the innate 
immune receptor complex CD14/Toll like receptor 4 (TLR4)/MD-2, in association with the 
cell membrane micro domain lipid raft [10]. Furthermore, circulating LPS concentrations 
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may also be augmented by permeability coupled to dietary lipids and chylomicrons [11].  
In recent years accumulating research has investigated the link between dietary fat 
and endogenous LPS in relation to metabolic inflammation [12, 13]. Current evidence 
suggests that dietary fat augments circulating endotoxin concentrations and the resultant 
postprandial endotoxemia leads to low-grade systemic inflammation which has been 
implicated in the development of several metabolic diseases [1, 3, 14]. Intestinal derived 
endotoxin and the subsequent acute endotoxemia are considered major predisposing factors 
for inflammation associated diseases such as atherosclerosis, sepsis, obesity, type 2 diabetes 
and Alzheimer's [15-17]. However, the ability of different types of oil and fatty acids to 
facilitate uptake of intestinal endotoxin has been poorly characterized. Interestingly, saturated 
and n-3 polyunsaturated fatty acids (PUFA) have been shown to reciprocally modulate the 
LPS receptor, TLR4 signaling and its redistribution to cell membrane micro domains lipid 
rafts [18]. This is postulated to be due to saturated fatty acids (SFA) such as lauric and 
myristic acid being part of the fatty acyl side chain composition of lipid-A component of LPS 
and the ability of n-3 PUFA to reduce the potency of LPS when substituted in place of 
saturated fatty acids in lipid-A [19, 20]. Thus, there is clear linkage between fatty acids 
(saturated, n-3 polyunsaturated, monounsaturated) and LPS signaling. 
Therefore, the aim of this study was to assess the effects of various dietary fats on in 
vivo and ex vivo intestinal LPS permeability and circulating concentrations using the pig as a 
biomedical model. We hypothesize that oils rich in saturated fatty acids (SFA) would 
augment, while the oils containing the n-3 PUFA (docosahexaenoic acid [DHA] and 
eicosapentaenoic acid [EPA]) would attenuate, intestinal endotoxin permeability and 
postprandial endotoxemia.  
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Methods 
Materials and Animals 
All the chemicals used for this study were purchased from Sigma-Aldrich (St. Louis, MO) 
unless otherwise stated. All animal use and procedures were approved by the Iowa State 
University Institutional Animal Care and Use Committee.   
 
Effect of dietary oil on postprandial serum endotoxin concentration  
Twenty four pigs (49 ± 7 kg BW) were raised on a typical corn-soybean diet that met or 
exceeded their nutrient requirements [21] and randomly allocated to one of four treatments. 
The treatments consisted of 500 g ground corn-soybean meal dough made up with either 1) 
50 ml water (Control); 2) 50 ml FO (Spring Valley Inc., UT); 3) 50 ml VO (Hy-Vee Inc., IA) 
; or 4) 50 ml  CO (Spectrum Naturals Inc., NY). After an overnight fast, six pigs were fed 
one of each porridge meal. Pigs voluntarily consumed the porridge meal with in ten minutes 
after the feed was offered in front of them. Blood was collected at 0, 1, 2, 3, and 5 hours 
postprandially by jugular venipuncture into pyrogen-free vaccutainer tubes using a sterile 
needle. Proper precautionary measures were taken to prevent external contamination of 
blood. Serum was separated by centrifuging at 2000 × g and was stored at -80 °C until 
further analysis in pyrogen-free tubes.  
Serum endotoxin concentration was measured using the end point fluorescent assay 
using the recombinant factor C (rFC) system (LonzaTM, Switzerland). Briefly, the serum 
samples were diluted 1000 times and 100 µl of the samples or standards were added to a 96 
well plate and incubated at 37 °C for 10 min. Thereafter, 100 µL of rFC enzyme, rFC assay 
buffer and rFC substrate were added at a ratio of 1:4:5 to the plate and an initial reading were 
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taken followed by 1 h incubation at 37 °C. The relative fluorescence unit (RFU) for each well 
was determined (excitation 380 nm and emission 440 nm). A positive control from the assay 
kit was used to ascertain the validity of the assay and the concentration of the endotoxin was 
interpolated from the standard curve constructed from the standards and corrected for sample 
dilution. 
 
Ex vivo intestinal integrity and LPS permeability 
Freshly isolated ileum segments from eleven pigs (21-28 days old) were placed in chilled 
Krebs-Henseleit buffer (consisting of, in mmol/L: 25 NaHCO3, 120 NaCl, 1 MgSO4, 6.3 
KCl, 2 CaCl2, 0.32 NaH2PO4; pH 7.4) for transport to the laboratory while under constant 
aeration. Intestinal tissues were then stripped of their outer serosal layer and immediately 
mounted into modified Ussing chambers (Physiologic Instruments Inc., San Diego, CA and 
World Precision Instruments Inc. New Haven, CT). Each chamber and intestinal segment 
(0.71 cm2) was bathed on its mucosal and serosal sides with 5 ml of Krebs-Henseleit buffer 
and constantly gassed with 95% O2-5% CO2 mixture. Chambers were connected to a pair of 
dual channel current and voltage electrodes containing 3% noble agar bridges and filled with 
3 M potassium chloride to measure electrophysiological parameters of the intestinal 
membranes or to measure the mucosal to serosal permeability of endotoxin. Transepithelial 
resistance (TER) was not different across pigs, indicating no differences in paracellular 
permeability or leaky gut (data not shown).  
To rule out any influence that bile acids may have on intestinal integrity, TER and 
macromolecule permeability was first tested on isolated ileum samples that were incubated 
with porcine bile acid (0, 3, 6 and 9 mg/ml) for thirty minutes. Thereafter, FITC-labeled 
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dextran (FITC-Dextran, 4.4 KDa) mucosal to serosal transport was measured as described 
previously [22]. Briefly, the mucosal chambers were challenged with 2.2 mg/mL FITC-
Dextran and chamber samples from both sides were collected every 10-15 min for eighty 
minutes. The relative fluorescence was then determined using a fluorescent plate reader (Bio-
Tek, USA) with the excitation and emission wavelengths of 485 and 520 nm, respectively. 
Thereafter, an apparent permeability coefficient (Papp) was calculated for each treatment:  
Papp = dQ/(dt×A×C0)  
Where: dQ/dt = transport rate (µg/min); C0  = initial concentration in the donor chamber 
(µg/ml); A = area of the membrane (cm2).  
 
The effect of dietary fat on endotoxin permeability was studied using ex vivo 
permeability of fluorescein isothiocyanate (FITC) labeled-LPS (Escherichia coli 055:B5) 
mounted into modified Ussing chambers. Briefly, segments of swine intestinal tissues were 
treated with either 12.5 % (v/v) buffered saline control (CON), FO or CLO manufactured by 
Spring Valley Inc., UT), VO, CO and OO purchased form Hy-Vee Supermarkets Inc., IA). 
All oils were commercial retail available and then mixed with 20 mM sodium 
taurodeoxycholate (bile acid) for micelle formation to simulate the intestinal milieu. Each 
mucosal chamber was then challenged with 20 µg/mL FITC-LPS and chamber samples were 
collected every 10-15 min for eighty minutes. The relative fluorescence of each sample was 
then determined using a fluorescent plate reader (Bio-Tek, USA) with the excitation and 
emission wavelengths of 485 and 520 nm, respectively.  The apparent permeability 
coefficient was then calculated similar to that described above for FITC-Dextran. 
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Lipid rafts, dietary oil and ex vivo intestinal endotoxin permeability 
To examine the role of lipid rafts in intestinal endotoxin permeability, ileum segments from 
16 pigs (56±4 days of age) were mounted in Ussing chambers as described above. Segments 
were pre-treated with or without 25 mM Methyl-β-cyclo dextrin (MβCD, a synthetic lipid 
raft modifier) for 30 min. Thereafter, the mucosal chamber was spiked with either saline-bile 
acid (CON) or Coconut oil-bile acid (12.5% v/v) and the FITC-LPS apparent permeability 
coefficient was calculated.  
 
Fatty acid analysis 
Fatty acid profiles of the dietary oils used to make the porridge were determined and 
analyzed by GC-MS [23, 24]. One ml oil was mixed with 0.5 mL of 4:1 hexane and 125 µg/L 
heptadecanoic acid was added to each sample as an internal standard. FAME were analyzed 
by GC on a Hewlett-Packard model 6890 fitted with an Omegawax 320 (30-m × 0.32-mm 
i.id. 0.25 um) capillary column. Hydrogen was the carrier gas. The temperature program 
ranged from 80 to 250°C with a temperature rise of 5°C/min. The injector and detector 
temperatures were 250°C and 1 µL of sample was injected and run split.  Fatty acids methyl 
esters were identified by their relative retention times on the column with respect to 
appropriate standards and heptadecanoic acid.  
 
Data analysis 
Results are presented as means ± S.E.M and were analyzed with the Proc Mixed procedure of 
SAS (Cary, NC). In the model, repetition or day of Ussing chamber run was used as a 
random effect. Statistical significance of difference was analyzed by analysis of variance 
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(ANOVA) followed by Tukey’s range test for pair wise comparison of all treatment means. 
Differences were considered significant at P ≤ 0.05 and a tendency at P ≤ 0.10. 
 
Results 
Dietary oil fatty acid profiles  
The fatty acid composition of the oils used to make the porridge meal and/or in the ex vivo 
transport study are reported in Table 1. The coconut oil contained high concentrations of 
saturated fatty acids (89 %), particularly lauric, myristic, and palmitic acids. Olive oil 
contained a very high content of monounsaturated oleic acid and a moderate amount of 
palmitic acid, with a saturated fat content of 29 %. Vegetable oil used in this study contained 
a high quantity (50 %) of arachidonic acid (20:4n6), 32 % oleic acid and 13 % palmitic acid. 
The fish oil used consisted of 35 % docosahexaenoic acid (DHA) and 19 % eicosapentaenoic 
acid (EPA), while the cod liver oil contained 32 % palmitic acid, 25 % arachidonic acid, 
8.6% EPA and 4.3% DHA. The n6:n3 ratio was highest in the olive oil > vegetable oil > cod 
liver oil > fish oil > coconut oil.  
Effect of dietary oil on postprandial serum endotoxin concentration  
To assess the effect of dietary lipids on postprandial serum endotoxin concentrations, pigs 
received a porridge meal containing either 50 mL of saline, CO, VO or FO. The endotoxin 
concentration of the various oils used did not differ (data not shown). Change in postprandial 
serum endotoxin concentration due to different meal treatments are presented in Figure 1A.  
The overall postprandial serum endotoxin concentrations were significantly lower in the 
meals constituting saline or FO, with the mean overall serum endotoxin concentration 
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increasing two-fold over the saturated coconut oil meal treatment (P<0.05, Figure 1B). 
However, meals made up with VO were not different from the saline, CO or FO treatments 
(P<0.05). Interestingly, the CO meal significantly elevated serum endotoxin concentrations 
after 2 hours versus the saline and FO, and these remained elevated at 3 and 5 hour 
postprandial (P<0.05, Figure 1A). 
Effect of exogenous porcine bile acid on ex vivo intestinal integrity  
Bile acids have been shown to increase the intestinal permeability in cultured Caco-2 cell 
lines [25]. To rule out the effect that exogenous bile acid may reduce intestinal integrity, 
freshly isolated pig ileum segments were used to measure TER (Figure 2A) and FITC-
Dextran permeability (Figure 2B). As these segments were exposed to increasing 
concentrations of porcine bile ex vivo, no differences in intestinal integrity were observed 
(P>0.10, Figure 2). This might be due to the tolerance of intestinal tissues towards bile acid 
because of previous exposure in vivo contrary to cell cultures where the cells are not exposed 
to the bile acids previously.  
Effect of dietary oil on ex vivo intestinal endotoxin permeability  
The ex vivo mucosal to serosal ileum endotoxin permeability was assessed using modified 
Ussing chambers and FITC-LPS permeability assay (Figure 3). Compared to the saline no oil 
control treatment, the endotoxin Papp was significantly lower in both the FO and CLO 
treatments (P<0.05). As hypothesized, the higher saturated fat content of CO significantly 
increased the endotoxin Papp compared to the saline, FO and CLO (P<0.05). However, 
mucosal treatment with VO and OO did not differ from the saline or n-3 treatments (P>0.05), 
but still attenuated endotoxin Papp versus the coconut oil treatment (P<0.05, Figure 3). 
Transepithelial resistance was not different due to ex vivo oil treatment (data not shown). 
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Effect of lipid raft modification of saturated fat induced endotoxin permeability  
To test the hypothesis that destabilization of intestinal lipid rafts would decrease saturated fat 
induced endotoxin permeability, colon samples were pretreated with the lipid raft modifier 
methyl-β-cyclodextrin (MβCD) and coconut oil ex vivo. FITC-LPS permeability was then 
measured (Figure 4A). As expected, the CO treatment significantly augmented the colon 
endotoxin Papp compared to the saline control (P<0.05). However, the endotoxin Papp was 
significantly reduced with the MβCD treatment compared to the saline control (1.54 vs. 0.07, 
P=0.04). In the presence of MβCD and CO, the colon Papp was attenuated three fold from 
the CO alone treatment (P<0.05).  Importantly, colon integrity and permeability as measured 
by transepithelial resistance was not altered by either short term CO, MβCD and the 
combination of these two treatments compared to the saline control (P=0.98, Figure 4B). 
 
Discussion 
In Western diets, vegetable, canola and palm oils are common components of the diet 
and to a lesser extent, long chain n-3 PUFA (DHA and EPA) oils from algal or marine 
sources [26, 27]. In recent years, the development of obesity, inflammation, atherosclerosis 
and other metabolic diseases has been linked to low grade endotoxemia associated with high 
dietary fat and energy intake [3, 14, 28-30]. Further, these studies and others have raised 
questions on whether this diet induced endotoxemia reflects changes in energy and fat 
content of the diet, intestinal permeability or diet induced changes in gut microbiota. In the 
current study, we used ex vivo and in vivo methods to examine intestinal permeability to 
endotoxin as it relates to dietary oil composition. All pigs were clinically healthy and raised 
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on typical commercial swine corn-soybean diets. We observed no differences in intestinal 
integrity due to our in vivo or ex vivo treatments [31]. Importantly, we only examined the 
acute actions of a meal or oil bolus treatment and did not conduct a prolonged feeding trial in 
an attempt to change the pig microbiota populations or the fatty acid profiles of tissues.     
We hypothesized that dietary intake of oils rich in DHA and EPA would attenuate 
intestinal LPS permeability and postprandial circulating endotoxin. We found that dietary 
cod liver and fish oils attenuated serum endotoxin concentrations compared to the coconut oil 
and the endotoxin levels in these pigs were similar to the control group (Figure 1). To the 
best of our knowledge, there are no other studies that have shown this effect of DHA and 
EPA on endotoxin transport and blood endotoxemia.  
Interestingly, only one paper has examined the effects of dietary oil composition on 
endotoxin uptake and related inflammation [6]. However, contrary to our results, the report 
by  [6]  laugerette et al states that rape seed (canola) and sunflower oil, with high unsaturated 
fatty acid content, augmented plasma endotoxemia by 50-75%.  Cani et al. [1], also observed 
a similar increase in endotoxemia in mice orally administered corn oil with or without LPS 
compared to water alone. However, we observed no change in serum postprandial endotoxin 
concentration or intestinal endotoxin transport due to dietary vegetable oil compared to the 
saline control (Figures 1 & 3). Further work is needed to explain these discrepancies between 
the two studies. Additionally, we also observed a significant increase in postprandial 
endotoxemia after a porridge meal mixed with coconut oil (Figure 1). Again, this contradicts 
data presented by Laugerette et al. [6] in which palm oil, high in saturated fatty acids, had no 
effect on plasma endotoxin concentrations in mice. However, these authors did report an 
increase in plasma LPS binding protein and argued that this protein is a better marker of 
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endotoxemia due to the short half-life of circulating endotoxin. One issue is that LPS binding 
protein can be up regulated by inflammation and acute stress as well as both gram positive 
and negative infections. As the magnitude of LBP response goes down with multiple 
episodes of infection [32], this could be a result of the agonistic effects of saturated fatty acid 
on pro-inflammatory signaling and not circulating endotoxin.   
Gram negative bacteria, particularly those found in the distal ileum and colon might 
be one of the major sources for circulating endotoxin [33]. It has been estimated that a single 
cell of Escherichia coli contains approximately 106 Lipid A or endotoxin molecules and a 
typical human intestinal tract could harbor approximately one gram of endotoxin [33-35]. 
Interestingly, the bacterial population in the intestine is not static. Multiple studies have 
shown that bacterial composition shifts to either gram positive majority or gram negative 
majority based on the composition of the diet consumed [36-38]. A majority of these studies 
show that consuming high saturated fat diet for longer period results in higher gram negative 
bacterial populations and high fiber diets results in gram positive bacterial populations. Even 
though there are no known techniques available to identify which bacterial species the LPS 
molecules originated from, it is believed that this endotoxemia is due to a raise in 
Enterobacteriaceae [37, 39]. Laugerette et al. [6], reaffirmed this and showed that fatty acid 
composition of different dietary oils can alter intestinal microbiota populations. Moreover, 
these authors demonstrated that feeding a diet high in palm oil which is rich in SFAs 
significantly increased the gram negative bacteria Escherichia coli groups, which can be 
significant source of endotoxin in the cecal content of mice compared to milk fat, rape seed 
and sunflower oil fed diets. 
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During intestinal stress, ischemia, inflammation and diseases, paracellular 
permeability occurs through the tight junction, as known as “leaky gut” [40]. Alternatively, 
transcellular or intracellular permeability can occur, particularly in healthy individuals [41]. 
Transcellular endotoxin transported across a cell membrane has been shown to occur via 
TLR4 and soluble GPI anchored receptor CD14 in a lipid raft mediated mechanism [42, 43]. 
Additionally, chylomicron associated LPS permeability has also been suggested to play a key 
role in intestinal LPS transport from the intestinal epithelial cell [11, 44, 45].  Importantly, 
we observed no decrease in intestinal integrity which might enhance paracellular 
permeability as assessed by transepithelial resistance or FITC-dextran permeability due to 
treatment or short term raft destabilization (Figure 4B). These data suggest that under healthy 
intestinal epithelial conditions, endotoxin is most likely transported via lipid raft mediated 
endocytosis.  
The signaling and transport process for endotoxin is initiated in specialized 
membrane micro domains called lipid rafts [43]. Lipid rafts are membrane regions rich in 
cholesterol, glycolipids, sphingolipids and saturated fatty acids, which result in a ‘rigid’ 
membrane structure compared to the adjacent ‘fluid’ regions [46]. In immune cells, LPS 
triggers the recruitment of TLR4 into the lipid raft, where it interacts with CD14 and other 
associated proteins such as MD-2 resulting in an inflammatory signaling cascade [47, 48].  
Thus, the two major consequences of preventing endotoxin recognition by dissociating the 
lipid raft to attenuate TLR4 recruitment include reduced inflammatory signaling and 
attenuated LPS permeability. We observed that if intestinal lipid rafts are dissociated ex vivo 
with MβCD, then endotoxin permeability is attenuated in the ileum (Figure 4). Interestingly, 
saturated fat induced endotoxin permeability is also significantly reduced. Stimulation of 
76 
 
 
 
TLR4 receptor has been shown to result in the endotoxin permeability across the intestinal 
epithelial cells [41]. TLR4 is not only implicated in the transcellular permeability of LPS but 
also for live bacteria [49]. Since saturated fatty acids and n-3 PUFA can reciprocally 
modulate TLR4 signaling [50], the fatty acid composition of oil in the diet has the potential 
to increase or decrease endotoxin transport. Altogether, these data suggest that apical 
endotoxin transport in the intestines is arguably raft mediated in healthy individuals. 
In vitro experiments show clearly that n-3 PUFA disrupt TLR4 signalling and the 
activation of NFκB by LPS in a murine monocytic cell line [51]. Moreover, DHA modulates 
TLR4 signaling in vitro in RAW 264.7 macrophages and 293T cells [50], human monocytes 
and dendritic cells [52] and adipose tissue. We have previously shown in pigs that dietary 
EPA and DHA are effective means of influencing the inflammatory status and pathways 
influenced by TLR4 signaling induced by LPS [53] and in altering intestinal function [24, 
54]. Therefore, one could postulate that antagonizing TLR4 recruitment to lipid rafts and it’s 
signaling by DHA and EPA, or stimulating these processes with saturated fatty acids, would 
lead to increased endotoxin transport and circulating postprandial endotoxin. 
Another mechanism through which LPS can enter the circulation is through micelles.  
Since the LPS side chains are made up of fatty acids, LPS can be incorporated into the 
micelles and transported into the intestinal epithelial cell [55]. In intestinal epithelial cells, 
chylomicrons transport the absorbed lipids into various parts of the body. High fat 
administration has been shown to proportionately increase the endotoxin content of the 
chylomicron indicating that high fat consumption indeed enhances higher endotoxin 
permeability into the intestinal epithelial cell and incorporation into chylomicron [11, 56]. 
Furthermore, even though the mechanism is not clear, high intake of fat has been shown to 
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cause internalization of tight junction proteins and increase in the paracellular permeability to 
macro molecules including endotoxin [37]. Even though, this mode of endotoxin 
permeability cannot be ruled out, we speculate that the rate of incorporation of fatty acids 
into micelles would not vary due to oil composition. Therefore, we propose that the 
difference in intestinal endotoxin permeability we observed is primarily transcellular 
permeability that involves lipid rafts and receptor mediated endocytosis [43]. 
In conclusion, these data suggest that dietary oils can differentially alter intestinal 
LPS permeability. Oils rich in DHA and EPA seem to attenuate LPS permeability, while oils 
high in saturate fatty acids seem to augment LPS permeability. Furthermore, intestinal LPS 
permeability in healthy subjects may be regulated through a lipid raft mediated mechanism. 
Saturated fatty acids may be stabilizing the lipid rafts allowing for greater LPS permeability. 
Even though a transient increase in the permeability level may not cause an immediate 
significant physiological effect, this has been shown to result in transient increase in the pro-
inflammatory cytokines. Additionally, the biological relevance of the transient increase in 
serum endotoxins and their associated impact on health need to be studied further.  
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Figure 1. Dietary oil alters postprandial serum endotoxin concentrations in pigs fed a single 
dietary oil-based meal. A) Delta change in serum endotoxin concentrations. B) Mean 
postprandial serum endotoxin concentration. Different letters (a,b) represent significant 
difference at P<0.05. Treatments are a porridge meal made with either no oil (saline), fish oil 
(FO), vegetable oil (VO) and coconut oil (CO). n=6 pigs/treatment. Data are means ± S.E.M. 
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Figure 2. The effect of increasing porcine bile acid concentration on ex vivo intestinal 
integrity and permeability.  A) Transepithelial resistance (TER) and B) FITC-Dextran 
transport (4.4 kDa). Freshly isolated ileum samples were mounted into modified Ussing 
chambers and incubated with the indicated concentration of bile acid for 30 minutes and then 
FITC-Dextran was added to mucosal side. Permeation coefficient was calculated by taking 
samples from chambers every 10-15 minutes and measuring the amount of fluorescence.  
Different letters represent significant difference at P < 0.05. n = 11 pigs. Data are means ± 
S.E.M.   
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Figure 3. Ex vivo endotoxin transport in pig ileum tissue exposed to different dietary oil 
treatments. Freshly isolated ileum samples were mounted into modified Ussing chambers and 
mixed with the indicated oils and 20mM bile acid for 120 minutes and FITC-LPS transport 
was measured. Different letters represent significant difference at P < 0.05. n = 11 per 
treatment. Data are means ± S.E.M.  
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Figure 4. Lipid raft modifier methyl beta cyclodextrin (MβCD) decreases ex vivo endotoxin 
transport. A) Endotoxin transport and B) transepithelial resistance was measured using 
Ussing chambers in ileum tissues treated with either control (water), MβCD, coconut oil, or 
coconut oil plus MβCD. Tissue (n= 7 /trt) were pretreated with these treatments for 30 min 
before FITC-LPS transport was assessed. Different letters represent significant difference at 
P < 0.05. Data are means ± S.E.M. 
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         Table 1. Dietary oil fatty acid composition used to make the porridge (g/100g FA) 
 Oil Source 
Compound Coconut oil1 Fish oil2 Olive oil3 Vegetable oil4 Cod liver oil5 
8:0   8.22   0.00   0.01   0.00   0.00 
10:0   6.98   0.00   0.00   0.00   0.00 
12:0 36.51   0.00   0.05   0.03   0.00 
14:0 21.00   6.87   0.32   0.09   4.62 
16:0 11.87 14.78 25.74 12.84 32.24 
16:1   0.02   8.40   1.67   0.10   4.19 
18:0   3.61   2.99   2.60   5.67   4.02 
18:1   8.74   8.51 55.69 25.89 12.65 
18:2 n6   1.93   0.92 12.66 47.19 25.28 
18:3 n3   0.00   0.40   0.54   6.92   4.05 
20:5 n3   0.00 19.19   0.00   0.00   8.68 
22:6 n3   0.00 34.57   0.00   0.00   4.27 
Other   1.11   3.38   0.71   1.26   0.00 
Saturated 88.96 24.63 29.20 19.70 40.88 
n3   0.00 54.17   0.54   6.92 17.00 
n6   1.93   1.99 12.66 47.19 25.28 
n6:n3   0.00   0.04 23.37   6.82   1.49 
 1Source coconut oil was (Spectrum Naturals, NY) 
            2Source fish oil was (Spring Valley, UT) 
3Source olive oil was (Hy-Vee, IA) 
4Source vegetable oil was (Hy-Vee, IA) 
5Source cod liver oil was (Spring Valley, UT)
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Abstract 
Fish oil and its n-3 polyunsaturated fatty acids (PUFA), particularly docosahexaenoic 
acid (DHA) and eicosapentaenoic acid (EPA), have been shown to antagonize 
lipopolysaccharide (LPS)  or endotoxin  signaling and alter membrane lipid raft  size and 
order in immune cells. Therefore, we hypothesized that enrichment of intestinal epithelial 
membrane phospholipids with DHA and EPA would alter membrane composition and 
function. This enrichment would also reduce intestinal lipid raft mediated LPS permeability 
and signaling. Further, we also hypothesized that in the presence of a peak inflammatory 
challenge, intestinal LPS permeability and signaling would be dramatically altered due to 
desensitization of Toll like receptor 4 (TLR4) recruitment into lipid rafts. Twenty pigs 
(22±2.4 kg) were fed two diets: 1) control (CON); 2) CON plus 0.5% Gromega™ (Dn3, JBS 
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United Inc.), high in DHA and EPA n-3 PUFA. After eight weeks, CON and Dn3 pigs were 
challenged (n=5 pigs/trt) with either an intramuscular injection of Escherichia coli LPS 
(LPS; 10 µg/kg BW) or saline (SAL). Four hours after LPS or SAL, pigs were euthanized 
and ileum and colon segments mounted into Ussing chambers to measure ex vivo FITC-LPS 
apparent permeability coefficient (Papp) as a marker of LPS permeability. Ileum and colon 
mucosa were assessed for n-3 FA enrichment, lipid raft isolated and membrane localization 
of TLR4 determined. Compared to the CON, pigs fed Dn3 had increased ileum and colon 
EPA, DHA and total n-3 PUFA content (P<0.05; 200, 250, 300%, respectively). Overall, 
ileum LPS permeability did not differ due to FA or LPS treatments. However, Dn3-SAL 
treated pigs tended to have decreased LPS permeability by 37% compared to the CON-SAL 
pigs (P=0.06). Pigs challenged with LPS had attenuated colon LPS permeability (P=0.02). 
Pigs fed Dn3 also had reduced colon LPS permeability compared to the CON (P=0.03; 2.0 
vs. 7.4 Papp, respectively). Compared to CON-SAL pigs, ileum and colon TLR4 recruitment 
into lipid raft micro domains was decreased in the Dn3-SAL pigs. However, LPS reduced 
ileum lipid raft TLR4 protein in CON, but not in Dn3 fed pigs.  Localization of TLR4 into 
lipid raft did not differ in the colon of CON-LPS and Dn3-LPS groups. These data indicate 
that DHA and EPA decrease TLR4 recruitment into intestinal lipid raft. This may explain 
how n-3 PUFA attenuate receptor mediated LPS permeability and febrile response. 
Furthermore, reduced lipid raft localization of TLR4 post LPS challenge, may describe an 
LPS tolerance mechanism. 
 
Supplementary key words:   Lipopolysaccharide • Endotoxin • Intestine • Lipid raft • n-3 
polyunsaturated fatty acids • Pigs 
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Introduction 
Lipopolysaccharide (LPS) and endotoxemia is associated with the prevalence and 
incidence of inflammation, sepsis, Alzheimer’s disease atherosclerosis and metabolic 
dysfunctions (1-3). Even though LPS is also synonymously known as endotoxin in the 
scientific literature, there are biochemical and physiological differences between these two 
compounds. Therefore, for scientific clarity we will refer to LPS in this chapter. 
Lipopolysaccharide is an integral component of the gram negative bacterial cell wall outer 
membrane. Importantly, gram negative bacteria particularly that found in the distal small 
intestine, cecum and colon, can be major sources of circulating Lipopolysaccharide (4). 
However, the intestinal epithelium provides a physical barrier that separates luminal bacteria 
and other inflammatory molecules from entering the systemic circulation. This is critical, as 
it has been estimated that a single cell of Escherichia coli contains approximately 106 LPS 
molecules (5).  
Lipopolysaccharide is recognized by numerous cell types including immune cells, 
myocytes, adipocytes and intestinal epithelial cells (IEC), to produce pro-inflammatory 
cytokines that contribute to the efficient control of invading molecule. Structurally, LPS 
consists of an O-polysaccharide, core polysaccharide and a Lipid A region which possess the 
most biological endotoxic activity. Its recognition and signaling is mediated via TLR4, a key 
membrane pattern recognition receptor that in association with LPS-binding protein (LBP), 
CD14 and MD2, results in the transmission of the signal into the cell to initiate the 
inflammatory signaling cascade (6). Moreover, recent work has revealed that for this signal 
to occur TLR4 protein is recruited in membrane microdomains called lipid rafts following 
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stimulation by LPS and that subsequent lipid raft integrity is crucial for LPS-induced cellular 
activation (7).  
Lipid rafts are membrane regions rich in cholesterol, glycolipids, sphingolipids and 
saturated fatty acids (SFA), which result in a ‘rigid’ membrane structure compared to the 
adjacent ‘fluid’ regions (8). However, these dynamic assemblies of cholesterol and 
sphingolipids are not only important in signal transduction and partitioning of receptors into 
raft regions, but also bacterial invasion (9). Interestingly, recent work in T cell and B cell 
models has demonstrated dietary fatty acids to alter lipid raft structure and function. 
Moreover, when n-3 polyunsaturated fatty acids (PUFA) such as docosahexaenoic acid 
(DHA) and eicosapentaenoic acid (EPA) are packed into raft microdomains, changes in the 
molecular composition and order of lipid rafts may occur (10-12). Consequently, these 
disordered-dissociated raft environments due to n-3 PUFAs alter protein clustering and 
cellular function and may explain the immuno-suppressive and anti-inflammatory benefits of 
n-3 PUFA.  
Therefore, in the present study we hypothesized that enrichment of intestinal epithelial 
membrane phospholipids with DHA and EPA would alter membrane composition and 
function. This enrichment would reduce intestinal lipid raft mediated LPS permeability and 
signaling. Further, in the presence of a peak immune challenge, intestinal LPS permeability 
and signaling would be dramatically altered due to desensitization of TLR4 recruitment to 
lipid rafts.  
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Materials and Methods 
Materials. All the chemicals used for the experiment were purchased from Sigma-Aldrich 
(St. Louis, MO) unless otherwise stated. The dietary source of n-3 PUFA, Gromega™ (JBS 
United Inc., Sheridan, IN) contained 14% DHA and 14% EPA of total fat.  Anti-TLR4, anti-
CD14 and anti-galectin4 and their respective secondary antibodies were obtained from Santa 
Cruz Biotechnologies (Santa Cruz, CA).  
 
Animals and Experimental Design. All animal procedures were approved by the Iowa State 
University Institutional Animal Care and Use Committee and adhered to the ethical and 
humane use of animals for research.  Twenty pigs (22 ± 2.4 kg BW) were individually 
penned and fed one of two diets for eight weeks. Ten pigs were fed a standard corn-soybean 
control diet (CON) and ten pigs were fed the basal diet supplemented with 0.5 % Gromega™ 
(Dn3, JBS United Inc., Sheridan, IN), which was high in DHA and EPA (Table 1). 
Gromega™ was mixed in the basal diet in substitution to corn. Both diets were formulated to 
meet or exceed the swine nutrient requirements (13). Pigs were fed ad libitum and had free 
access to water all the time. After 8 weeks of tissue n-3 PUFA enrichment, both the CON and 
Dn3 groups were fasted overnight, equally sub-divided (n=5/trt) and challenged with either 
an intramuscular injection of saline (SAL) or lipopolysaccharide (LPS, from Escherichia coli 
serotype 055:B5, 10 µg/kg BW, Sigma, St. Louis, MO). Following the peak febrile response, 
as measured by rectal temperature, blood was collected for measuring serum endotoxin 
concentrations and other inflammatory parameters. Blood was collected by venipuncture in 
pyrogen-free vaccutainer tubes using a sterile needle. Proper precautionary measures were 
taken to prevent external contamination of blood.   Pigs were euthanized via captive bolt and 
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immediate exsanguination.  Immediately following euthanasia, fresh segments of ileum and 
colon were collected for intestinal function assays. A 20 cm segment of ileum 120 cm from 
the ileal-cecal junction and a 10 cm segment of proximal colon 60 cm from the rectum were 
isolated. Serosal stripped segments and mucosal scrapings were collected from both the 
ileum and colon, snap frozen in liquid nitrogen and stored at -80 oC until further analysis. All 
fresh and frozen segments of ileum and colon were flushed with ice cold Krebs buffer to 
remove any undigested food material before freezing as well as before mucosal scrapings 
collection. 
 
Intestinal Function and Permeability.  Fresh segments of the ileum and colon were removed 
and placed in chilled Krebs-Henseleit buffer (consisting of, in mmol/L: NaHCO3, 120 NaCl, 
1 MgSO4, 6.3 KCl, 2 CaCl, 0.32 NaH2PO4; pH 7.4) for transport to the laboratory while 
under constant aeration until clamped in the modified Ussing chambers. Tissues stripped of 
outer serosal layers were immediately mounted in a modified Ussing Chamber. Each 
segment (0.71 cm2) was bathed on its mucosal and serosal sides with Krebs buffer and 
constantly gassed with 95% O2-5% CO2 mixture and the temperature was maintained at 37°C 
by circulating water. Each chamber was connected to a pair of dual channel current and 
voltage electrodes submerged in 3% noble agar bridges and filled with 3M potassium 
chloride for electrical conductance (Physiologic Instruments Inc., San Diego, CA and World 
Precision Instruments Inc. Sarasota, FL) to measure tight junction integrity and the mucosal 
to serosal permeability. A short circuit current was established and stabilized for about 10 
minutes and basal measurements like potential difference (PD), resistance (R), short circuit 
current (ISC) were taken using the included software (Acquire and Analyze, Physiological 
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instruments). The measurements were observed in a computer monitor in real-time as line 
graphs and tissue responses were monitored continuously.  Resistance of the tissue was 
determined by passing a current of 100 µA across the tissue using the electrodes and 
correcting for the PD deflection for fluid resistance. The current required to nullify the PD 
present on the tissue is termed ISC and it is a measure of net active ion transport in the 
intestinal tissue. The ISC of the intestinal tissue was calculated from simultaneous PD and R 
measurements by using ohm’s law, I = V/R, where I is the current in amperes, V is the 
electromotive force in volts, and R is the resistance in ohms.  
Additionally, the mucosal to serosal permeability of LPS was assessed as previously 
described by Tomita et al (14). Briefly, the mucosal chambers were challenged with 20 
µg/mL fluorescein isothiocyanate labeled LPS (FITC-LPS) and chamber samples from both 
sides were collected every 10-15 min. The relative fluorescence was then determined using a 
fluorescent plate reader (BioTek, Winooski, VT) with the excitation and emission 
wavelengths of 485 and 520 nm, respectively.  An apparent permeability coefficient (Papp) 
was then calculated (14) using the area of the membrane and rate of FITC-LPS permeability, 
where dQ/dt = transport rate (µg/min); C0 = initial concentration in the donor chamber 
(µg/mL); A = area of the membrane (cm2): 
   Papp = dQ/(dt×A×C0) 
 
Serum Endotoxin Assay. Serum LPS concentration was measured by an end point fluorescent 
assay using the recombinant factor C (rFC) system (LonzaTM, Basel, Switzerland). Briefly, 
the serum samples were diluted 1,000 times and 100 µL of the samples and standards were 
added to a 96 well round bottom plate and incubated at 37 °C for 10 min. After incubation, 
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100 µL of rFC enzyme, rFC assay buffer and rFC substrate were added at a ratio of 1:4:5 to 
the plate and an initial reading were taken followed by 1 h incubation at 37 °C. Thereafter the 
relative fluorescence unit (RFU) for each well was determined (excitation 380 nm and 
emission 440 nm). A positive control from the assay kit was used to ascertain the validity of 
the assay and the concentration of the endotoxin was interpolated from the standard curve 
constructed from the standards and corrected for sample dilution. 
 
Subcellular Fractionation of the Intestinal Epithelium. Apical membranes were isolated from 
fresh mucosal scrapings based on divalent cation precipitation method as previously 
described (15, 16). All the procedures were performed on ice unless otherwise stated. Briefly, 
the mucosal scrapings were homogenized (1:10 w/v) in a homogenization buffer (containing 
2 mM Tris-HCL and 50 mM mannitol, pH 7.1 and protease inhibitor cocktail (Complete, 
Roche, IN)) using a mechanical homogenizer. The resulting homogenate was centrifuged at 
500 x g for 10 min to remove all the unbroken cells and nuclear debris. The resulting 
supernatant was then further centrifuged at 2,700 x g for 10 min to sediment the 
mitochondria. The supernatant was then adjudged with 10 mM MgCl2, incubated on ice for 
10 min and centrifuged at 1,150 x g. The supernatant was then further centrifuged at 48,000 x 
g for 60 min. The resulting pellet was saved and contained the apical membranes. Purity of 
the apical membrane preparation was ascertained by measuring the alkaline phosphatase 
activity using quantichrom™ alkaline phosphatase assay kit (DALP-250, Gentaur, 
Kampenhout, Belgium) according to the manufacturer’s instructions. 
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Lipid Raft Isolation. Lipid raft fractions from the pig intestinal membranes were obtained 
according to the method described by Danielsen et al (17) and  Nguyen et al (18). Briefly, 1-
2 mg/mL of apical membrane protein were dissolved in a Hepes/NaCl buffer (pH 7.1, 25 mM 
and 150 mM, respectively) containing 1% triton-100 for 10 min on ice. The extracts were 
then laid on top of equal volume of 80% sucrose with in an ultracentrifuge tube resulting in a 
final concentration of 40% sucrose. This preparation was layered on top with 30% and 5% 
sucrose with a volume of 4.3 mL and 1.75 mL respectively. This was centrifuged at 217,000 
x g for 20 h at 4 °C and 12 fractions were collected per tube. Each fraction was 800 µL 
starting with fraction one at the top and twelve at the bottom. The protein concentration of 
each lipid raft fraction was determined using BCA assay (Pierce, Rockford, IL). Lipid raft 
fractions were confirmed by cholesterol enrichment and the presence of the intestinal lipid 
raft marker protein galectin 4. Cholesterol content of the lipid raft fractions were measured 
using a Cholesterol Assay Kit (Molecular Probes, Eugene, OR) according to the 
manufacturer’s instructions. 
  
Protein Expression. Lipid raft protein marker galectin 4 and proteins of interest, TLR4 and 
CD14, were measured by dot blot method. Briefly, 10-20 µg protein of the lipid raft fractions 
were applied directly on a nitrocellulose membrane by vacuum and then blocked with 5% 
non-fat dry milk. The primary antibody was added at a concentration according to the 
manufacturer’s instruction and incubated overnight. The secondary antibody was added at a 
concentration of 1:10,000 to 1:20,000. Blots were developed by a chemiluminescence 
detection kit according to the protocol supplied by the manufacturer (Pierce, Rockford, IL). 
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Phospholipid fatty acid composition. Total lipids from lipid raft and non-raft regions of the 
membrane fractions were extracted by the method of Folch et al (19). Individual 
phospholipids were separated by one dimensional thin layer chromatography as described by 
Chapkin et al (10) using silica gel 60 G plates. Developing solvent used was 
Chloroform/methanol/acetic acid/water (50:37.5:3.5:2, v/v). Individual phospholipids were 
scraped from TLC plate and spiked with 125 µg/L of heptadecanoic acid (17:0) as an internal 
standard. Trans-esterification was carried out using 6% methanolic-HCl for 16-18 h while 
heating at 75 oC. The resulting FAME were then analyzed using gas chromatography by the 
method described below.  
 
Fatty acid profiles.  Intestinal fatty acid profiles were determined according to Lepage and 
Roy (20) and analyzed by GC-MS. Briefly, 0.5 g of tissue was homogenized in 2.5 ml of 4:1 
Hexane and 125 µg/L of heptadecanoic acid/L methanol was added to each sample as an 
internal standard. FAME were analyzed by GC on a Hewlett-Packard model 6890 fitted with 
a Omegawax 320 (30-m × 0.32-mm i.d, 0.25 µm) capillary column (Sigma-Aldrich, St Louis, 
USA). Hydrogen was the carrier gas. The temperature program ranged from 80 to 250°C 
with a temperature rise of 5°C/min. The injector and detector temperatures were 250°C and 1 
µL of sample was injected and run splitless.  Fatty acids methyl esters were identified by 
their retention times on the column with respect to appropriate standards.  
 
Statistical Analysis. All data are expressed as means ± SEM. The main effects of dietary 
treatment, challenge and their interaction were determined by the Proc Mixed procedure in 
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SAS (Cary, NC), and differences were established using the least significant difference. 
Differences were deemed significant at P < 0.05 and tendency at P < 0.10. 
 
Results 
EPA and DHA supplementation leads to enrichment of the intestine. Pigs were fed a 
regular corn-soybean meal diet (CON, n=10) or a diet supplemented with 0.5% EPA and 
DHA (Dn3, n=10) for eight weeks from weaning. Although not the objective of this study, 
no differences in feed intake or body weight gains were observed between the two treatments 
(data not shown). Both ileum and colon mucosal scrapings fatty acid profiles were analyzed 
to ascertain the EPA and DHA enrichment of the intestinal epithelial tissue (Table 2). As 
expected, the Dn3 group had a significantly higher EPA and DHA in both ileum and colon 
than the CON group indicating that the intestinal epithelium was enriched with n-3 PUFA’s 
(Table 2).  Interestingly, we saw a corresponding decrease in the n-6 fatty acid, arachidonic 
acid (AA) in ileum, as well as colon. The n6:n3 PUFA ratio was also reduced in the Dn3 
treatment. The 4 h LPS challenge did not affect the fatty acid composition of the tissues (data 
not shown). 
 
Dietary n-3 PUFA reduces serum LPS concentration.  Circulating LPS concentrations 
were measured in serum to assess whether dietary EPA and DHA could attenuate blood 
endotoxemia. Compared to the CON group, serum LPS concentrations were significantly 
lower in the Dn3 pigs (P<0.05, Fig. 1). This indicates that long term dietary n-3 PUFA 
supplementation can modulate endogenous blood endotoxin concentrations.  
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Anti-inflammatory effect of EPA and DHA supplementation. CON and Dn3 pigs were 
subdivided into two groups (n=5) and challenged with either an intramuscular injection of 
saline or lipopolysaccharide to study the effect of dietary n-3 PUFA on an inflammatory 
challenge. A gross assessment of this inflammatory challenge was indicated by the changes 
in the pig’s febrile response to SAL or LPS (Figure 2). Irrespective of diet, LPS challenged 
pigs had higher rectal temperatures than SAL group (P<0.001). After 1 h, both the LPS 
challenged groups had significantly higher rectal temperatures compared to the SAL groups. 
However, the Dn3 pigs had an attenuated febrile response to LPS compared to the CON-LPS 
pigs (P=0.011). Interestingly, Dn3 challenged group had a numerically lower febrile response 
at two hours which became significantly lower than the CON challenged group by 4 hour 
(P<0.05).   
 
Ileum integrity increases under EPA and DHA supplementation. Transepithelial 
electrical resistance (TER) is a measure of intestinal permeability and integrity. Higher TER 
values indicate a healthy, less macromolecular permeable intestine with well-formed tight 
junctions. TER was measured in the ileum of CON and Dn3 pigs before the FITC-LPS 
permeability.  Dn3-SAL group had a higher TER than any other treatment groups indicating 
supplementation with EPA and DHA improves the health of the intestine. Interestingly, LPS 
challenge did not change the TER integrity in the CON-LPS, but lowered the TER in the 
Dn3-LPS group (Fig. 3). This indicates that n-3 PUFA helps in maintaining a healthy 
intestine under normal circumstances, but not under a systemic immune challenge.  
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We hypothesized that EPA and DHA enrichment of the intestinal epithelium would 
mitigate mucosal to serosal permeability of LPS from the intestinal lumen. To test this 
hypothesis, we used the Ussing chamber model to study the ex-vivo permeability of FITC-
LPS in the ileum and colon tissues. In ileum, the Dn3-SAL group tended to have a lower ex-
vivo LPS permeability compared to the CON-SAL group (4.7 vs. 1.8). Furthermore, LPS 
challenges tended to reduce the LPS permeability compared to the CON-SAL (P < 0.10). 
However, colon LPS permeability (Fig. 4B) in the CON-SAL pigs were higher than the Dn3-
SAL pigs (11.4 vs. 3.3, P=0.02). Irrespective of diet, LPS challenge lowered LPS 
permeability compared to SAL challenged pigs in colon. However, colon LPS permeability 
did not differ between the CON-LPS and Dn3-LPS pigs (P>0.05).  
 
EPA and DHA enrichment alters the fatty acid composition of ileum and colon lipid 
rafts. The fatty acid composition of phospholipids in the lipid raft fractions from the ileum 
(Fig. 5) and colon (Fig. 6) which were separated using thin layer chromatography was 
analyzed by GC-MS. Lipopolysaccharide challenge did not affect the phospholipid 
composition in the raft and non-raft fractions and therefore only the CON and Dn3 treatment 
is shown. The sphingomyelin raft fractions were rich in the n-6 fatty acid, arachidonic acid 
(AA). The CON raft fractions were numerically higher in AA compared to other Dn3 raft and 
CON and Dn3 diet non-raft fractions. In the colon, again sphingomyelin AA content was 
higher in the CON raft fraction versus the Dn3 lipid raft, CON and Dn3 non-raft fractions. 
Interestingly, EPA and DHA were not detected in the sphingomyelin irrespective of dietary 
treatment (Fig. 5A and 6A).  
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Phosphatidyl serine had a better distribution of fatty acids across the fractions. AA 
was approximately three-fold higher in the CON raft and non-raft fractions of ileum, and 
two-fold higher in CON lipid raft colon fraction compared to Dn3 counterparts. EPA was 
detectable across all fractions. In ileum, Dn3 non-raft fraction was ten-fold higher in EPA 
than CON. In colon, Dn3 raft and non-raft fractions were eight- and eighteen-fold higher than 
their respective raft and non-raft fractions. DHA concentration, in ileum and colon, was four-
fold higher in the Dn3 raft fraction compared to the CON raft. In the non-raft fractions, DHA 
was 1.5-fold higher in ileum compared to 3-fold higher in colon (Fig. 5B and 6B). 
Phosphatidyl ethanolamine had a more even distribution of EPA, and DHA, as well 
as AA between the raft and non-raft fractions (Fig. 5C and 6C).  Ileum AA concentration was 
1.8-fold higher in CON non-raft fraction compared to raft.  Colon concentration of AA was 
approximately three- and two-fold higher in both CON raft and non-raft fractions, 
respectively, compared to Dn3 fractions. EPA was undetectable in CON raft from ileum and 
in the colon, higher EPA was present in CON non-raft ileum, while only trace amounts were 
present in CON non-raft colon. Both ileum and colon Dn3 raft and non-raft fractions were 
enriched with EPA and DHA. DHA was detectable in all the fractions and DHA 
concentration was four-to six-fold higher in the Dn3 raft fractions compared to the CON.  
Phosphatidyl inositol (Fig. 5D and 6D) had a higher AA in non-raft fractions of both 
ileum and colon and there was a corresponding decrease in the AA concentration in the Dn3 
fractions. EPA was not present in any of the lipid raft fractions.  EPA concentration was six-
fold higher in the Dn3 non-raft group in ileum, whereas present in equal concentration in 
colon non-raft fractions. DHA was not present in any of the lipid raft groups except colon 
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Dn3. In the non-raft groups, DHA concentration was ten-fold higher in Dn3 than CON in 
ileum, and five-fold higher in colon (Figure 5D and 6D).  
Phosphatidyl choline non-raft fractions were enriched with AA in both ileum and 
colon, and raft fractions contained only low quantities of AA (Fig. 5E and 6E). Surprisingly, 
we couldn’t detect EPA and DHA in raft fractions of both ileum and colon. EPA was rich in 
non-raft fractions of Dn3 ileum and CON and Dn3 colon. DHA was three-fold higher in both 
non-raft fractions of ileum and colon compared to CON (Fig. 5E and 6E).  
 
Dietary n-3 PUFA and LPS challenge alter TLR4 and CD14 localization in the 
intestinal epithelium lipid rafts. To pursue the mechanistic aspect of the difference in the 
LPS  between the CON and Dn3 enriched pigs, lipid rafts were isolated from the apical 
membrane of ileum (Fig. 7) and colon (Fig. 8) mucosal scrapings. Purity of the membrane 
preparation from contamination by immune cells was ascertained by measuring the alkaline 
phosphatase levels in both ileum and colon apical membranes (Supplemental figure 1and 2). 
Lipid raft and lipid insoluble (non-raft) fractions were identified by the presence of intestinal 
lipid raft marker protein galectin 4 and cholesterol. In our system and based on galectin 4 and 
cholesterol content, the raft fractions were identified as fractions 2-7, compared to the non-
raft fractions 1 and 8-12.  Irrespective of location, treatment with n-3 PUFA decreased TLR4 
protein levels in the rafts of pig ileum (Fig. 7) and colon (Fig. 8) fractions. Interestingly, the 
colon tissues had higher TLR4 expression than the ileum. However, exposure to LPS for four 
hours reduced TLR4 protein expression in the CON lipid raft fractions, but not the Dn3 
fractions. CD14 protein was found predominantly in the lipid raft fractions in both the ileum 
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(Fig. 7) and colon (Fig. 8). Similarly, LPS challenge also attenuated CD14 expression in 
these fractions. 
 
Modifications of lipid rafts reduce intestinal LPS permeability. Lipid rafts have been 
shown to be essential for TLR4 recruitment and LPS signaling as well as permeability in 
immune cells (21, 22). Therefore, we wanted to further test the role of lipid rafts in ileum and 
colon LPS permeability. To do this, freshly isolated ileum and colon segments were treated 
on their mucosal side with the lipid raft modifier methyl-β-cyclodextrin (MβCD; 25 mM).  
Methyl-β-cyclodextrin is a carbohydrate molecule with a pocket for binding cholesterol and 
its mode of action depletes cholesterol from the lipid raft microdomain to dissociate rafts (9). 
We hypothesized that by increasing raft dissociation and reducing TLR4 recruitment into the 
lipid raft microdomain, intestinal transcellular LPS permeability would be attenuated.  Thus, 
we have shown that incubation with MβCD significantly reduced the FITC-LPS permeability 
in both ileum and colon (Fig. 9). Interestingly, the effect was more pronounced in the colon 
compared to the ileum. This is indirect evidence that lipid raft play a significant role in 
intestinal LPS permeability.  
 
Discussion 
The health benefits of long chain n-3 PUFA such as those found in fish oil and algae, 
DHA and EPA, have been widely touted (23, 24). However, the biological impact of DHA 
and EPA enrichment into intestinal cell membranes and on LPS permeability and signaling 
has not been well established. We hypothesized that enrichment of intestinal epithelial 
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membrane phospholipids with DHA and EPA would alter membrane composition and 
function. Furthermore, this n-3 PUFA enrichment would reduce intestinal lipid raft mediated 
LPS permeability and signaling.  
We have previously shown that dietary EPA and DHA are effective in influencing the 
inflammatory status and those pathways influenced by TLR4 signaling (25). Moreover, this 
is further supported by the high consumption of EPA and DHA, 7.6 g/d, which inhibited 
TLR4 and NOD2 signaling pathways and improved intestinal integrity under inflammatory 
conditions in pigs (26).  Although not the main objective of the current study, the Dn3 pigs 
had a reduced LPS induced febrile and cytokine response to LPS compared to the CON pigs. 
Altogether, these data supports work that has shown n-3 PUFA to modulate the immune 
response and to be immuno-suppressive and anti-inflammatory (27, 28).  
Interestingly, the signaling process for LPS is initiated in specialized membrane 
micro domains called lipid rafts (7). Lipid rafts are membrane regions rich in cholesterol, 
glycolipids, sphingolipids and saturated fatty acids, which result in a ‘rigid’ membrane 
structure compared to the adjacent ‘fluid’ regions (8). In immune cells, LPS triggers the 
recruitment of TLR4 into the lipid raft where it interacts with CD14 and other associated 
proteins such as MD-2 resulting in an inflammatory signaling cascade (29, 30).  Thus, 
preventing LPS recognition by dissociating the lipid raft to attenuate TLR4 recruitment may 
have two major consequences. Firstly, reduced inflammatory signaling and secondly, 
attenuated LPS permeability.  
Enrichment of the membrane phospholipids with n-3 PUFA have been shown to alter 
membrane composition and function (26, 31, 32). This is in agreement with our current work 
in which dietary n-3 PUFA in the Dn3 pigs increased intestinal membrane DHA and EPA 
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contents compared to the CON pigs. Importantly, n-3 PUFA enrichment results in the 
dissociation of lipid rafts in T-cells (10, 11) and decreases the recruitment of TLR4 to the raft 
region in macrophages (28). n-3 PUFA enrichment of phosphatidyl ethanolamine and 
phoshphatidyl serine has been shown to dissociate the lipid rafts in T-cells (10). We also 
observed a similar result in our study. Therefore, lipid rafts may be a major target of DHA 
and EPA that lead to the down regulation of TLR4 signaling (33). Although TLR4 
recruitment into the lipid rafts has been poorly characterized, we have demonstrated that this 
does also occur in the pig intestinal epithelium and that DHA and EPA enrichment attenuates 
TLR4 protein recruitment into raft microdomains. Changes in raft lipid composition by DHA 
and EPA affect both the size and order of rafts (21) and cellular function (9, 34, 35).  
The permeability of gastrointestinal tract LPS has been shown to be modified by high 
dietary fat and caloric intake in humans and animals (36-38). Mechanistically, both bacteria 
and LPS intestinal permeability can occur via either a paracellular pathway through tight 
junction openings or transcellular pathways. Paracellular permeability is often associated 
with intestinal stress and hypoxia that modifies tight junction complexes and intestinal 
integrity (39). However, transcellular mediated LPS or bacterial permeability may also be 
independent to that of paracellular or tight junction facilitated permeability. Bacteria and LPS 
permeability across the intestinal epithelium has been shown to be mediated by TLR4 present 
in the IEC (14, 40). Additionally, lipids rafts have been found to be important in transcellular 
permeability of LPS and bacteria including E. coli, Salmonella, Listeria and Mycoplasma 
(41, 42). Thus, bacterial invasion and LPS permeability may exploit endocytic pathways 
facilitated by clustered lipid rafts.  This notion is supported by the fact that when colon or 
ileum segments are treated with MβCD, we observed a significant reduction in FITC-LPS 
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permeability. Pretreatment of IEC cells with MβCD has also shown to reduce LPS-mediated 
NFκB activation in a dose dependent manner which was reversed with cholesterol addition 
because MβCD acts by decreasing the cholesterol content of the cell membrane (43). 
Collectively, these data suggest that LPS permeability and TLR4 mediated signaling in 
intestinal epithelial cells requires the presence of lipid rafts. 
An intriguing result from our current study was the observation that a four hour LPS 
challenge decreased TLR4 localization into the lipid raft fractions. This decreased membrane 
protein localization must be a mechanism for LPS tolerance. Studies have shown that prior 
exposure to LPS leads to a transient state of refractoriness to further LPS re-stimulation and 
decreases cell surface expression of TLR4 (25, 44). However, LPS tolerance studies using 
human THP-1 cells have shown TLR4 surface expression is unchanged post LPS challenge, 
but LPS mediated TLR4 mobilization to lipid rafts was attenuated during tolerance (45). 
Furthermore, this tolerance appears to be protein kinase C (PKC)-ζ and the phosphatase 
SHIP dependent and is restored upon the restoration of PKC activity (45). Therefore, TLR4 
appears to be not constitutively found within the rafts, but recruited following initial 
stimulation to initiate a receptor response. 
 In conclusion, our data demonstrates that EPA and DHA supplementation enriches 
specific intestinal epithelial membrane phospholipids. This results in dissociation of lipid 
rafts leading to dislocation of LPS signaling proteins like TLR4 and CD14 from the rafts. 
Thus, giving rise to decreased recognition, permeability and signaling of LPS. This may 
mechanistically explain why endogenous and exogenous LPS induced inflammatory and 
febrile responses are attenuated due to dietary DHA and EPA. Our results also indicate that 
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during an immune challenge, EPA and DHA supplemented animals are well equipped to 
fight the challenge.  
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Table1. Feed composition of the experimental diet (%, as fed basis) 
                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Gromega™ was supplied by JBS United, Inc., containing approximately 14% EPA and 14% DHA 
of total fatty acids. 
2Supplied per kilogram of diet: vitamin A, 8364 IU; vitamin D3, 1533 IU; vitamin E, 45 IU; vitamin 
K, 2.2 IU; choline, 6.5 mg; riboflavin, 4.2 mg; niacin, 21 mg; pantothenic acid, 17 mg; vitamin B-12, 
28 mg; biotin, 1.6 mcg; folic acid, 0.0005 mg; Zn, 112 ppm as zinc sulfate and zinc oxide; Mn, 54 
ppm as manganous oxide; Fe, 145 ppm as ferrous carbonate and ferrous sulfate; Cu, 20 ppm as 
copper chloride; I, 0.76 ppm as ethylenediamine dihydriodide; Se, 0.25 ppm as sodium selenite. 
 
   Feed Component Control Dn3 
Corn 61.11 60.59 
Soybean meal 48% 31.67 31.67 
Meat & bone Meal 5.00 5.00 
Salt 0.56 0.56 
Gromega™ 1 - 0.53 
Dicalcium phosphate 0.41 0.41 
L-Lysine 0.36 0.36 
DL-Methionine 0.18 0.18 
Limestone 0.17 0.17 
Threonine 0.11 0.11 
Premix2 0.36 0.36 
Selenium 0.05 0.05 
Choline chloride 0.03 0.03 
Calculated composition   
   Energy, kcal/kg 3,238 3,238 
   Crude Protein, % 22.36 22.36 
   SID Lysine, % 1.35 1.35 
   Available Phosphorus, % 0.37 0.37 
   Ether Extract, % 3.80 3.80 
   Crude Fiber, % 2.36 2.36 
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Table 2. Fatty acid composition of ileum and colon of mucosal scrapings in pigs fed either 
the control diet (CON) or a diet enriched with long chain n-3 PUFA (Dn3). 
  Ileum Colon 
Fatty Acid (%) CON1 Dn31 P-value3 CON1 Dn31 P-value3 
14:0   0.23 ± 0.09   0.57 ± 0.09    0.03   1.00± 0.14   0.76± 0.14    0.27 
16:0 22.51 ± 0.86 25.29 ± 0.86    0.05 22.41± 0.28 22.32± 0.28    0.83 
16:1   1.66 ± 0.31   2.09 ± 0.31    0.37   2.73 ± 0.32   2.64 ± 0.32    0.84 
18:0 14.85 ± 0.63 16.00 ± 0.63    0.43 23.71 ± 0.74 18.9 ± 0.74    0.0018 
trans-18:1n-9   3.13 ± 0.9   3.12 ± 0.9    0.83   4.43 ± 0.61   4.96± 0.61    0.24 
cis-18:1n-9 18.99 ± 0.49 19.27 ± 0.49    0.98 22.80 ± 0.25 23.91 ± 0.25    0.18 
18:3n-3   0.67 ± 0.07   0.63 ± 0.07    0.70 ND2 ND2  
20:0   0.00 ± 0.07   0.15 ± 0.07    0.14   0.19 ± 0.08   0.00± 0.08    0.14 
20:1   0.08 ± 0.11   0.26 ± 0.11    0.25   0.29 ± 0.12   0.20 ± 0.12    0.62 
20:2   0.67 ± 0.03   0.62 ± 0.03    0.13   0.47 ± 0.11   0.47 ± 0.11    0.98 
20:3n-6   0.57 ± 0.03   0.73 ± 0.03    0.006   0.41 ± 0.08   0.78  ± 0.08    0.01 
20:4n-6   7.40 ±0.38   5.83 ± 0.38    0.02   6.17 ± 0.42   4.64 ± 0.42    0.03 
20:5n-3 (EPA)   0.00 ± 0.07   1.18 ± 0.07 < 0.0001   0.00 ± 0.04   0.87 ± 0.04 < 0.0001 
22:0   0.47 ± 0.03   0.53 ± 0.03    0.15   0.27 ± 0.12   0.21 ± 0.12    0.77 
24:0   0.85 ± 0.06   0.98 ± 0.06    0.14   0.81 ± 0.05   1.01 ± 0.05    0.03 
24:1   0.37 ± 0.07   0.47 ± 0.07    0.35   0.36 ± 0.12   0.24 ± 0.12    0.51 
22:6n-3 (DHA)   0.88 ± 0.24   1.72 ± 0.24    0.006   0.07 ± 0.11   1.31 ± 0.11 < 0.0001 
Saturated 39.00 ± 1.24 43.37 ± 1.24    0.04 49.66 ± 0.73 44.26 ± 0.73    0.0008 
∑(n-3) PUFA   1.56 ± 0.35   3.98 ± 0.35    0.001   0.07 ± 0.13   2.18 ± 0.13 < 0.0001 
∑(n-6) PUFA 29.35 ± 1.34 24.47 ± 1.34    0.03 15.77 ± 0.98 17.21 ± 0.98    0.33 
(n-6)/(n-3) 20.51 ± 1.57   6.29 ± 1.57    0.0006 46.37 ± 1.7   8.11 ± 1.7 < 0.0001 
1Fatty acid composition was measured by GC-MS on five pigs per treatment and expressed 
as a percentage of total fatty acids analyzed (mean fatty acid ± SEM). 
2ND, not detected. 
3Within tissue, significant difference between CONT verses Dn3.  
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Fig. 1. Dietary n-3 PUFA decreases endogenous serum LPS concentrations in pigs. Pigs were 
fed either a control (CON) or DHA and EPA rich (Dn3) diets for eight weeks. n= 5 pigs/trt. 
Different letters represent significant difference at P < 0.05.  
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Fig. 2. Dietary n-3 PUFA attenuates the febrile response in pigs induced by 
lipopolysaccharide (LPS) immune challenge. Pigs fed either a control (CON) or n-3 PUFA 
(Dn3) diet for eight weeks were immune challenged with LPS 10 µg/kg (LPS) or saline 
(SAL) control non-challenged. Rectal temperatures were measured every hour to assess the 
febrile response. Different letters a,b,c represent significant differences (P<0.05) within each 
hour. n = 5 pigs/trt/challenge/time.  
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Fig. 3. Effect of dietary n-3 PUFA supplementation and LPS challenge on transepithelial 
electrical resistance (TER) of the ileum measured in the Ussing chamber in pigs fed either 
control (CON) or n-3 PUFA (Dn3) diets and immune challenged with either saline (SAL) or 
Lipopolysaccharide 10 µg/kg (LPS) four hours post-challenge. n= 5 pigs/trt. Different letters 
represent significant difference at P < 0.05.  
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Fig. 4. Dietary n-3 PUFA supplementation and inflammatory challenge decrease LPS 
permeability  in ileum and colon. Ex vivo ileum (a) and colon (b) LPS permeability in the 
Ussing chamber in pigs fed either control (CON) or n-3 FA’s rich (Dn3) diets and immune 
challenged with either saline (SAL) or lipopolysaccharide 10 µg/kg (LPS) four hours post 
challenge. n= 5 pigs/trt. Different letters represent significant difference at P < 0.05 and * 
represents tendency P < 0.10.  
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Fig. 5.  Dietary n-3 PUFA supplementation enriches PUFA content of specific phospholipid classes  of ileum. Lipid raft fractions 
were isolated from the apical membrane of ileum, phospholipids were isolated from the fractions  using thin layer 
chromatography. Fatty acid composition of each phospholipid was identified and quantified. Phosphatidyl serine and phosphatidyl 
ethatnolamine were enriched in n-3 PUFA. 
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Fig. 6.  Dietary n-3 PUFA supplementation enriches PUFA content of specific phospholipid classes of colon. Lipid raft fractions 
were isolated from the apical membrane, phospholipids were isolated from the fractions  using thin layer chromatography. Fatty 
acid composition of each phospholipid was identified and quantified. Phosphatidyl serine and phosphatidyl ethatnolamine were 
enriched in n-3 PUFA.    
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Fig. 7. Dietary n-3 PUFA supplementation and immune challenge decrease the localization 
of LPS signaling proteins TLR 4 and CD 14. Lipid raft fractions were isolated from the brush 
border membrane of ileum, cholesterol and Galectin 4 were used as lipid raft markers. 
Fractions 2-7 were considered raft or lipid soluble fractions and 8-12 were considered non-
raft or lipid insoluble fractions.   
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Fig. 8.  Dietary n-3 PUFA supplementation and inflammatory challenge decrease the 
localization of LPS signaling proteins TLR 4 and CD 14. Lipid raft fractions were isolated 
from the apical membrane of colon, cholesterol and Galectin 4 were used as lipid raft 
markers. Fractions 2-7 were considered raft or lipid soluble fractions and 8-12 were 
considered non-raft or lipid insoluble fractions.  
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Fig. 9. Lipid raft modifier methyl-β-cyclodextrin (MβCD) decreases LPS permeability in 
ileum and colon. Ex vivo ileum and colon LPS permeability was measured in the Ussing 
chamber in tissues treated with either control (CON) or MβCD for thirty minutes. n= 7 
pigs/trt. Different letters represent significant difference at P < 0.05.  
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Supplemental Fig. 1. Alkaline phosphatase activity in the CON and Dn3 treatment groups in 
the brush border membrane (BBM) and basolateral membrane (BLM) of ileum indicating the 
purity of the membrane preparations. Different letters represent significant difference at 
P<0.05. 
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Supplemental Fig. 2. Alkaline phosphatase activity in the CON and Dn3 treatment groups in 
the apical membrane and basolateral membrane (BLM) of colon indicating the purity of the 
membrane preparations. Different letters represent significant difference at P<0.05. 
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Abstract  
Long-chain n-3 polyunsaturated fatty acids (PUFA) such as DHA and EPA possess 
strong anti-inflammatory properties. Together with the fact that the maternal diet can have 
beneficial effects on the offspring later in life, we hypothesized that maternal dietary EPA 
and DHA exposure would have beneficial anti-inflammatory effects in the offspring later in 
life. To test this, 30 piglets from the following treatment groups were used in a 3×2 factorial 
design. Ten pigs whose dams fed diets devoid of DHA and EPA (CON); 10 pigs which were 
from dams and themselves fed diets containing DHA and EPA (Cn3); and 10 pigs with only 
maternal dietary exposure to DHA and EPA (Mn3).  All diets were corn-soybean meal based 
and the n-3 PUFA diets were the same supplemented with 0.5 % algal DHA and EPA in 
place of corn. At ten weeks of age, five pigs from each treatment were challenged with either 
                                                 
2 This research was supported by the Iowa Pork Producers Association and the USDA/Iowa 
State University Nutrition and Wellness Research Center. 
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saline (SAL) or 10 µg/kg BW lipopolysaccharide (LPS). At 4h post challenge, blood was 
collected and pigs were euthanized. Overall, the Cn3-LPS and Mn3-LPS groups had a lower 
febrile and serum tumor necrosis factor-α (TNF-α) response. Further buffy coat mRNA 
expression of cytokines TNF-α, Interleukin (IL)-1β and IL-10 were attenuated compared to 
CON-LPS (P<0.05) in these two groups. Additionally, post inflammatory challenge mRNA 
for the LPS signaling proteins TLR4, CD14, and Myd88 were down-regulated in both n-3 
PUFA treatments compared to the CON-LPS group (P<0.05). Dietary treatment did not 
affect the LPS detoxification mRNA abundance for acyloxyacyl hydrolase and the acute 
phase protein C-reactive protein (P>0.05). These results indicate that maternal n-3 PUFA 
supplementation can have beneficial effects in offspring towards attenuating LPS induced 
inflammation later in life.  
Key words: Inflammation, Lipopolysaccharide, Maternal diet, n-3 PUFA,  
 
Introduction 
Western diets are low in n-3 polyunsaturated fatty acids (PUFA), and provide 
excessive amounts of n-6 fatty acids, such as linoleic acid and arachidonic acid, which leads 
to a very high n-6:n-3 ratio of up to 15:1 – 17:1(1). This is important as n-3 and n-6 fatty 
acids can regulate the expression and function of proteins and genes that control cell growth, 
metabolism and communication differentially (2). High n6:n3 ratio promotes the 
pathogenesis of many diseases, including cardiovascular diseases, cancer, diabetes and 
inflammatory diseases (3). A lower n-6:n-3 ratio is associated with decreased risk and this 
was highlighted in a cardiovascular disease prevention study, where a ratio of  4:1 was 
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associated with a major decrease in total mortality (4). The long chain PUFA 
eicosapentaenoic acid (EPA, C20:5n3) and docosahexaenoic acid (DHA, C22:6n3) have been 
shown to possess strong anti-inflammatory properties (5). However, these n-3 PUFA need to 
be  supplemented through diet as they have limited synthesis in mammals due to low Δ5 and 
Δ6 desaturase enzyme expression (6).  DHA and EPA exert their anti-inflammatory action 
through three key processes. Firstly by competition and suppression of arachidonic acid (AA) 
derived pro-inflammatory eicosanoids as they compete for cyclooxygenase and lipoxygenase 
enzymes (7). Secondly, via Toll-like receptor 4 (TLR4) and nuclear factor (NF)-κβ 
suppression that leads to decreased pro-inflammatory cytokine secretion (8). Thirdly, by 
incorporation into plasma membrane phospholipids and changing membrane structure and 
function that antagonizes inflammatory signaling (9, 10).  
 Inflammation is part of initial immune response to protect an animal from harmful 
agents such as lipopolysaccharide (LPS) as well as live pathogenic microbes (11). 
Irrespective of the stimuli the classical immune activation for inflammation starts with the 
sensing of the inflammatory agent by either the cell surface or intracellular TLR’s and NOD 
like receptors (12). The subsequent activation of the master transcription factor NF-κβ, 
results in the secretion of pro-inflammatory cytokines and inflammation (13, 14). If this is 
persistent, it has the potential to cause tissue damage and predisposing subjects to metabolic 
diseases such as diabetes, obesity and atherosclerosis (15, 16).  
 Infant and piglet survival is markedly dependent on the ability to transition from the 
prenatal to postnatal phase in which intestinal maturation is still occurring.  During the 
transition from the prenatal to postnatal environment and from suckling to weaning, infants 
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undergo dramatic shifts in nutrient supply and profiles. These transition periods are 
associated with early inflammatory responses that may contribute to physiological and 
functional disorders (17, 18). Furthermore, studies have shown that maternal diet during 
gestation and lactation induces stable alterations to the physiology and phenotype of the 
offspring through epigenetic programming as well as enrichment of the fetal tissue (19).  
Fatty acids and their derivatives can influence both the early immune system development 
and maturation by regulating metabolic processes and the gene and protein expression of 
important enzymes and cytokines (20). It has been shown that maternal dietary fatty acid 
changes can modify neonatal neutrophil function in the offspring (21). This gives an 
opportunity where the young ones can be physiologically and immunologically prepared 
through maternal supplementation of n-3 PUFA for their early part of life when they are 
vulnerable to many diseases which are detrimental for the health and production performance 
later (22). 
Therefore, based on previous research in which DHA and EPA attenuated LPS 
induced Inflammation (23, 24), we hypothesized that maternal (gestation and lactation) 
supplementation of DHA and EPA would attenuate an inflammatory challenge by LPS and 
antagonize the production of pro-inflammatory cytokines and febrile response in offspring 
later in life.    
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Materials and Methods 
Materials. All the chemicals used for the experiment were purchased from Sigma-Aldrich (St 
Louis, MO) unless otherwise stated. The dietary source of n-3 PUFA, Gromega™ (JBS 
United Inc., Sheridan, IN) contained 14% DHA and 14% EPA.   
 
Animals and Experimental Design. All animal procedures were approved by the Iowa State 
University Institutional Animal Care and Use Committee and adhered to the ethical and 
humane use of animals for research. Five sows were fed a basal diet and 10 sows a diet 
enriched with n-3 PUFA upon confirmation of pregnancy: 1) standard corn-soybean meal 
diets were fed to one group (CON) and 2) the basal diet supplemented with 0.5% Gromega™ 
(JBS United Inc., Sheridan, IN), which is an enriched source of algal EPA and DHA. Upon 
farrowing, litters were standardized to 10 piglets per litter within 24 h of birth, with cross 
fostering only occurring within treatment.  At weaning (18-21 days of age), two piglets from 
each sow were separated and individually penned during the ten week nursery period.  In the 
nursery, CON pigs stayed on a DHA and EPA devoid diets (n=10), while piglets from five n-
3 PUFA fed sows (n=10) were also switched to the CON diet in the nursery (Mn3). The 10 
remaining piglets were fed nursery diets supplemented with 0.5 % Gromega™ (Cn3). In all 
diets, Gromega™ was mixed in the basal diet in substitution to corn and formulated to meet 
or exceeded the nutrient requirements of the respective growth period (25). An example of 
the later nursery diet is given in Table 1.  
Pigs were fed ad libitum and had free access to water all the time. After 8 weeks in 
the nursery and performance data collection, all pigs were fasted overnight and challenged 
with either an intramuscular injection of saline (SAL) or lipopolysaccharide (LPS, from 
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Escherichia coli Serotype 055:B5, 10 µg/kg BW, Sigma-Aldrich, St. Louis, MO). Following 
the peak febrile response at four hours as measured by rectal temperature, blood was 
collected for isolating buffy coat and blood assays.  
 
Buffy coat isolation. Twenty mL of blood was mixed with 30 ml of RBC lysis buffer (1.45 M 
NH4Cl, 0.1M KHCO3, 5 mM EDTA, pH 8.0) and vigorously shaken for 15 min. The tubes 
were centrifuged at 300 g for 5 min at 4°C. The supernatant was discarded leaving the white 
blood cells and 20 mL of ice cold RBC lysis buffer was added again. This was vortexed for 
few minutes and centrifuged at 300 x g for 5 min at 4°C. Supernatant was discarded and 20 
mL of room temperature phosphate buffered saline (PBS; containing 137 mM NaCl, 2.7 mM 
KCl, 10 mM Na2HPO4.2H2O, 2 mM KH2PO4, pH 7.4) was added. This tube was vortexed 
and centrifuged at 300 x g for 5 min at 4°C. The supernatant was discarded and the pellet was 
resuspended in 1 mL of PBS and stored at -80°C until further analysis.  
 
Serum inflammatory cytokine concentration. Tumor necrosis factor-α levels were quantified 
from the serum collected after four hours of immune challenge with LPS. A quantitative 
sandwich enzyme immunoassay ELISA was performed using a commercially available kit 
(R&D Systems Inc., Minneapolis, MN). 
 
RNA isolation and quantitative PCR. Total RNA was isolated from tissue samples using 
Trizol (Invitrogen, Inc., Carlsbad, CA) reagent according to the manufacturer’s protocol and 
the RNA pellets were resuspended in nuclease free water. Total RNA was quantified by 
measuring the absorbance at 260nm using a spectrophotometer (ND-100, NanoDrop 
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Technologies, Rockland, DE) and the purity was assessed by determining the ratio of the 
absorbance at 260 and 280 nm (NanoDrop). All samples had 260/280 nm ratios above 1.8. 
The integrity of the RNA preparations was verified by visualization of the 18S and 28S 
ribosomal bands stained with SYBR® Safe DNA gel stain (Life technologies, Carlsbad, CA) 
after electrophoresis on 2% agarose gels. Total RNA (1μg) was transcribed in a reaction 
combining genomic DNA elimination using a commercially available cDNA synthesis kit 
(Quantitect® reverse transcription kit, Qiagen, Valencia, CA). cDNA was quantified using 
NanoDrop and used for real-time quantitative PCR reaction. Amplification was carried out in 
a total volume of 25 μL containing 2X quantitect SYBR Green PCR master mix (Quantitect® 
SYBR® Green PCR kit, Qiagen, Valencia, CA), forward and reverse primers (0.3 μM) and 
400 ng of cDNA. The primers used are listed in Table 1. The cycling conditions were, after 
an initial 15 min denaturation step at 95°C, the reactions were cycled 50 times under the 
following parameters: 95°C for 30 s, 55°C for 30 s, and 72°C for 30 s. Optical detection was 
carried out at 72°C. At the end of the PCR, melt curve analysis was conducted to validate the 
specificity of the primers. A non-template control was run with every assay and all 
determinations were performed in triplicate. The mRNA abundance values for each sample 
were normalized to RPL32 according to the 2-ΔΔCT method (26). 
 
Fatty acid analysis. Fatty acid profiles of the whole blood were determined and analyzed by 
GC-MS (27, 28). 0.2 g of buffy coat tissue was mixed with 2.5 ml of 4:1 hexane and 125 
µg/L heptadecanoic acid was added to each sample as an internal standard. FAME were 
analyzed by GC on a Hewlett-Packard model 6890 fitted with an Omegawax 320 (30-m × 
0.32-mm i.id. 0.25 um) capillary column. Hydrogen was the carrier gas. The temperature 
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program ranged from 80 to 250°C with a temperature rise of 5°C/min. The injector and 
detector temperatures were 250°C and 1 µL of sample was injected and run split.  Fatty acids 
methyl esters were identified by their relative retention times on the column with respect to 
appropriate standards and heptadecanoic acid.  
 
Statistical Analyses. All data are expressed as means ± SEM. The main effects of dietary 
treatment and LPS challenge were determined by the Proc Mixed procedure in SAS (Cary, 
NC), and treatment differences were established using the least significant difference. 
Differences were deemed significant at P < 0.05 and tendencies at P < 0.10. 
 
Results 
Fatty acid composition. Fatty acid profiles were measured in the buffy coats in all three 
dietary treatment groups of pigs to ascertain the difference in n-3 PUFA enrichment or 
depletion (Table 3). As expected, the Cn3 group had a high EPA and DHA content compared 
to the CON (P<0.0001). Interestingly, the Mn3 buffy coats also had moderate amounts of 
EPA and DHA ten weeks after last dietary exposure from maternal milk (P<0.05).  However, 
the DHA and EPA content of Mn3 treatment was only half of the Cn3 treatment content 
(P<0.05). As such, all three treatment groups differed in total n-3 PUFA content, with the 
CON having the lowest, Mn3 and Cn3 treatments having the highest (1.53 vs. 3.70 vs. 5.98, 
respectively, P<0.0001). The CON group also had the highest n6:n3 ratio, followed by the 
Mn3 and CON groups (P=0.0003). The four hour LPS challenge (SAL vs. LPS) did not alter 
these fatty acid profiles (data not shown). 
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Effect of dietary fat on the febrile response induced by LPS. To assess the anti-inflammatory 
effect of maternal and continuous dietary n-3 PUFA on nursery pigs, an acute systemic LPS 
challenge was given. Irrespective of diet, LPS challenged pigs had higher febrile response as 
assessed by rectal temperature changes compared to the SAL groups (P < 0.001, Fig. 1). 
After 1 h, all three LPS challenged groups had significantly elevated rectal temperatures 
compared to the SAL groups. Moreover, the Cn3-LPS pigs had a lower febrile response 
within the four hour challenge period than the CON-LPS pigs (P = 0.011).  While the Mn3-
LPS group tended to have a comparatively lower febrile response compared to the CON-LPS 
pigs (P < 0.10, Fig. 1).  
 
Blood cytokine response to inflammatory challenge. Tumor necrosis factor-α concentration, a 
marker of systemic inflammation, was measured in serum collected 4 h post challenge (Fig. 
2). As expected all the LPS challenged pigs had an augmented TNF-α concentration 
compared to the SAL pigs (P<0.0001). Dietary n-3 PUFA supplementation attenuated serum 
TNF-α concentration (P<0.0073) and there was a diet and challenge interaction (P<0.0172). 
Furthermore, CON-LPS pigs had a significantly higher TNF-α concentration than both the 
Mn3-LPS and Cn3-LPS pigs (P<0.01).  
 
Buffy coat LPS signaling pathway mRNA expression.  Lipopolysaccharide challenge caused 
an increase in the mRNA abundance of major LPS signaling molecules such as TLR4, CD14 
and Myd88 in the peripheral blood cells irrespective of the dietary treatment (P=0.0003, 
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Table 3). There was no dietary effect on mRNA abundance. However, there was a diet by 
LPS interaction for these three genes (P<0.0012).  Interestingly, TLR4, CD14 and Myd88 
mRNA abundance followed the same pattern as the febrile response and serum TNF-α 
concentration. The Cn3-LPS and Mn3-LPS mRNA levels were lower than CON-LPS 
(P<0.05).   
As expected, the LPS challenge also caused an increase in the mRNA abundance of 
major pro-inflammatory cytokines TNF-α and IL-1β, and the anti-inflammatory cytokine IL-
10, irrespective of the dietary treatment (P<0.05, Table 3). There was no dietary effect but 
there was a diet by LPS interaction. All cytokine mRNA expression also followed the same 
trend as the LPS signaling genes with CON-LPS group having  higher expression compared 
to a significantly lower expression in Mn3-LPS and Cn3 LPS groups (P<0.05) indicating the 
pro-inflammatory effect of LPS challenge and anti-inflammatory effect of  supplementing n-
3 PUFA either maternally or continuously. Inducible nitric oxide synthase (iNOS) expression 
was not affected by the LPS challenge (P=0.15) or dietary treatment (P=0.47). 
 Acyloxyacyl hydrolase (AOAH) is a major LPS detoxification enzyme present in the 
liver and immune cells and C-reactive protein (CRP) is one of the major acute phase proteins 
secreted during inflammatory challenge by liver and immune cells. The LPS challenge 
resulted in an approximately 5 fold increase in the AOAH mRNA expression and more than 
a 1000 fold increase in CRP mRNA expression, irrespective of the dietary treatment 
(P<0.05). There was no diet by LPS interaction (P>0.05), for both genes. 
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Discussion 
Long chain n-3 PUFA such as DHA and EPA are known to attenuate LPS induced 
inflammation (24, 29-32). Recently, fish oil has been shown to directly inhibit TLR4 and 
NOD2 signaling and inflammation in pigs (23). Moreover, we and others have also shown 
that maternal supplementation of n-3 PUFA has beneficial effects in the offspring (20, 33). In 
pigs, maternal n-3 PUFA supplementation increases glucose absorption in weanling piglets 
and helps maintain the nutritional status and health during this early weaning transition 
period (28). Therefore, this study herein was conducted to examine whether maternal 
supplementation of DHA and EPA during gestation and lactation would have long lasting 
protective effects against acute inflammatory challenges and inflammation in the offspring 
later in life.  
 Nutritional manipulation of tissue fatty acid profiles in utero is not a new 
phenomenon. Providing supplemental fat to sows in late gestation and lactation not only 
improves body condition scores and productivity, but also enhances piglet performance (34-
36). It is also well established that the fatty acid content of the suckling piglet is determined 
by the fatty acid content of the sow diet (37-39). Rooke et al., (38, 40, 41) and Fritsche et al., 
(39), fed sows salmon and tuna oils late in gestation and showed both sow and neonatal 
tissue enrichment of DHA and EPA. In our study, the evidence of continuous 
supplementation of n-3 PUFA was obvious in the Cn3 treatment in which enrichment with 
EPA and DHA was clearly seen. Surprisingly, the Mn3 treatment also had significant DHA 
and EPA content, even after supplementation of diets devoid of DHA and EPA for seven 
weeks post weaning. Interestingly, it has been shown that maternal supplementation does not 
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enrich the fatty acid composition of all the tissues evenly. Liver n-3 PUFA enrichment is 
highest followed by muscle and then the subcutaneous adipose tissue (42, 43).  Usually, 
when supplementation of n-3 PUFA is stopped, the fatty acid composition of the tissues 
change rapidly reflecting the current dietary fatty acid intake (34). Lymphocytes have long 
life span of about 30 days (44). So, the possibility of immune cells enriched through maternal 
supplementation present in the circulation for two months is remote. However, Hoile et al., 
(45) showed that maternal n-3 PUFA supplementation causes stable DNA methylation 
pattern changes in Fads2 gene which encodes Δ6 desaturase, a rate limiting enzyme in n-3 
PUFA synthesis. This epigenetic mechanism may also partially explain the higher DHA and 
EPA content of the buffy coat in our Mn3 pigs.  
Piglet survival is markedly dependent on the ability to transition in the pre and 
postnatal phases (46).  This is even more critical as early weaning (15-21 days of age) stress 
can result in sustained impairment in intestinal barrier function and heightened inflammation 
post weaning (47). Interestingly, fatty acids and their derivatives could be used to influence 
the early immune system development and maturation by regulating metabolic processes and 
the gene and protein expression of important enzymes and cytokines (20). It has been shown 
that maternal dietary fatty acid changes can modify neonatal neutrophil function (21). 
Epigenetic studies have also shown that some nutrients consumed during pregnancy and/or 
lactation induces stable alterations to the physiology and phenotype of the offspring (19). 
Along these lines, evidences currently exists for maternal n-3 PUFA supplementation to 
cause stable alterations in the epigenetic machinery that the beneficial effect is carried over 
for a long duration (45).  The higher n-3 PUFA content of buffy coat from maternally 
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supplemented pigs in our study confirms that epigenetic mechanism may be involved. We 
currently have collaborators examining DNA methylation profiles in these pigs to test this 
theory (Boddicker and Ross, unpublished).  
Protective effect of maternal n-3 PUFA supplementation towards inflammation was 
studied by administering an LPS challenge and collecting blood samples at the peak immune 
response. Webel et al. (48) have shown that the peak inflammatory response induced by 
exogenous LPS occurs at 2-4 h post challenge in pigs. This is associated with elevated body 
temperature and blood TNF-α, cortisol, and IL-6 concentrations. Blood urea nitrogen 
concentrations are elevated compared to the control between 6-12 h post challenge.  
Knowing the peak response occurs at 2-4 h, by design we examined the impact Cn3 and Mn3 
treatments have on LPS induced febrile response and inflammation markers. As expected, 
LPS induced an elevated febrile and serum cytokine response over the 4 h period. As 
hypothesized, Mn3 and Cn3 supplementation attenuated both responses. This is in agreement 
with other DHA and EPA research showing n-3 PUFA decreasing the LPS induced 
inflammatory response (23, 24, 29). Additionally, EPA and DHA can replace arachidonic 
acid in the cell membrane and act as competitive agonist for cyclooxygenase and 
lipoxygenase enzymes which otherwise synthesize pro-inflammatory mediators from the 
arachidonic acid (49). These pro-inflammatory mediators stimulate the secretion of cytokines 
such as TNF-α and IL-1β. This competition leads to the production of less inflammatory or 
anti-inflammatory eicosanoids and resolvins (50). Furthermore, DHA and EPA can also 
decrease the action of pro-inflammatory transcription factor NF-κB and activate the nuclear 
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receptor PPARγ which reduces the secretion of pro-inflammatory cytokines and increasing 
the anti-inflammatory cytokine secretion (10). 
Lipopolysaccharide, when present in the circulation is bound to LPS binding protein 
(LBP) which presents the LPS monomer to CD14. Toll like receptor 4 recognizes the LPS 
presented by CD14 in association with MD-2 and then the signal is transmitted intracellularly 
through  Myd88 dependent and independent pathways both ultimately stimulating the 
secretion of cytokines (14, 51). Recent evidences indicate that saturated and n-3 PUFA can 
reciprocally modulate the expression and signaling of LPS signaling receptor TLR4 (52). 
Additionally, n-3 PUFA enrichment in macrophage and T cell membranes dissociate the lipid 
raft, preventing the TLR4 localization into the raft which will attenuate the LPS recognition 
and signaling, and cell function (32, 53).  
All evidences point to the fact that under n-3 PUFA supplementation decreased 
expression and signaling of TLR4 occurs. We also observed a decreased mRNA expression 
of TLR4 and other LPS signaling pathway proteins CD14 and Myd88 under n-3 PUFA 
supplementation in both the continuous and maternal supplemented pigs. Since maternal 
supplemented pig buffy coat cells are also enriched with n-3 PUFA it is a plausible 
mechanism through which they might attenuate the inflammation by decreasing the 
expression of these LPS signaling genes either through the decreased expression of pro-
inflammatory mediators or through activation of nuclear receptor PPARγ (10).  
Lipopolysaccharide detoxification enzyme AOAH is secreted by monocyte-
macrophages, dendritic cells and neutrophils. Acyloxyacyl hydrolase removes the secondary 
acyl chains of the lipid-A component of LPS rendering it unable to be bind to TLR4 (54). 
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Faster LPS detoxification is essential after an inflammatory challenge to limit the detrimental 
effects of LPS. Higher mRNA expression of AOAH in LPS treated pig immune cells indicate 
the immune cells trying to limit the negative effects of LPS via increased detoxification. 
However, diet had no influence on AOAH mRNA expression. Further, acute phase protein 
C-reactive protein (CRP) mRNA levels in the blood cells were very highly elevated 
indicating the acute phase response happening after the LPS challenge. Acute phase proteins 
are inflammatory mediators mainly secreted by liver and also by peripheral immune cells 
which usually bind to the immune stimulant which in turn helps facilitate its neutralization 
through the complement system (55). C-reactive protein (CRP) is a major acute phase protein 
and shown to be secreted by immune cells in response to an LPS challenge (56, 57). n-3 
PUFA supplementation did not have any impact on the secretion of CRP again indicating the 
need for a maximum response from the acute phase proteins.  
Overall, our results indicate that maternal n-3 PUFA supplementation enriches the 
immune cells and attenuates the adverse effects of an acute inflammatory challenge even ten 
weeks after birth (58). Maternal supplementation with n-3 PUFA may provide protective 
effect like a regular n-3 PUFA supplementation later in the life, importantly during the early 
stages of life which might be important for maintaining the health of the animal during the 
crucial transition period.  
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Table1. Example of the nursery diet feed composition (%, as fed basis) 
 
 
 
                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
1Gromega™ was supplied by JBS United, Inc., containing approximately 14% EPA and 14% DHA 
of total fatty acids. 
2Supplied per kilogram of diet: vitamin A, 8364 IU; vitamin D3, 1533 IU; vitamin E, 45 IU; vitamin 
K, 2.2 IU; choline, 6.5 mg; riboflavin, 4.2 mg; niacin, 21 mg; pantothenic acid, 17 mg; vitamin B-12, 
28 mg; biotin, 1.6 mcg; folic acid, 0.0005 mg; Zn, 112 ppm as zinc sulfate and zinc oxide; Mn, 54 
ppm as manganous oxide; Fe, 145 ppm as ferrous carbonate and ferrous sulfate; Cu, 20 ppm as 
copper chloride; I, 0.76 ppm as ethylenediamine dihydriodide; Se, 0.25 ppm as sodium selenite. 
 
 
   Feed Component Control Dn3 
Corn 61.11 60.59 
Soybean meal 48% 31.67 31.67 
Meat & bone Meal 5.00 5.00 
Salt 0.56 0.56 
Gromega™ 1 - 0.53 
Dicalcium phosphate 0.41 0.41 
L-Lysine 0.36 0.36 
DL-Methionine 0.18 0.18 
Limestone 0.17 0.17 
Threonine 0.11 0.11 
Premix2 0.36 0.36 
Selenium 0.05 0.05 
Choline chloride 0.03 0.03 
Calculated composition   
   Energy, kcal/kg 3,238 3,238 
   Crude Protein, % 22.36 22.36 
   SID Lysine, % 1.35 1.35 
   Available Phosphorus, % 0.37 0.37 
   Ether Extract, % 3.80 3.80 
   Crude Fiber, % 2.36 2.36 
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Table 2. Primer sequences for quantitative real-time PCR1 
Gene Sense (5’- 3’) Antisense (5’- 3’) 
TLR4 GAA TAT TTT TCT AAC CTG CCC AAC CTG GAG CCA GCC AGA CCT TGA ATA CAA GTT TTC ATT ACA TC 
CD14 TGG ACC TCA GTC ACA ACT CG CCT TTA GGC ACT TGC TCC AG 
Myd88 AAG TTT GCA CTC AGC CTC TCT CCA ACA GAC AGT GAT GAA CCG CAG GAT 
TNF-α ACT CGG AAC CTC ATG GAC AG AGG GGT GAG TCA GTG TGA CC 
IL-1β AAA GGG GAC TTG AAG AGA G CTG CTT GAG AGG TGC TGA TAT 
IL-10 ATG GGC GAC TTG TTG CTG AC CAC AGG GCA GAA ATT GAT GAC A 
iNOS ATG TCC GAG GCA AAC ACC ACA TTC GCA TGC TGC TGA GAG CTT TGT TGA 
AOAH TCA GGG GGA CAG AAA TAT GG CCA GAA TCA CGC AGA ATC AC 
CRP TGC CCA GAC AGA CAT GAT CGG AAA TGA GCC TTG CAG TCA GAC TCA CAT 
Primer Abbreviations: TLR4, Toll like receptor4; CD14, Cluster of differentiation 14; Myd88, Myeloid differentiation factor 88; TNF-α, 
Tumor Necrosis Factor- α; IL-1β, Interleukin-1β; IL-10-Interleukin-10; iNOS, inducible nitric oxide synthase; AOAH, Acyloxyacyl 
hydrolase; CRP-C-Reactive Protein. 
 
 
 
 
149 
 
 
 
Table 3. Buffy coat fatty acid composition of pigs fed either the control diet (CON) or a diet 
enriched with long chain n-3 PUFA only through maternally (Mn3) or continuously (Cn3). 
Fatty Acid (%)1 CON Mn3 Cn3 P-value2 
16:0 20.10 ± 0.34 20.61 ± 0.34 21.41 ± 0.34 0.33 
18:0 17.36 ± 1.40 14.22 ± 1.39 16.89 ± 1.39 0.30 
18:3n-3 0.87 ± 0.09   0.84 ± 0.09  1.00 ± 0.09 0.42 
18:3n-6 0.29 ± 0.17   0.28 ± 0.17  0.21 ± 0.17 0.94 
20:2 0.69 ± 0.27   1.24 ± 0.27  0.33 ± 0.27 0.14 
20:3n-6 1.26 ± 0.25   1.51 ± 0.25  0.85 ± 0.25 0.25 
20:4n-6 11.23 ± 0.30 11.35 ± 0.30 10.67 ± 0.30 0.30 
20:5n-3 (EPA)   0.00 ± 0.03   0.45 ± 0.03  1.10 ± 0.03 < 0.0001 
22:6n-3 (DHA)   0.00 ± 0.06   1.10 ± 0.06  2.09 ± 0.06 < 0.0001 
Saturated 34.07 ± 0.62 34.46 ± 0.62 35.85 ± 0.62 0.18 
∑(n-3) PUFA   1.53 ± 0.26   3.70 ± 0.26   5.98 ± 0.26 < 0.0001 
∑(n-6) PUFA 42.96 ± 0.46 42.32 ± 0.46 42.65 ± 0.46 0.63 
(n-6)/(n-3)  23.80 ± 1.36 11.43 ± 1.36  7.13 ± 1.36    0.0003 
1Fatty acid composition was measured by GC-MS on three pigs per treatment and expressed 
as a percentage of total fatty acids (mean ± SEM). 
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Table 4. Effects of maternal n-3 PUFA supplementation on mRNA expression of major LPS signaling molecules, cytokine genes, 
LPS detoxification gene AOAH and acute phase protein gene CRP under an acute inflammatory challenge in peripheral immune 
cells1 
Genes Control Maternal Continuous SEM P-value 
Saline LPS Saline LPS Saline LPS Diet Challenge Diet*Challenge 
TLR4 1.00a 18.54b 2.16a 8.45c 1.41a 8.51c 2.74 0.19     0.0003     0.0012 
CD14 1.00a 5.41b 2.30a 3.49b 1.65a 2.34c 0.98 0.48 0.02 0.05 
  Myd88 1.00a 18.59b 2.29a 8.80c 2.84a 10.19cb 2.93 0.37     0.0004   0.003 
 TNF-α 1.00a 5.07b 0.25a 1.79c 0.88a 1.57c 0.94 0.12 0.08   0.008 
IL-1β 1.00a 2.27b 0.40a 1.38c 0.27a 1.45c 0.28 0.01     0.0001     0.0009 
iNOS 1.00 1.14 1.31 0.34 1.64 0.36 0.53 0.83 0.15 0.47 
IL-10 1.00a 4.34b 0.59a 2.61bc 0.99a 2.21c 0.69 0.22     0.0009 0.01 
  AOAH 1.00 6.73 1.05 4.80 1.07 6.21 1.28 0.64     0.0002 0.32 
  CRP 1.00 1215 1.33 1205 1.17 1140 90.43 0.93     0.0001 0.23 
1Values are mean and pooled SE, n=5 pigs/trt. Means in the same row without a common letter differ, P < 0.05. All data were 
acquired using real time PCR. RPL32 was used as the housekeeping gene and the Control-Saline treatment was used as the 
reference sample per gene. The expression values were normalized to RPL32 housekeeper.  
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Figure 1. Febrile response of pigs fed either control (CON) or n-3 PUFA rich   diets until the 
lactation through maternal supplementation (Mn3) or throughout the life (Cn3) and 
challenged with either saline (SAL) or LPS 10 µg/kg (LPS) after eight weeks. n = 5 pigs/trt. 
Different letters a,b,c represent significant differences within each hour (P<0.05). Diet P = 
0.011, Challenge P < 0.001, Time P < 0.001. 
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Fig. 2. Effects of maternal n-3 PUFA on serum tumor necrosis factor (TNF)-α concentration 
after a 4 hour LPS challenge in pigs. Pigs fed either control (CON) devoid of DHA and EPA, 
n-3 PUFA diets throughout life (Cn3) or only during maternal period of gestation and 
lactation (Mn3). Pigs where challenged with either saline (SAL) or LPS 10 µg/kg (LPS) at 11 
weeks of age. n = 5 pigs/trt. Different letters a,b,c represent significant differences at 
(P<0.05). Diet P = 0.0073, Challenge P < 0.0001, Diet*Challenge P < 0.0172. 
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CHAPTER 6: INTESTINAL INTEGRITY, ENDOTOXIN TRANSPORT AND 
DETOXIFICATION IN PIGS DIVERGENTLY SELECTED FOR RESIDUAL FEED 
INTAKE3 
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Abstract 
Microbes and microbial components potentially impact the performance of pigs 
through immune stimulation and altered metabolism. These immune modulating factors can 
include endotoxin from gram negative bacterial outer membrane component, commonly 
referred to as lipopolysaccharide (LPS). In this study, our objective was to examine the 
relationship between intestinal barrier integrity, endotoxin and inflammation with feed 
efficiency (FE), using pig lines divergently selected for residual feed intake (RFI) as a 
                                                 
3 This research was supported by the Agriculture and Food Research Initiative Competitive 
Grants 2010-65206-20670 (to N. K. Gabler) and 2011-68004-30336 (to J. F. Patience) 
from the USDA National Institute of Food and Agriculture. 
4 Corresponding author:  ngabler@iastate.edu 
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model. Twelve gilts (62 ± 3 kg BW) from the low RFI (LRFI, more efficient) and 12 from 
the high RFI (HRFI, less efficient) were used. Individual performance data was recorded for 
five weeks. At the end of the experimental period, ADFI of LRFI pigs was lower (P < 0.001), 
average daily gain (ADG) not different between the two lines (P = 0.72) but the Gain: Feed 
ratio of LRFI pigs was higher than for HRFI pigs (P = 0.019).  Serum endotoxin 
concentration (P<0.01) and the acute phase protein haptoglobin (P<0.05) were higher in 
HRFI pigs. Transepithelial resistance of the ileum, transport of FITC-Dextran and FITC-LPS 
in ileum and colon, as well as tight junction protein mRNA expression in ileum, did not 
differ between the lines, indicating the two lines did not differ in transport characteristics at 
the intestinal level. Ileum inflammatory markers, myeloperoxidase and IL-8, were found to 
be higher in HRFI pigs (<0.05).  Alkaline phosphatase (ALP) activity was significantly 
increased in the LRFI pigs in ileum and liver tissues and negatively correlated with blood 
endotoxin (P<0.05). Lysozyme activity in the liver was not different between the lines, 
however, the LRFI pigs had a twofold higher lysozyme activity in ileum (P<0.05). Despite 
the difference in their activity, ALP or lysozyme mRNA expression was not different 
between the lines in either tissue. Lower endotoxin and inflammatory markers and the 
enhanced activities of antimicrobial enzymes in the LRFI line may not fully explain the 
difference in the feed efficiency between the lines; but they have the potential to prevent the 
growth potential in HRFI pigs. Further studies are needed to identify the other mechanisms 
that may contribute to the higher endotoxin levels in the HRFI pigs and the higher feed 
efficiency in the LRFI pigs. 
 
Key words: Endotoxin • Feed efficiency • Intestinal integrity • Pig  
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Introduction  
            Feed efficiency has become a major goal in pig research and breeding programs for 
economic, environmental and food security reasons. Residual feed intake (RFI) has been 
adopted as a reliable method for measuring, selecting for and studying FE.  Pigs with low 
RFI (LRFI) consume less feed for a given amount of growth and backfat as pigs with higher 
RFI (HRFI) (Cai et al., 2008; Gilbert et al., 2007). Yorkshire pigs selected for LRFI for 5 
generations, differed by up to 124 g/day in ADFI with no significant reduction in weight gain 
compared to randomly selected HRFI pigs (Boddicker et al., 2011). However, the physiology 
that underlies this improved FE has been poorly defined.  
Inflammation can have a major impact on growth performance and feed efficiency 
(Schinckel et al., 1995) and could contribute to lower maintenance nutrient requirements in 
pigs selected for reduced RFI (Barea et al., 2010; Boddicker et al., 2011). Lipopolysaccharide 
(LPS), a Gram negative bacterial outer membrane component referred  also as endotoxin, is a 
chronic innate immune stimulator in pigs (Gabler et al., 2008; Webel et al., 1997; Weber and 
Kerr, 2008). Importantly, Gram negative bacteria are present in the gastrointestinal tract in 
large amounts and can serve as a major source of systemic endotoxin (Cani and Delzenne, 
2010; Ravin et al., 1960). However, intestinal barrier integrity plays critical host defense 
functions against luminal immunogens such as endotoxin. Once in circulation, endotoxin 
activates the immune system via toll like receptors (TLR), which results in repartitioning of 
nutrients for immune function, rather than towards anabolism (Kimball et al., 2003; 
Rakhshandeh and de Lange, 2012). Additionally, detoxification processes can prevent the 
negative effects of endotoxin (Elsbach, 2000). Therefore, our objective was to examine the 
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relationship between intestinal barrier integrity, endotoxin and inflammation with FE, using 
pig lines divergently selected for RFI as a model.  
 
Materials and Methods 
All animal procedures were approved by the Iowa State University Institutional 
Animal Care and Use Committee and adhered to the ethical and humane use of animals for 
research. All chemicals used for the experiment were purchased from Sigma-Aldrich (St. 
Louis, MO) unless otherwise stated.   
 
Animals and Experimental Design 
Twelve pigs per line (62 ± 3 kg, BW) were selected and matched across lines for age 
and weight from the seventh generation of the Iowa State University RFI selection project 
(Cai et al., 2008). Pigs were individually penned and had free access to water and feed at all 
times. All pigs were fed a common commercial corn-soybean meal-distillers dry grain with 
soluble diet formulated to meet or exceed the nutrient requirements for this size pig (NRC, 
1998). Feed intake and body weights were recorded on a weekly basis and used to calculate 
average daily gains and RFI for each pig, as previously described (Cai et al., 2008; Young et 
al., 2011).  
After five weeks, all pigs were fasted overnight and whole blood (10 mL) was 
collected via venipuncture and serum separated by centrifugation at 2000 × g at 4°C. 
Thereafter, pigs were euthanized via captive bolt followed by exsanguination.  Immediately 
following euthanasia, segments of ileum and mid colon were collected and flushed with ice 
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cold Krebs-Henseleit buffer (consisting of, in mmol/L: 25 NaHCO3, 120 NaCl, 1 MgSO4, 6.3 
KCl, 2 CaCl2, 0.32 NaH2PO4; pH 7.4) to remove any undigested food material. Fresh ileum 
and colon segments were used for ex vivo integrity measures and for mucosal scrapings. A 20 
cm segment of ileum 150 cm from the ileal-cecal junction and a 10 cm segment of proximal 
colon 60 cm from the rectum were isolated. Ileum and colon segments were flushed with ice 
cold Krebs-Henseleit buffer. For mucosal scrapings, intestinal segments were then cut open 
longitudinally along the mesenteric border and the epithelial layer gently scrapped with a 
glass slide without disturbing the underlying lamina propria. Ileum and colon samples that 
were not used for ex vivo work were then snap frozen in liquid nitrogen and stored at -80oC 
until analysis.  
 
Intestinal Integrity 
Electrophysiological measurements were taken using modified Ussing chambers as 
previously described (Albin et al., 2007; Gabler et al., 2009; Moeser et al., 2012). Briefly, 
fresh segments of the ileum and colon were removed and placed on ice in Krebs-Henseleit 
buffer for transport to the laboratory while under constant aeration until clamped in the 
modified Ussing chambers. To assess tight junction integrity and the mucosal to serosal 
endotoxin transport, tissues stripped of outer serosal layers were immediately mounted in a 
modified Ussing Chamber, with each chamber connected to a pair of dual channel current 
and voltage electrodes submerged in 3% noble agar bridges and filled with 3M potassium 
chloride for electrical conductance (Physiologic Instruments Inc., San Diego, CA and World 
Precision Instruments Inc., New Haven, CT). Each segment (0.71 cm2) was bathed on its 
mucosal and serosal sides with Krebs buffer and constantly gassed with 95% O2-5% CO2 
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mixture. The temperature of all tissues and apparatus was constantly maintained at 37 oC 
using circulating warm water. A short circuit current was established and stabilized for about 
10 minutes and transepithelial resistance (TER) was measured using the included software 
(Acquire and Analyze, Physiological instruments, San Diego, CA).  
After recording the basal electrophysiological measurements, the mucosal to serosal 
macromolecule transport of fluorescein isothiocyanate labeled dextran (4.4 KDa; FITC-
Dextran) was assessed to measure the integrity of both ileum and colon, as previously 
described (Wang et al., 2001). Briefly, the mucosal chambers were treated with 2.2 mg/mL 
FITC-Dextran, and chamber samples from both sides were collected every 10-15 min. The 
relative fluorescence was then determined using a fluorescent plate reader (Bio-Tek, 
Winooski, VT), with excitation and emission wavelengths of 485 and 520 nm, respectively.  
An apparent permeability coefficient (Papp) was then calculated using the area of the 
membrane and rate of FITC-Dextran transport, where dQ/dt = transport rate (µg/min); C0 = 
initial concentration in the donor chamber (µg/mL); A = area of the membrane (cm2):    
 
 Papp = dQ/ (dt×A×C0) 
 
The mucosal to serosal transport of LPS was also assessed as previously described by Tomita 
et al., (2004). Briefly, the mucosal chambers were challenged with 20 µg/mL fluorescein 
isothiocyanate labeled LPS (FITC-LPS) and chamber samples from both sides were 
collected every 10-15 min. The fluorescence and apparent permeability coefficient was 
calculated as described for FITC-Dextran.  
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Circulating Endotoxin 
Serum endotoxin concentrations were measured by an end point fluorescent assay 
using the recombinant factor C (rFC) system (Lonza, Basel, Switzerland). Briefly, the serum 
samples were diluted 1000X in pyrogen free water and 100µL of the samples and standards 
were added to a 96 well round bottom plate and incubated at 37°C for 10 min. After 
incubation, 100 µL of rFC enzyme, rFC assay buffer and rFC substrate were added at a ratio 
of 1:4:5 to the plate and an initial reading were taken followed by 1h incubation at 37°C. 
Thereafter, the relative fluorescence unit (RFU) for each well was determined (excitation 380 
nm and emission 440 nm). The concentration of the endotoxin was interpolated from the 
standard curve constructed from the standards and corrected for sample dilution. 
 
Alkaline Phosphatase activity 
Alkaline phosphatase (ALP) activity was measured using the Quantichrom ALP 
assay kit (DALP-250, Gentaur, Bioassay systems, Hayward, CA). Protein was extracted 
using potassium phosphate buffer (PPB), pH 6.0 from liver and ileum and the protein 
concentration was determined using BCA assay (Pierce, Rockford, IL) and 50 µL of sample 
was added to a 150 µL working solution containing magnesium acetate, p-nitrophenyl 
phosphate and assay buffer in a 96 well plate. The optical density at 405 nm was measured at 
time 0 and after 4 minutes using a Synergy 4 microplate reader (Bio-Tek, Winooski, VT) and 
ALP activity was calculated according to the manufacturer’s instructions.   
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Myeloperoxidase Activity 
Myeloperoxidase (MPO) activity was measured in the whole ileal tissue as an 
indicator of inflammation and neutrophil infiltration using an o-dianasidine assay (de La 
Serre et al., 2010; Suzuki et al., 1983).  Tissue samples were homogenized in PPB pH 6.0, 
containing 0.5% hexadecyltrimethylammonium bromide (HTAB) and then freeze-thawed on 
ice and vortexed three times.  Samples were then centrifuged for 15 min at 10,000 x g.  The 
resulting supernatant was transferred to a new tube and the remaining pellet was resuspended 
in 500 µL of PPB + 0.5% HTAB.  The re-suspended pellet was freeze-thawed and 
homogenized twice and 500 µL of this solution was transferred to a new tube.  Samples were 
then centrifuged again at 10,000 x g for 15 min and the supernatant was collected.  The final 
supernatant was mixed with o-dianasidine dihydrochloride and 0.005% hydrogen peroxide.   
One unit of MPO activity was expressed as the amount of MPO needed to degrade 1 µmol of 
hydrogen peroxide/min/mL.  Absorbance was read at 460 nm for 10 min reaction time and 
absorbance was calculated on mL sample/mg tissue basis.   
 
Lysozyme activity 
Whole ileum and liver samples were analyzed for lysozyme activity using the 
EnzChek fluorescent assay which compares sample lysozyme activity to lysozyme activity 
on Micrococcus Lysodeikticus cell walls (Invitrogen-Molecular Probes, Carlsbad, 
California).  Samples were diluted and fluorescence was measured using excitation emission 
wavelengths of 485 and 530nm and the lysozyme activity were interpolated from the 
standard curve constructed from the standards and corrected for sample dilution. 
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Interleukin-8 and Haptoglobin Assays 
Ileal protein (100 μg) extracts were analyzed for interleukin-8 (IL-8) concentration 
using a porcine-specific ELISA (DuoSet® Porcine IL8, catalog number DY535, R&D 
systems, Minneapolis, MN, USA) per the manufacturer’s instructions. Haptoglobin was 
analyzed using a commercially available ELISA (ALPCO diagnostics, Salem, NH). Briefly, 
samples were added to wells adsorbed with anti-porcine haptoglobin antibodies. After 
washing, horseradish peroxidase (HRP) conjugated anti haptoglobin antibodies were added 
to the plate. After another washing, the HRP was assayed by the addition of the chromogenic 
substrate 3,3’,5,5’-tetramethylbenzidine (TMB) and the absorbance was measured at 450 nm. 
The quantity of haptoglobin in the test sample was interpolated from the standard curve 
constructed from the standards and corrected for sample dilution. 
 
Quantitative real-time PCR  
Total RNA was isolated from tissue samples using Trizol (Invitrogen Inc., Carlsbad, 
CA) reagent according to the manufacturer’s protocol and the RNA pellets were resuspended 
in nuclease free water. To eliminate potential genomic DNA contamination, the RNA 
samples were treated with a DNase I kit (DNA-free, Ambion Inc., Austin, TX) per the 
manufacturer’s instructions. Total RNA was quantified by measuring the absorbance at 
260nm using a spectrophotometer (ND-100, NanoDrop Technologies, Rockland, DE) and the 
purity was assessed by determining the ratio of the absorbance at 260 and 280 nm. All 
samples had 260/280 nm ratios above 1.8. The integrity of the RNA preparations was 
verified by visualization of the 18S and 28S ribosomal bands stained with ethidium bromide 
after electrophoresis on 1.2% agarose gels (E-gel; Invitrogen Inc., Carlsbad, CA). A good 
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preparation was indicated by the presence of 28S and 18S bands that were not smeared and 
by the 28S band stained with a greater intensity than the 18S band. Total RNA (1 μg) was 
reverse transcribed using a commercially available cDNA synthesis kit (iScript, BioRad 
Laboratories, Hercules, CA). The iScript kit used a blend of oligo (dT) and random hexamer 
primers for cDNA synthesis and the reverse transcriptase is RNAse H+ to ensure removal of 
the RNA template. The primers used for real-time RT-PCR are presented in Table 1. 
Amplification was carried out in a total volume of 25 μL containing 1X iQ SYBR 
Green Supermix (BioRad Laboratories, Hercules, CA), forward and reverse primers (0.1 
μg/μL) and 1 μL of the 20 μL cDNA reaction. After an initial 5 min denaturation step at 
95°C, the reactions were cycled 40 times under the following parameters: 95°C for 30 s, 
60°C for 30 s, and 72°C for 30 s. Optical detection was carried out at 72°C. At the end of the 
PCR, melt curve analysis was conducted to validate the specificity of the primers. A non-
template control was run with every assay and all determinations were performed in 
duplicate. Presence of a single PCR product of the correct size for each primer set was 
verified by visualizing the PCR products via electrophoresis on 1% agarose gels stained with 
ethidium bromide. The mRNA abundance values for each sample were normalized to β2 
microglobulin according to the 2-ΔΔCT method (Livak and Schmittgen, 2001).  
 
Statistical Analyses 
All results were expressed as LS means ± SEM. The main effect of line (HRFI versus 
LRFI) was determined by the Proc Mixed procedure in SAS (Cary, NC) with age matched 
pairs (repetition) as a random effect. However, for Ussing chamber data tissue (colon verses 
ileum) was also included as a fixed effect. Statistical significance of differences was 
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determined by Tukey’s range test for pair wise comparisons.  Differences were deemed 
significant at P ≤ 0.05 and tendencies at P ≤ 0.10. Phenotypic correlations between serum 
endotoxin, ileum Endotoxin permeability, ALP and lysozyme with RFI, ADG, ADFI and G:F 
were computed based on residuals derived from the above models using the CORR 
procedure of SAS. 
 
Results 
Twelve gilts per line weighing approximately (62±3, kg BW) were used for the study. 
At the end of the experimental period, growth performance was measured. As expected, the 
LRFI pigs consumed less feed than their HRFI counterparts (ADFI: 1.90 vs. 2.23 kg/day, P < 
0.001).  However, the ADG did not differ between the lines (0.67 vs. 0.65, kg/day, P = 0.72). 
Since the LRFI pigs consumed less feed for the same ADG, their G:F ratio was higher than 
the HRFI pigs (0.35 vs. 0.29, P = 0.019). These results confirm that the effect of selection for 
RFI was maintained in the gilts used for this study.  
  Intestinal integrity was assessed by measuring the TER and macromolecule 
permeability in freshly isolated ileum and colon samples.  Transepithelial resistance, an 
electrophysiological measure of intestinal integrity, was not different in either the ileum or 
colon of pigs divergently selected for RFI (Ileum: 108 vs. 103 Ω/cm2, Colon: 78 vs. 73 
Ω/cm2, Table 1). However, irrespective of line, colon TER was significantly lower than in 
the ileum (P < 0.05). Further, these data were supported by additional ex vivo analysis of 
intestinal integrity using FITC-Dextran, a macromolecule permeability marker. No 
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differences between lines were observed in Papp for either the ileum or colon (P > 0.05, 
Table 1).  
Ex vivo intestinal endotoxin transport characteristics were also assessed using FITC-
LPS in modified Ussing chambers in the two RFI lines. Similar to the TER and FITC-
Dextran values, we found no differences between the lines in either ileum and colon FITC-
LPS transport (P > 0.05, Table 2). The tight junction proteins claudin 3 and 4 and occludin 
are three important proteins involved in intestinal barrier function and integrity.  Gene 
expression analysis of these tight junction proteins also indicated no difference between the 
lines (P > 0.05, Table 3).  
Serum endotoxin concentrations were found to be lower in the LRFI than in the HRFI 
gilts (6.19 vs. 17, EU/ml, P < 0.05, Figure 1). Furthermore, the serum acute phase protein, 
haptoglobin, was also lower in LRFI pigs than in HRFI gilts (P ≤ 0 .05, Figure 2). The 
presence of a higher endotoxin load and the consequent increase in haptoglobin secretion has 
the potential to cause a generalized inflammation. The ileum was assessed for the presence of 
general inflammatory markers. Ileum myeloperoxidase activity was lower in the LRFI pigs 
than in the HRFI pigs (P = 0.047, Figure 3). The proinflammatory cytokine, IL-8 protein 
expression, also tended to be lower in the ileum of LRFI versus HRFI pigs (1.7 vs. 1.1, µg/g 
protein, P = 0.062, Figure 4).   
Alkaline phosphatase activity (Figure 5) was measured and found to be significantly 
increased in the LRFI pigs in both liver (62 vs. 93 mU/mg protein, P<0.018) and ileum (597 
vs. 947 mU/mg protein, P<0.01). Lysozyme activity in the liver was not different between 
the lines but ileum lysozyme activity in LRFI pigs was almost twice as high as in HRFI pigs 
(8.7 vs. 14.4, U/mg protein, P<0.01, Figure 6). Although we saw differences in activity of 
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these enzymes, surprisingly, no difference was found in the mRNA expression in either 
ileum or liver (Table 4). mRNA expression of LPS detoxification gene acyloxyacyl 
hydrolase (AOAH) present in liver and ileum tissues was quantified to assess differences 
between the two lines. The expression profiles of these genes was not different, indicating 
that at the mRNA level, LPS detoxification enzyme AOAH expression was not altered due to 
blood endotoxin, selection for RFI, or FE (Table 4).  
Residual correlations of performance traits with endotoxin transport and serum 
concentrations, ALP and RFI were generally moderate (Table 5). Interestingly, this is the 
first data to our knowledge in swine that shows a significant positive correlation between 
intestinal endotoxin transport and circulating endotoxin (P = 0.019). Weak negative 
correlations were observed with FE measures and endotoxin permeability and circulating 
concentrations.  Furthermore, ileum ALP activity was moderately negatively correlated with 
endotoxin concentration (P = 0.027). Lysozyme activity was poorly correlated with all 
parameters measures (P > 0.05). 
 
Discussion 
The current study was conducted to identify if differences in intestinal integrity, 
circulating endotoxin and its associated inflammatory markers may partially be responsible 
for difference in FE between pigs that were divergently selected for RFI. The physiological 
mechanisms underlying RFI or FE in swine are poorly defined.  However, differences in 
nutrients and energy digestibility, metabolic efficiency of nutrient use, basal metabolic rate 
and energy expenditure are presumed to be contributing to differences in RFI, either alone or 
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in combination (Barea et al., 2010; Boddicker et al., 2011; Herd and Arthur, 2009). 
Endotoxin and its associated inflammation can reduce digestibility and alter intestinal 
nutrient transport and post-absorptive metabolism (Rakhshandeh and de Lange, 2012). The 
net effect of increased circulating endotoxin or endotoxemia is reduced growth, increased 
energy expenditure and antagonizing lean tissue accretion (Orellana et al., 2007). Thus, it 
results in partitioning energy and other nutrients away from growth and towards immune 
system requirements and thus may contribute to differences in FE. 
The gastrointestinal tract contains large quantities of both gram positive and negative 
bacteria in which bacterial populations gradually increase from approximately 0-103 per mL 
of luminal contents in the duodenum to 1011 per mL in the colon (Berg, 1999). The gram-
negative bacterial family Enterobacteriaceae, includes genera such as Escherichia, 
Salmonella, Shigella, Klebsiella, Citrobacter and Enterobacter, and serves as a major source 
of endotoxin (Billiar et al., 1988). Some of these strains are commensals, while others can be 
classified as opportunistic pathogens.  The outer leaf of the gram negative bacterial outer 
membrane is mainly composed of a unique glycolipid generally known as endotoxin, or if 
purified, often referred to as LPS. Lipid A is the bioactive-immunogenic component that can 
stimulate localized or systemic inflammation via its recognition through toll like receptors 
(TLR) and other immune system sensing mechanisms (Beutler, 2000).  Endotoxin may enter 
systemic circulation through routes including: 1) nonspecific paracellular transport through 
the tight junctions; 2) transcellular transport, potentially through lipid raft membrane 
domains via TLR4 mediated endocytosis (Tomlinson and Blikslager, 2004; Triantafilou et 
al., 2002); or 3) chylomicron facilitated transport into circulation during fat digestion (Kelly 
et al., 2012). All three transport routes may be altered by diet, management conditions and 
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environmental stressors (Mani et al., 2012).  Furthermore, although characterization of 
intestinal microbial populations was not within the scope of this study, we cannot rule out 
RFI line specific differences in Enterobacteriaceae populations that may partially explain the 
increase in circulating endotoxin. 
Interestingly, the presence of higher circulating endotoxin also has the potential to 
affect intestinal health and function (Gardiner et al., 1995). Ileal MPO activity and IL-8 
protein expression were lower in the LRFI pigs. Both of these markers are commonly used 
for assessing intestinal inflammation and neutrophil infiltration (Suzuki et al., 1983). A 
“leaky” or porous intestine allows the harmful agents into the circulation, which can cause 
localized inflammation of the intestine and systemic inflammation (Vaarala et al., 2008). 
Further, decreased expression of tight junction proteins claudin 3 and 4 during inflammation 
have been implicated in increased intestinal permeability (Pinton et al., 2010). In our study, 
TER was not different between the lines and this was corroborated further by no differences 
in the paracellular transport of FITC-Dextran or FITC-LPS transport. Furthermore, mRNA 
expression of the tight junction proteins claudins 3 and 4 and occludin were not different 
between the lines.  Together, these data indicate that in healthy pigs, intestinal integrity is 
tightly controlled and may not contribute significantly to differences in FE.  
The presence of higher blood endotoxin has the potential to contribute to the 
development of an inflammatory state and reduce growth potential. In our study, serum 
endotoxin and the acute phase protein, haptoglobin, were found to be significantly lower in 
the LRFI pigs. Repeated exposure to endotoxin augments haptoglobin concentration 
compared to a single endotoxin exposure (Dritz et al., 1996; Wright et al., 2000).  As 
haptoglobin is a good marker of tissue damage and the acute phase response in swine (Hall et 
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al., 1992), this supports our serum endotoxin data, which suggest that the LRFI pigs were 
exposed to comparatively lower levels of endotoxin intermittently, although the two lines 
shared the same environmental conditions (i.e. housing and diets). Furthermore, LRFI pigs 
appear to be experiencing a comparatively lower acute phase response. However, the high 
immune response of HRFI pigs appear not to be a result of increased intestinal permeability 
or endotoxin transport but could be a result of differences in detoxification processes.  
Animals and humans harbor low concentrations of circulating endotoxin even in 
normal and healthy conditions (Erridge et al., 2007). Intriguingly, we found that the LRFI 
pigs had lower endotoxin levels compared to the HRFI pigs, with no difference in the 
intestinal integrity and transport characteristics between the lines. The potential biological 
process that might account for the lower endotoxin levels in the LRFI pigs may include the 
efficiency of endotoxin clearance, neutralization or detoxification. These processes occur in 
various tissues, including immune cells, liver, kidney and intestine. Furthermore, various 
binding proteins and enzymes such as ALP, lysozyme, and AOAH are involved (Munford et 
al., 2009). Alkaline phosphatase is a hydrolase enzyme present in liver, intestine and kidney 
tubules and it dephosphorylates bacterial LPS and reduces its toxicity (Bates et al., 2007; 
Poelstra et al., 1997). Further, in the intestine ALP reduces trans-mucosal passage of bacteria 
and also protects against LPS-induced inflammation (Lallès, 2010). Higher ALP activity in 
both liver and ileum of LRFI pigs indicates that they deactivated or neutralized endotoxin 
more efficiently. This may be affirmed by the moderately negative correlation between ALP 
and serum endotoxin concentration.  Further evidences suggest that ALP can also mitigate 
body weight loss after an immune challenge (Bol-Schoenmakers et al., 2010).  
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To further explore the difference in endotoxin metabolism, we measured AOAH 
mRNA expression. Acyloxyacyl hydrolase is an important lipase enzyme that selectively 
removes the secondary fatty acyl chains attached to the primary chains in the lipid A moiety 
and detoxifies endotoxin (McDermott and Fenwick, 1992). This leads to an LPS molecule 
which could bind the signaling proteins MD2/TLR4 but does not have the potential to initiate 
the signal or can only be a partial agonist (Lu et al., 2005). The fact that we did not see 
evidence of differential AOAH mRNA expression in the intestine or liver was surprising. 
However, AOAH mRNA and activity appear to be correlated in a tissue or cell specific 
manner (Feulner et al., 2004). Therefore, liver and intestinal mRNA expression may not be 
correlated in swine or immune and Kupffer cell specific expression needs to be determined, 
where activity and expression of AOAH are greater.    
Lysozyme is another important antimicrobial peptide secreted by various cells of the 
body, including cells in the intestine and liver. Lysozyme regulates microbial populations by 
lysing the bacterial cell wall component peptidoglycan and it also binds to and detoxifies 
LPS (Takada et al., 1994). In our study, although lysozyme activity in the liver was not 
different between the two lines, ileum lysozyme activity was higher in LRFI pigs, which may 
explain the lower serum endotoxin and haptoglobin levels in the LRFI pigs and higher FE. 
Supporting this hypothesis, a recent study found that feeding lysozyme to young pigs 
improved their health and FE (May et al., 2012). Surprisingly, although ALP and lysozyme 
activity was different between the two lines in ileum and liver, mRNA expression of both 
enzymes were not different in the liver and ileum, indicating a post-translational mechanism 
which may act differently in the two lines of pigs.   
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In conclusion, our results indicate that LRFI pigs seem to have a more robust 
intestinal and liver endotoxin detoxification and higher active anti-microbial enzymes 
including ALP, ileum lysozyme and the inflammatory mediator enzyme myeloperoxidase, 
and that HRFI pigs seem to be undergoing a greater level of basal inflammation. Although 
lower serum endotoxin and the associated decreased inflammatory markers and the enhanced 
activities of antimicrobial enzymes in the LRFI pigs may not explain the line difference in 
FE wholly, it has the potential to be a significant contributing factor. Further studies are 
needed to identify other mechanisms that contribute to the lower endotoxin levels in the 
LRFI pigs and how this is associated with their higher FE.  
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Figure 1. Circulating serum endotoxin levels in pigs divergently selected for high (HRFI) or 
low (LRFI) residual feed intake. N= 12 pigs/line. 
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Figure  2. Serum haptoglobin concentration in pigs divergently selected for high (HRFI) or 
low (LRFI) residual feed intake. N= 12 pigs/line.  
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Figure  3. Ileum myeloperoxidase activity in pigs divergently selected for high (HRFI) or 
low (LRFI) residual feed intake. N= 12 pigs/line.  
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Figure  4. Ileum interleukin 8 protein concentration in pigs divergently selected for high 
(HRFI) or low (LRFI) residual feed intake. N= 12 pigs/line. 
 
 
 
 
 
 
 
 
 
 
0.0
0.5
1.0
1.5
2.0
2.5
In
te
rl
eu
ki
n-
8
(µ
g/
g 
pr
ot
ei
n)
HRFI          LRFI
P = 0.062
179 
 
 
 
 
 
 
 
Figure 5. Liver and Ileum alkaline phosphatase activity in pigs divergently selected for high 
(HRFI) or low (LRFI) residual feed intake. N= 6 pigs/line.  
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Figure 6.  Liver and ileum lysozyme activity in pigs divergently selected for high (HRFI) or 
low (LRFI) residual feed intake. N= 6 pigs/line.  
 
 
 
 
 
 
 
 
 
0
5
10
15
20
Liver Ileum
Ly
so
zy
m
e 
ac
tiv
ity
 
(U
/m
g 
pr
ot
ei
n) HRFI
LRFI
P < 0.01
P = 0.25
 
 
 
 
181 
 
 
Table 1. Primer sequences for quantitative real-time PCR 
Target gene Sense (5'- 3') Antisense (5'- 3') 
AOAH (159 bp) TCAGGGGGACAGAAATATGG CCAGAATCACGCAGAATCAC 
Lysozyme (NM_214392.2; 80 bp) CGGTGCGAGTTCGCCAGAATTC AAACACACCCAGTTCGCCAGGC 
Intestinal alkaline phosphatase  
(XM_003133729; 139 bp) 
 
GTCAGAACGGAGTTCGGAAG 
 
AGGCCCATGAGGTGTGTTAC 
Claudin 3 (NM_001160075; 95 bp) CATCGGCAGCAGCATTATC ACACTTTGCACTGCATCTGG 
Claudin 4 (NM_001161637.1; 110 bp) AGGTGATGGGTATCGCCCTGGC CGACGTGACGATGTTGCTGCC 
Occludin (NM_00163647; 115 bp) ATCCTGGGTGTGATGGTGTT ACTGGTTGCAGAGGGCATAG 
β-2-Microglobulin TGGTCTTTCTACCTTCTGGTCC TGTGATGCCGGTTAGTGGTCTC 
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Table 2. Intestinal integrity is not altered in gilts divergently selected for low (LRFI) and high (HRFI) residual feed intake 
Parameters 
Ileum Colon 
SEM 
P-value 
LRFI1 HRFI1 LRFI1 HRFI1 Line Tissue Line*Tissue 
TER2 (Ω/cm2) 108 103 78 73 13.9 0.66 0.04 0.99 
FITC-Dextran3 (Papp) 0.48 0.52 0.13 0.19 0.09 0.15 <0.001 0.50 
FITC-LPS3 (Papp) 2.76 3.63 3.95 3.39 0.72 0.83 0.54 0.35 
1 n=6 pigs/line.  
2 Transepithelial resistance (TER). 
3Papp=Apparent permeability coefficient (µg/mL/min/cm). 
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Table 3. Ileum tight junction protein gene expression pigs selected for high (HRFI) or low 
residual feed intake (LRFI). 
 
Gene   HRFI1,2 LRFI1,2 SEM P-value 
Claudin 3 14.76 14.41 0.530 0.65
Claudin 4   8.09   8.00 0.874 0.94 
Occludin 13.75 12.01 0.936 0.22 
1 N=6 pigs/line.  
2 Mean gene expression (ΔΔCT) from β-2-microglobulin housekeeper. 
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Table 4. Lipopolysaccharide and Gram positive bacteria detoxification mRNAs in pigs 
divergently selected for high (HRFI) and low (LRFI) residual feed intake 
 
 
 
 
 
 
 
 
 
1 N=6 pigs/line.  
2 Mean gene expression (ΔΔCT) from β-2-microglobulin housekeeper. 
 
 
 
Gene  HRFI1,2  LRFI1,2 SEM P-value 
Liver Acyloxyacyl hydrolase    5.38    6.34  0.87 0.30 
Ileum Acyloxyacyl hydrolase    7.45    6.98  0.35 0.37 
Ileum Lysozyme    8.22    7.41  0.97 0.57 
Ileum Alkaline Phosphatase  12.38  11.97  0.77 0.71 
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Table 5.  Residual correlations of performance parameters, endotoxin transport and serum concentration, and alkaline phosphatase 
in gilts divergently selected for residual feed intake1 
 ADFI2  ADG2 Gain:Feed2 RFI 
Index3 
Serum 
endotoxin2 
Ileum 
Endotoxin 
permeability2 
Ileum Alkaline 
Phosphatase2  
Ileum 
Lysozyme2 
ADFI1 1.000 0.35 
0.003 
-0.58 
0.003 
0.65 
0.0008 
0.57 
0.003 
0.50 
0.10 
-0.45 
0.14 
-0.21 
0.49 
ADG1  1.00 0.55 
0.006 
0.02 
0.92 
0.14 
0.52 
-0.29 
0.35 
0.28 
0.38 
0.40 
0.20 
Gain:Feed1   1.00 -0.55 
0.007 
-0.40 
0.052 
-0.47 
0.13 
0.47 
0.12 
0.34 
0.27 
RFI Index2    1.00 0.34 
0.13 
0.57 
0.052 
-0.43 
0.17 
-0.26 
0.41 
Serum 
endotoxin1 
    1.00 0.66 
0.019 
-0.63 
0.027 
-0.43 
0.16 
Ileum 
Endotoxin 
permeability1 
     1.00 -0.40 
0.19 
-0.49 
0.105 
Ileum Alkaline 
Phosphatase1 
      1.00 0.25 
0.43 
Ileum 
Lysozyme2 
       1.00 
 
1Upper row = residual correlations. Bottom row = P ‐ values. 
2ADFI = kg/d, ADG = g/d, Serum endotoxin = EU/mL, Ileum Endotoxin permeability = Papp, Ileum Alkaline Phosphatase = mU/mg; Ileum 
Lysozyme = U/mg. 
3Residual feed intake (RFI) = adfi‐β1(ontest wt deviation)+β2(offtest wt deviation)+β3(metabolic mid‐wt)+β4(adg)+β5(offtest backfat) 
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CHAPTER 7.  GENERAL CONCLUSIONS 
A multitude of factors affect the health and production performance of farm animals 
and human health and wellbeing. Lipopolysaccharide and its associated inflammation is one 
such factor that has received much attention. This thesis research provided further 
understanding into the mechanism by which LPS enters the body and its ability to induce 
inflammation as well as the impact dietary fat has on modulation of intestinal LPS 
permeability and signaling. A particular emphasis was placed on the role DHA and EPA n-3 
PUFA have on these processes. 
Recent evidence suggests that high caloric and high dietary fat increases serum LPS 
concentration and induce acute low grade inflammation, a predisposing factor for common 
metabolic diseases such as obesity, insulin resistance and atherosclerosis (Erridge et al., 
2007; Ghanim et al., 2010). In Chapter 3 of this thesis, we first sought to explore whether 
fatty acid composition of common household dietary oils differentially modulates intestinal 
LPS permeability using in vivo and ex vivo pig models. Dietary oils were orally administered 
to pigs and postprandial serum LPS concentration determined. Additionally, freshly isolated 
ileum tissues were pretreated ex vivo in modified Ussing chambers with different dietary oils 
and FITC-LPS permeability was assessed.  These experiments indicated that oils rich in n-3 
PUFA, such as fish and cod liver oil decreased postprandial LPS concentration.  Oils rich in 
saturated fatty acids, such as coconut oil, increased the ileum LPS permeability. However, 
oils rich in monounsaturated fatty acids, i.e. corn oil and olive oil, did not alter LPS 
permeability or circulating LPS concentration. Interestingly, corn oil has been previously  
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Figure 1. Schematic representation of lipopolysaccharide (LPS) intestinal permeability and 
systemic signaling under normal, n-3 PUFA supplemented and LPS challenge conditions. 
Under normal conditions, lipid rafts are enriched with cholesterol, n-6 and saturated fatty 
acids and they are stable or ordered to facilitate membrane signaling. Lipopolysaccharide 
stimulation causes toll-like receptor (TLR)-4 localization into lipid rafts which facilitate 
receptor mediated LPS permeability or signaling. This results in increased pro-inflammatory 
cytokine production and immune activation.  However, n-3 PUFA such as docosahexaenoic 
acid (DHA) and eicosapentaenoic acid (EPA) enrich membrane phospholipids and cause 
lipid rafts to become less ordered and dissociated. This leads to decreased localization of 
TLR4 into the rafts which eventually results in attenuated LPS signaling and 
permeability.  Alternatively, after LPS challenge, decreased localization of TLR4 into raft 
occurs which causes an attenuated inflammatory response and desensitization to subsequent 
LPS. The dotted lines and boxes indicate mechanisms which are not completely understood 
yet. 
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shown to increase postprandial endotoxemia (Cani et al., 2007; Laugerette et al., 2012). This 
discrepancy may be due to the different species of animals used in these papers and divergent 
experimental conditions. Finally, in this Chapter we explored the role of saturated fatty acids 
and lipid raft mediated LPS permeability in ex vivo intestinal segments. We showed that 
saturated fatty acids stabilize the lipid rafts which enhance LPS permeability and dissociation 
of lipid raft lead to decreased saturated fatty acid mediated LPS permeability implicating 
lipid raft’s essential role in LPS permeability.  
Lipopolysaccharide enters the circulation from the intestine through three major 
routes. 1) Receptor mediated endocytosis through toll like receptor (TLR) 4 mediated 
mechanisms; 2) paracellular permeability through tight junctions if the intestine is damaged; 
or 3) postprandial permeability through micelles (Kelly et al., 2012; Tomita et al., 2004). 
Paracellular and micellar mode of entry may not account completely for the decreased LPS 
permeability we observed with dietary n-3 PUFA in Chapter 3. To explore the mechanisms 
by which of n-3 PUFA attenuate intestinal LPS permeability, we raised pigs on either a corn-
soybean or EPA and DHA enriched diets (Chapter 4). Thereafter, we stimulated an 
inflammatory response in these pigs with LPS and measured their inflammatory parameters. 
These data suggest n-3 PUFA attenuated the LPS induced febrile and inflammatory response. 
This work agrees with research by Huang et al in which DHA and EPA reduced LPS 
signaling and inflammation (Huang et al., 2012).  
Interestingly, n-3 PUFA supplemented pigs also had lower endogenous circulating 
LPS concentration and reduced ex vivo intestinal LPS permeability (Chapter 4). Intestinal 
epithelial cells are part of innate immune system and express TLRs similar to immune cells 
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such as macrophages (Abreu, 2010). In macrophages, DHA attenuated LPS mediated 
immune signaling by preventing the localization of the LPS receptor TLR4 into the cell 
membrane lipid raft microdomains (Fan et al., 2004; Wong et al., 2009). Therefore, we 
explored whether the same phenomena might be exhibited in the intestinal epithelium and 
that n-3 PUFA dissociation of the lipid raft order may explain attenuated transcellular LPS 
permeability. Lipid raft from the intestinal epithelium were isolated and the LPS signaling 
and permeability proteins (TLR4 and CD14) localization into lipid rafts were measured. 
Herein, we report that dietary n-3 PUFA enrichment decreased localization of TLR4 and 
CD14 in the lipid rafts. Phospholipid fatty acid composition of the lipid raft fractions 
revealed the enrichment of phosphatidyl ethanolamine and phosphatidyl serine with DHA 
and EPA which has the potential to dissociate the lipid rafts and prevent the localization of 
proteins (Fan et al., 2003). Therefore, n-3 PUFA enrichment associated destabilization and 
dissociation of the lipid raft results in decreased LPS signaling and permeability which might 
account for the decreased LPS permeability and circulating LPS concentrations in our pig 
models. 
An acute systemic inflammatory challenge resulted in the removal of intestinal TLR4 
and CD14 from the lipid rafts of control pigs making the animal vulnerable to any further 
immune challenge whereas n-3 PUFA supplemented pigs had TLR4 and CD14 still present 
in the rafts giving the advantage of defending the next immune challenge. Our results 
indicate that enrichment of intestinal epithelial cell membrane phospholipids with n-3 PUFA 
destabilizes and dissociates the lipid raft resulting in decreased LPS signaling and 
permeability.   
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Long term supplementation of high dietary saturated fat shifts the microbial 
population of the intestine resulting in the death of gram negative bacteria in large numbers 
which subsequently become sources of serum LPS as well as decreasing the beneficial gram 
positive bacteria which would contribute to gram negative bacterial overgrowth (Cani et al., 
2007; Kim et al., 2012; Laugerette et al., 2012). Interestingly, long term n-3 PUFA 
supplementation has not been shown to change the microbial population of the intestine 
(Geier et al., 2009; Li et al., 2011).  So, in our study n-3 PUFA supplementation may not 
have shifted the microbial population towards more Gram negative organisms which might 
have led to more LPS production. The differences we observed with regard to the serum LPS 
might have come mostly from differences in intestinal TLR4 localization in the lipid rafts 
and transcellular LPS permeability. 
Maternal supplementation of n-3 PUFA during gestation and lactation has been 
shown to have beneficial effects in the offspring immediately after birth as well as later in 
life such as increasing IQ and controlling obesity and neutrophil infiltration (Helland et al., 
2003; Taylor and Poston, 2007). In Chapter 5 of our research we examined the effect of 
maternal n-3 PUFA supplementation during both gestation and lactation modulating LPS 
induced inflammation later in life. Maternal n-3 PUFA supplementation had an anti-
inflammatory effect which is almost equivalent to the continuously supplemented pigs. 
Maternal n-3 PUFA supplementation induced  the n-3 PUFA enrichment of buffy coat, 
decreased the febrile response, decreased the serum cytokine levels for TNF-α and mRNA 
abundance of cytokines TNF-α, IL-1β and IL-10 in buffy coat cells. Further supplementation 
also decreased expression of LPS signaling proteins including TLR4, CD14 and Myd88 in 
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buffy coat cells under LPS challenge. Our research indicates that maternal supplementation 
with n-3 PUFA provides protective advantages against inflammation later in life.   
To understand the relationship between intestinal barrier integrity, endotoxin and 
inflammation with feed efficiency, in Chapter 6 we used pigs divergently selected for 
residual feed intake (RFI, with low RFI being more efficient compared to high RFI). These 
two lines of pigs provide an excellent model to study the physiological mechanisms behind 
feed efficiency in pigs.  HRFI pigs exhibited a greater level of basal inflammation compared 
to their LRFI counterparts. Furthermore, the LRFI pigs had lower circulating endotoxin 
concentration and more robust LPS detoxification and anti-microbial enzyme machinery. 
Chronic immune stimulation like persistent presence of higher endotoxin in the serum has the 
potential to divert nutrients away from anabolic processes to immune functions resulting in 
reduced growth (Buchanan and Johnson, 2007; Gabler and Spurlock, 2008). Lower 
endotoxin and inflammatory markers and the enhanced activities of antimicrobial enzymes in 
the LRFI line may not fully explain the difference in the feed efficiency between the lines; 
but they have the potential to prevent the growth potential in HRFI pigs. 
Overall, this research lays the foundation for several hypothesis driven objectives 
which will have immense beneficial effects for humans and livestock. The first line of 
research could be to measure the exact contribution of LPS and its associated inflammation 
on feed efficiency, appetite and lean tissue accretion in livestock. This work could be done 
with animals of same genetic background and raised in germ free environment administered 
with a known dose(s) of LPS.  
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A second line of research could identify the changes in intestinal bacterial populations 
and their contribution to endotoxemia. Little is known about the effects of dietary fats on 
intestinal microbiota. Metagenomic and bacteria viability assays could be used to determine 
the dynamic shift in bacterial populations during fatty acid administration. Further, whether 
processed oils have the same biological effects as unprocessed oils should also be 
investigated as cooking at high temperatures is known to degrade unsaturated fatty acids 
which might have a different biological function and also has the potential for negative health 
consequences.  
Thirdly, one could identify the exact percentage of n-3 PUFA need to be 
supplemented to give the beneficial anti-inflammatory effects and also does not compromise 
the carcass quality. Further, studying immune cell infiltration into the intestinal epithelium 
and the extent of intestinal inflammation contributes towards intestinal integrity and function 
warrants more attention. Further, investigation of mechanisms of anti-inflammatory effect of 
n-3 PUFA in the intestine will have beneficial effects and therapeutic applications in two 
most important human intestinal diseases like infectious bowel disease and ulcerative colitis.  
Finally, Mechanism of n-3 PUFA epigenetic modifications during maternal 
supplementation and the anti-inflammatory effect in the offspring of n-3 PUFA could also be 
a potential avenue for research. Changes in methylation pattern through binding assays, 
assessing chromatin remodeling through histone modifications using chromatin immune 
precipitation assay as well as deep sequencing for identifying single nucleotide 
polymorphisms under n-3 PUFA supplementation can be carried out.  
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In conclusion, this dissertation presented evidence that the presence of LPS is 
correlated to feed efficiency. Furthermore, dietary fat in particular saturated and n-3 PUFA 
differentially modulates intestinal LPS permeability and signaling. These fatty acids appear 
to play a critical role in lipid raft mediated signaling and assembly of signaling proteins. By 
studying the role of lipid rafts and dietary fatty acids in LPS and bacterial pathogenesis, gives 
us opportunities to better understand, prevent and treat disease and inflammation. This 
research will then enable us to improve livestock performance and human health and 
wellbeing. 
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APPENDIX: ABSTRACTS SUBMITTED 
  The modulation of intestinal endotoxin transport by different dietary fats 
Venkatesh Mani1,3 and Nicholas K. Gabler1,2 
1Department of Animal Science, 2Nutrition and Wellness Research Center (NWRC), 
3Interdepartmental Toxicology Graduate Program, Iowa State University, Ames, IA, 50010 
Experimental Biology, Anaheim, CA, April, 2010,  
 Intestinal derived endotoxin and the subsequent endotoxemia are considered to be 
major predisposing factors for diseases such as atherosclerosis, sepsis, obesity and diabetes. 
Therefore, the aim of this study was to assess the effects of dietary fat on intestinal endotoxin 
transport. We hypothesized that saturated fat (SF) would augment, while n-3 fatty acids (FA) 
would attenuate endotoxin transport across the small intestine of pigs. Eleven pigs (three-four 
weeks of age) were euthanized and jejunum segments were mounted in modified Ussing 
chambers. Segments were treated with either no oil (CON), 12.5% (v/v) vegetable oil (VO), 
DHA (DO), cod liver oil (CLO), coconut oil (CO) or olive oil (OO) in 20 mM bile acid. Ex 
vivo endotoxin transport was measured by the addition of fluoroscein isothiocyanate labeled 
lipopolysaccharide (FITC-LPS, 20 µg/mL) and serial sampling of the mucosal and serosal 
chambers. Fluorescence was measured in a plate reader and an apparent permeability 
coefficient (Papp) was calculated using the surface area and transport rate. Compared to the 
CON, DO and CLO reduced the endotoxin Papp by 50% (P<0.01). However, versus the 
CON, CO increased the Papp by 60% (P=0.008). OO and VO Papp were not different from 
the CON. Overall, these data indicate that fat high in n-3 FA can attenuate intestinal 
endotoxin transport, while SF augments endotoxin transport. This work was supported by the 
USDA and NWRC.  
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Dietary n-3 fatty acids attenuates colon endotoxin transport in growing pigs 
 
Venkatesh Mani 1,, Nicholas Boddicker 1,, Emily Kuntz 1,, Allison Flinn 1,, Joel Spencer 12 
and Nicholas Gabler1 
1Iowa State University, Ames, IA, 2JBS United, Sheridan IN, 3USDA-ARS, Ames, IA. 
Midwest Animal Science Meeting, Des Moines, IA, March, 2010 
                   Intestinal absorption of the bacterial endotoxin plays an important role in the 
development of intestinal dysfunction, inflammation, peripheral tissue catabolism and 
reduced pig performance by activating the immune system. However, the ability of dietary n-
3 fatty acids (FA), such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), to 
regulate intestinal endotoxin transport in growing pigs is unknown. Therefore, this study 
aimed to evaluate the ability of dietary n-3 FA to attenuate large intestine endotoxin transport 
and circulating endotoxin levels in growing pigs under basal or immune challenged 
conditions. Ten pigs (22±2.4 kg BW) were fed one of two diets, either a standard corn-
soybean control diet (CON) or the CON plus 0.5% Gromega™ (JBS United Inc., Sheridan, 
IN), which was high in DHA and EPA (GRO). After 8 weeks of feeding, the CON and GRO 
groups were sub-divided and challenged (n=5 pigs/trt) with an intramuscular injection of 
either saline (SAL) or lipopolysaccharide (CH; LPS 10 µg/kg BW). The febrile response was 
measured by rectal temperature hourly, blood was collected at 0 and 4 h for serum endotoxin 
levels and the pigs were euthanized 4 hrs post-challenge. Segments of the mid-colon were 
isolated, flushed and mounted in modified Ussing chambers to measure ex vivo FITC-LPS 
endotoxin transport and an apparent permeability coefficient (Papp) was calculated using the 
area of the membrane and transport rate. Average rectal temperatures tended to be reduced in 
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the GRO vs CON pigs, P<0.055. Furthermore, CON pigs had higher endotoxin transport 
compared to the GRO pigs (7.4 vs 2.0, respectively, P=0.02).  Irrespective of diet, CH 
lowered the endotoxin transport compared to the SAL pigs (P=0.02). There is significant 
difference between CON-SAL and GRO-SAL colon Papp (11.4 vs 3.3, respectively, P<0.01), 
however, there were no differences between the CON-CH and GRO-CH pigs. Four hour 
post-challenge serum endotoxin level tended to five-fold higher in the CON vs GRO pigs 
(P=0.07). Overall, these data indicate that n-3 FA may mitigate colon transport and serum 
levels of endotoxin 
 
 
 
 
 
 
 
 
 
 
 
198 
 
 
 
Bitter compounds decrease gastric emptying and influence intestinal nutrient transport 
Venkatesh Mani1’4, James Hollis2,3 and Nicholas K. Gabler1, 3,4 
1Department of Animal Science, 2Department of Food Science and Human Nutrition, 
3Nutrition and Wellness Research Center, 4Interdepartmental  Toxicology Program, Iowa 
State University, Ames, IA, 50010 
Experimental Biology, Washington D.C, April, 2011. 
                Taste alters food perception and may contribute to body weight regulation. Bitter 
taste receptor expression has been demonstrated in the tongue, stomach, intestine, and lung. 
Bitter compounds increase intestinal hormone secretions of GLP-1, PYY, GIP and CCK, 
which are associated with gastric emptying, intestinal motility and satiety.  Therefore, the 
aim of this study was to assess the effect of bitter compounds on gastric emptying (GE) and 
nutrient transport (NT) in pigs. Sixteen pigs (35±3 kg body weight) were fasted overnight 
and fed a 600 g meal that was either a control meal or an identical meal containing 1 mM 
phenylthiocarbamide (PTC). Exactly 45 min after completing the meal, all pigs were 
euthanized and the weight of gastric contents measured. Further, jejunum segments were 
excised and mounted into modified Ussing chambers for NT. The jejunum was pre-treated 
for 30 minutes with or without 5 mM PTC before measuring glucose, lysine and glutamine 
transport.  All pigs ate their respective meal. However, the PTC meal decreased gastric 
emptying by 30% compared to the control (P < 0.01). Glucose, lysine and glutamine NT was 
increased by 250% compared to the control pigs (P<0.05). However, ex vivo jejunum pre-
treatment with PTC had no effect on NT (P > 0.1). Overall, these data indicate that feeding 
PTC decreases GE and increases NT in the intestine, but localized exposure of the intestine 
to PTC doesn’t have any effect.  
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The effects of immune stressors on porcine intestinal epithelial cell integrity and 
inflammation 
V. Mani1, S.C. Pearce1, A. J.Harris1, T.E. Weber 2 and N.K. Gabler1 
1Department of Animal Science, 2USDA-ARS, Ames, IA, Iowa State University, Ames, IA 
Digestive Physiology of Pigs, Keystone, Colorado, June, 2012 
Intestinal epithelial cells continually encounter luminal pathogens, immunogens and toxins. 
However, data regarding the effects of these substances on intestinal integrity and function in 
pigs are limited. Our study objective was to examine the effect of immunogens on barrier 
integrity and inflammation in IPEC-J2 cells. Cells were plated on 0.4 µm pore size collagen 
coated transwells, where they form a single confluent monolayer, polarize and form tight 
junctions (TJ). The transepithelial electrical resistance (TER) was measured to evaluate TJ 
formation and integrity along with FITC-Dextran (FD, 4 kDa) macromolecule permeability. 
When the cells attained peak TER, approximately 9 days post confluence, cells were treated 
with the immune agonists lipopolysaccharide (LPS, 10 µg/ml, E.coli 055:05), PolyI:C (PIC, 
20 µg/ml), zymosan (ZYM, 100 µg/ml) and deoxynivalenol (DON, 20 µm) on the luminal 
side, or with tumor necrosis factor α (TNFα) and interleukin 1β (IL1β) on the basolateral side 
for 48 hours. The TER and FD permeability was assessed for membrane integrity. Interleukin 
8 (IL-8) secreted into the media was measured as a marker of inflammation. After 48 h of 
DON or TNFα treatment, TER was significantly reduced compared to the non-challenged 
control (P<0.05; 53 and 63%, respectively). The TER was not different from the control 
when cells were exposed to ZYM, PIC or IL1β. Further, FD permeability did not differ 
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between the treatments.  Compared to the control, media IL-8 concentrations were increased 
by TNFα and LPS (P<0.05; 0.03, 2.68 and 0.96 ng/ml, respectively).  Treatment with PIC 
and ZYM did not increase IL-8 secretion (P>0.10; 0.61 and 0.31 ng/ml respectively). These 
data indicate that IPEC-J2 cells are particularly responsive to inflammation and barrier 
integrity modifications induced by DON, TNFα and LPS. However, barrier integrity appears 
to be maintained under most challenge conditions.   
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Lipopolysaccharide and n-3 fatty acids alter intestinal Toll like receptor 4 (TLR4) 
recruitment and function 
V. Mani1, J.D. Spencer2, J. Hollis1, T.E. Weber 3 and N.K. Gabler1 
1Iowa State University, Ames, IA, 2JBS United, Sheridan IN, 3USDA-ARS, Ames, IA. 
Digestive Physiology of Pigs, Keystone, Colorado, June, 2012 
Previously we reported that dietary n-3 fatty acids (FA) decrease intestinal 
lipopolysaccharide (LPS) transport (LT) and serum endotoxin in pigs. Endotoxin or LPS is 
recognized by TLR4 to initiate an innate immune response. Localization of TLR4 to lipid raft 
(LR) membrane micro domains is critical for cellular LT and signaling in numerous cells. 
Our objective was to examine the effects of n-3 FA and LPS on intestinal TLR4 LR 
recruitment and LT. Twenty pigs (22±2.4 kg) were fed two diets: 1) control (CON); 2) CON 
plus 0.5% Gromega™ (GRO, JBS United Inc.), high in docosahexaenoic acid (DHA) and 
eicosapentaenoic acid (EPA) n-3 FA. After eight weeks, the CON and GRO pigs were 
challenged (n=5 pigs/trt) with either an I.M. injection of E. coli LPS (CH; 10 µg/kg BW) or 
saline (SAL). Four hours after CH or SAL, pigs were euthanized and ileum and colon 
segments mounted into Ussing chambers to measure ex vivo FITC-LPS apparent 
permeability coefficient (Papp) as a marker of LT. Ileum and colon mucosa were assessed for 
n-3 FA enrichment, LR isolated and membrane localization of TLR4 determined. Compared 
to the CON, pigs fed GRO had increased ileum and colon EPA, DHA and total n-3 FA 
content (P<0.05; 200, 250, 300%, respectively). Overall, ileum LT did not differ due to FA 
or CH treatments. However, GRO-SAL treated pigs tended to have decreased LT by 37% 
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compared to the CON-SAL pigs (P=0.06). Pigs injected with CH had attenuated colon LT 
(P=0.02). Pigs fed GRO also had reduced colon LT compared to the CON (P=0.03; 2.0 vs. 
7.4 Papp, respectively). Compared to CON-SAL treated pigs, ileum and colon TLR4 
recruitment into LR micro domains was decreased in the GRO-SAL pigs. However, CH 
reduced ileum LR TLR4 protein in CON, but not GRO fed pigs.  Localization of TLR4 into 
LR didn’t differ in the colon of CON-CH and GRO-CH treatment groups. These data 
indicate that n-3 FA decrease TLR4 recruitment into intestinal LR. This may explain how 
DHA and EPA attenuate receptor mediated LT and LPS induced febrile response. 
Furthermore, reduced LR localization of TLR4 post CH, may describe an LPS tolerance 
mechanism. 
 
 
